
<!DOCTYPE html>
<html class="ArticlePage" lang="en-US"
 data-lead="nested">
    <head>
    <meta charset="UTF-8">

    <meta property="og:title" content="Genentech Presents New Data for Ocrevus and Fenebrutinib Across Broad Patient Populations at ECTRIMS 2025">

    <meta property="og:url" content="https://www.biospace.com/press-releases/genentech-presents-new-data-for-ocrevus-and-fenebrutinib-across-broad-patient-populations-at-ectrims-2025">

    
        <meta property="og:image" content="https://static.biospace.com/dims4/default/d32393a/2147483647/strip/true/crop/1120x630+40+0/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fcc%2F88%2Fa9fddaf440db946b77e1d45d2e26%2Fbiospace-5.png">
    
        
        <meta property="og:image:url" content="https://static.biospace.com/dims4/default/d32393a/2147483647/strip/true/crop/1120x630+40+0/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fcc%2F88%2Fa9fddaf440db946b77e1d45d2e26%2Fbiospace-5.png">
        
        <meta property="og:image:width" content="1440">
        <meta property="og:image:height" content="810">
        <meta property="og:image:type" content="image/png">
        
    


    <meta property="og:site_name" content="BioSpace">



    <meta property="og:type" content="article">

    <meta property="article:published_time" content="2025-09-24T10:30:52.188">

    <meta property="article:modified_time" content="2025-09-24T10:30:52.188">

    <meta property="article:section" content="Press Releases">

    <meta property="article:tag" content="Multiple sclerosis">

    <meta property="article:tag" content="Northern California">

    <meta property="article:tag" content="Data">

    <meta property="article:tag" content="Phase II">

    <meta property="article:tag" content="Events">

    
    <meta name="twitter:card" content="summary_large_image"/>
    
    
    
    
    

    
    
    <meta name="twitter:site" content="@biospace"/>
    
    
    
    <meta name="twitter:title" content="Genentech Presents New Data for Ocrevus and Fenebrutinib Across Broad Patient Populations at ECTRIMS 2025"/>
    

    <meta property="fb:app_id" content="2120989681618413">

<link rel="alternate" href="https://www.biospace.com/press-releases/genentech-presents-new-data-for-ocrevus-and-fenebrutinib-across-broad-patient-populations-at-ectrims-2025" hreflang="en-US" /><style type="text/css">:root {
    

    
    
    
    
    --color-border-theme: #EFEFEF;
    

    
    
    
    

    
    

    
    

    --color-footer-bg-theme: #222222;
    --color-footer-text-theme: #ffffff;

    --color-link-text-theme: #222222;
    

    --color-button-bg-theme: #D02C24;
    --color-button-border-theme: #D02C24;
    
    
    
    --color-button-hover-text-theme: #D02C24;
    

    
    
    

    
    
}
</style>
    <style type="text/css">:root {
            --button-border-radius:0;
        }
</style>
    <style type="text/css">:root {
  --font-1: "Arial";
  --font-2: "Times";
}

body {
  --font-1: "Helvetica";
  --font-2: "Merriweather";
  --font-page-titles: var(--font-1);
  --font-list-titles: var(--font-1);
  --font-promo-titles: var(--font-1);
  --font-description: var(--font-1);
  --font-quote: Helvetica;
  --font-rte-body: var(--font-1);
}
</style>

    
        <link data-cssvarsponyfill="true" class="Webpack-css" rel="stylesheet" href="https://static.biospace.com/resource/0000018c-e9c4-deef-a1fd-fbfe1e4b0000/styles/default/All.min.94f95c21cb6934fa466e7720e1799a5a.gz.css">
    <meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1, maximum-scale=5"><title>Genentech Presents New Data for Ocrevus and Fenebrutinib Across Broad Patient Populations at ECTRIMS 2025 - BioSpace</title><link rel="canonical" href="https://www.biospace.com/press-releases/genentech-presents-new-data-for-ocrevus-and-fenebrutinib-across-broad-patient-populations-at-ectrims-2025"><meta name="brightspot.contentId" content="00000199-7a85-d809-a1fd-7aa7ca300001"><link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png">
<link rel="icon" type="image/png" href="/favicon-32x32.png">
<link rel="icon" type="image/png" href="/favicon-16x16.png">
<script type="application/ld+json">{"@context":"http://schema.org","@type":"","@graph":[{"@context":"http://schema.org","@type":"Organization","@id":"https://www.biospace.com/#organization","name":"BioSpace","sameAs":["https://www.facebook.com/biospacecommunity","https://www.linkedin.com/company/biospaceinc/","https://x.com/biospace","https://www.instagram.com/biospacenews/"],"url":"https://www.biospace.com"},{"@context":"http://schema.org","@type":"Website","description":"BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. ","@id":"https://www.biospace.com/#website","inLanguage":"en-US","name":"BioSpace","publisher":{"@id":"https://www.biospace.com/#organization"},"url":"https://www.biospace.com"},{"@context":"http://schema.org","@type":"WebPage","potentialAction":[{"@context":"http://schema.org","@type":"ReadAction","target":"https://www.biospace.com/press-releases/genentech-presents-new-data-for-ocrevus-and-fenebrutinib-across-broad-patient-populations-at-ectrims-2025"}],"breadcrumb":{"@type":"BreadcrumbList","itemListElement":[{"@context":"http://schema.org","@type":"ListItem","item":"https://www.biospace.com/press-releases","name":"Press Releases","position":1}]},"@id":"https://www.biospace.com/press-releases/genentech-presents-new-data-for-ocrevus-and-fenebrutinib-across-broad-patient-populations-at-ectrims-2025/#webpage","inLanguage":"en-US","name":"Genentech Presents New Data for Ocrevus and Fenebrutinib Across Broad Patient Populations at ECTRIMS 2025","isPartOf":{"@id":"https://www.biospace.com/#website"},"datePublished":"2025-09-24T10:30:52.188Z","dateModified":"2025-09-24T10:30:52.188Z","url":"https://www.biospace.com/press-releases/genentech-presents-new-data-for-ocrevus-and-fenebrutinib-across-broad-patient-populations-at-ectrims-2025"}]}</script>

    <!-- this will add webcomponent polyfills based on browsers. As of 04/29/21 still needed for IE11 and Safari -->
    <script src="https://static.biospace.com/resource/0000018c-e9c4-deef-a1fd-fbfe1e4b0000/webcomponents-loader/webcomponents-loader.ce44f83d1399e8dd41e607b70e0642c9.gz.js"></script>

    <script>
        /**
            This allows us to load the IE polyfills via feature detection so that they do not load
            needlessly in the browsers that do not need them. It also ensures they are loaded
            non async so that they load before the rest of our JS.
        */
        var head = document.getElementsByTagName('head')[0];
        if (!window.CSS || !window.CSS.supports || !window.CSS.supports('--fake-var', 0)) {
            var script = document.createElement('script');
            script.setAttribute('src', "https://static.biospace.com/resource/0000018c-e9c4-deef-a1fd-fbfe1e4b0000/util/IEPolyfills.min.4e804e24ca7aa61e14b66eca853bb6e7.gz.js");
            script.setAttribute('type', 'text/javascript');
            script.async = false;
            head.appendChild(script);
        }
    </script>
    
        <script src="https://static.biospace.com/resource/0000018c-e9c4-deef-a1fd-fbfe1e4b0000/styles/default/All.min.70d1582aa00eb7aead2f561f7849658d.gz.js" async></script>
    <script async="async" src="https://securepubads.g.doubleclick.net/tag/js/gpt.js"></script>

<script type="text/javascript">
    // Google tag setup
    var googletag = googletag || {};
    googletag.cmd = googletag.cmd || [];

    googletag.cmd.push(function () {
        googletag.pubads().enableSingleRequest()
        googletag.pubads().enableAsyncRendering()
        googletag.pubads().disableInitialLoad()
        googletag.enableServices()
    })

    // setup of ad slots
    var dfpAdSlotsObject = {}
    var dfpAdSlots = []
    var staticAdSlots = []
</script>
<link rel="preconnect" href="https://connect.facebook.net">
<script>
  window.fbAsyncInit = function() {
      FB.init({
          
              appId : '2120989681618413',
          
          xfbml : true,
          version : 'v2.9'
      });
  };

  (function(d, s, id){
     var js, fjs = d.getElementsByTagName(s)[0];
     if (d.getElementById(id)) {return;}
     js = d.createElement(s); js.id = id;
     js.src = "//connect.facebook.net/en_US/sdk.js";
     fjs.parentNode.insertBefore(js, fjs);
   }(document, 'script', 'facebook-jssdk'));
</script>
<script>var script = document.createElement('script');
script.async = true;
script.src = 'https://analytics.ahrefs.com/analytics.js';
script.setAttribute('data-key', 'ijoT0Tuv31/VTArPbpYiGg');
document.getElementsByTagName('head')[0].appendChild(script);</script>
<script>window.dataLayer = window.dataLayer || [];
const pageType = document.documentElement.className || 'Page';

window.dataLayer.push({
    event: 'gtm_data_load',
    page_type: pageType
});</script>
<link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com">
    <script>
        var link = document.createElement('link');
        link.setAttribute('href', '//fonts.googleapis.com/css?family=Helvetica:300,400,700|Merriweather:300,400,700&display=swap');
        var relList = link.relList;

        if (relList && relList.supports('preload')) {
            link.setAttribute('as', 'style');
            link.setAttribute('rel', 'preload');
            link.setAttribute('onload', 'this.rel="stylesheet"');
            link.setAttribute('crossorigin', 'anonymous');
        } else {
            link.setAttribute('rel', 'stylesheet');
        }

        head.appendChild(link);
    </script>

    
    
    <!-- Google Tag Manager -->
    <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
                new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
            j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
            'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
    })(window,document,'script','dataLayer','GTM-NBF2TMB');</script>
    <!-- End Google Tag Manager -->

</head>


    <body class="Page-body">
        
    <!-- Google Tag Manager (noscript) -->
    <noscript>
        <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NBF2TMB" height="0" width="0" style="display:none;visibility:hidden">
        </iframe>
    </noscript>
    <!-- End Google Tag Manager (noscript) -->



<svg xmlns="http://www.w3.org/2000/svg" style="display:none" id="iconsMap">
    <symbol id="mono-icon-facebook" viewBox="0 0 16 16">
        <path fill-rule="evenodd" clip-rule="evenodd" d="M8.66667 6.16667H10.5L10.2708 8H8.66667V13.5H6.28906V8H5V6.16667H6.28906V4.9349C6.28906 4.13281 6.48958 3.52648 6.89062 3.11589C7.29167 2.70529 7.96006 2.5 8.89583 2.5H10.5V4.33333H9.52604C9.16319 4.33333 8.92925 4.39062 8.82422 4.50521C8.71918 4.61979 8.66667 4.81076 8.66667 5.07812V6.16667Z" />
    </symbol>
    <symbol id="mono-icon-google" viewBox="0 0 16 16">
        <path fill="currentColor" d="M15.545 6.558a9.42 9.42 0 0 1 .139 1.626c0 2.434-.87 4.492-2.384 5.885h.002C11.978 15.292 10.158 16 8 16A8 8 0 1 1 8 0a7.689 7.689 0 0 1 5.352 2.082l-2.284 2.284A4.347 4.347 0 0 0 8 3.166c-2.087 0-3.86 1.408-4.492 3.304a4.792 4.792 0 0 0 0 3.063h.003c.635 1.893 2.405 3.301 4.492 3.301 1.078 0 2.004-.276 2.722-.764h-.003a3.702 3.702 0 0 0 1.599-2.431H8v-3.08h7.545z"/>
    </symbol>
    <symbol id="mono-icon-instagram" viewBox="0 0 17 17">
        <g>
            <path fill-rule="evenodd"
                d="M8.281 4.207c.727 0 1.4.182 2.022.545a4.055 4.055 0 0 1 1.476 1.477c.364.62.545 1.294.545 2.021 0 .727-.181 1.4-.545 2.021a4.055 4.055 0 0 1-1.476 1.477 3.934 3.934 0 0 1-2.022.545c-.726 0-1.4-.182-2.021-.545a4.055 4.055 0 0 1-1.477-1.477 3.934 3.934 0 0 1-.545-2.021c0-.727.182-1.4.545-2.021A4.055 4.055 0 0 1 6.26 4.752a3.934 3.934 0 0 1 2.021-.545zm0 6.68a2.54 2.54 0 0 0 1.864-.774 2.54 2.54 0 0 0 .773-1.863 2.54 2.54 0 0 0-.773-1.863 2.54 2.54 0 0 0-1.864-.774 2.54 2.54 0 0 0-1.863.774 2.54 2.54 0 0 0-.773 1.863c0 .727.257 1.348.773 1.863a2.54 2.54 0 0 0 1.863.774zM13.45 4.03c-.023.258-.123.48-.299.668a.856.856 0 0 1-.65.281.913.913 0 0 1-.668-.28.913.913 0 0 1-.281-.669c0-.258.094-.48.281-.668a.913.913 0 0 1 .668-.28c.258 0 .48.093.668.28.187.188.281.41.281.668zm2.672.95c.023.656.035 1.746.035 3.269 0 1.523-.017 2.62-.053 3.287-.035.668-.134 1.248-.298 1.74a4.098 4.098 0 0 1-.967 1.53 4.098 4.098 0 0 1-1.53.966c-.492.164-1.072.264-1.74.3-.668.034-1.763.052-3.287.052-1.523 0-2.619-.018-3.287-.053-.668-.035-1.248-.146-1.74-.334a3.747 3.747 0 0 1-1.53-.931 4.098 4.098 0 0 1-.966-1.53c-.164-.492-.264-1.072-.299-1.74C.424 10.87.406 9.773.406 8.25S.424 5.63.46 4.963c.035-.668.135-1.248.299-1.74.21-.586.533-1.096.967-1.53A4.098 4.098 0 0 1 3.254.727c.492-.164 1.072-.264 1.74-.3C5.662.394 6.758.376 8.281.376c1.524 0 2.62.018 3.287.053.668.035 1.248.135 1.74.299a4.098 4.098 0 0 1 2.496 2.496c.165.492.27 1.078.317 1.757zm-1.687 7.91c.14-.399.234-1.032.28-1.899.024-.515.036-1.242.036-2.18V7.689c0-.961-.012-1.688-.035-2.18-.047-.89-.14-1.524-.281-1.899a2.537 2.537 0 0 0-1.512-1.511c-.375-.14-1.008-.235-1.899-.282a51.292 51.292 0 0 0-2.18-.035H7.72c-.938 0-1.664.012-2.18.035-.867.047-1.5.141-1.898.282a2.537 2.537 0 0 0-1.512 1.511c-.14.375-.234 1.008-.281 1.899a51.292 51.292 0 0 0-.036 2.18v1.125c0 .937.012 1.664.036 2.18.047.866.14 1.5.28 1.898.306.726.81 1.23 1.513 1.511.398.141 1.03.235 1.898.282.516.023 1.242.035 2.18.035h1.125c.96 0 1.687-.012 2.18-.035.89-.047 1.523-.141 1.898-.282.726-.304 1.23-.808 1.512-1.511z">
            </path>
        </g>
    </symbol>
    <symbol id="mono-icon-mailto" viewBox="0 0 16 16">
        <path d="M14 3H2C1.86739 3 1.74021 3.05268 1.64645 3.14645C1.55268 3.24021 1.5 3.36739 1.5 3.5V12C1.5 12.2652 1.60536 12.5196 1.79289 12.7071C1.98043 12.8946 2.23478 13 2.5 13H13.5C13.7652 13 14.0196 12.8946 14.2071 12.7071C14.3946 12.5196 14.5 12.2652 14.5 12V3.5C14.5 3.36739 14.4473 3.24021 14.3536 3.14645C14.2598 3.05268 14.1326 3 14 3ZM12.7144 4L8 8.32187L3.28562 4H12.7144ZM13.5 12H2.5V4.63688L7.66187 9.36875C7.75412 9.45343 7.87478 9.50041 8 9.50041C8.12522 9.50041 8.24588 9.45343 8.33813 9.36875L13.5 4.63688V12Z" />
    </symbol>
    <symbol id="mono-icon-print" viewBox="0 0 16 16">
        <path d="M13.4169 4.5H12.5V2.5C12.5 2.36739 12.4473 2.24021 12.3536 2.14645C12.2598 2.05268 12.1326 2 12 2H4C3.86739 2 3.74021 2.05268 3.64645 2.14645C3.55268 2.24021 3.5 2.36739 3.5 2.5V4.5H2.58313C1.71 4.5 1 5.17313 1 6V11C1 11.1326 1.05268 11.2598 1.14645 11.3536C1.24021 11.4473 1.36739 11.5 1.5 11.5H3.5V13.5C3.5 13.6326 3.55268 13.7598 3.64645 13.8536C3.74021 13.9473 3.86739 14 4 14H12C12.1326 14 12.2598 13.9473 12.3536 13.8536C12.4473 13.7598 12.5 13.6326 12.5 13.5V11.5H14.5C14.6326 11.5 14.7598 11.4473 14.8536 11.3536C14.9473 11.2598 15 11.1326 15 11V6C15 5.17313 14.29 4.5 13.4169 4.5ZM4.5 3H11.5V4.5H4.5V3ZM11.5 13H4.5V10H11.5V13ZM14 10.5H12.5V9.5C12.5 9.36739 12.4473 9.24021 12.3536 9.14645C12.2598 9.05268 12.1326 9 12 9H4C3.86739 9 3.74021 9.05268 3.64645 9.14645C3.55268 9.24021 3.5 9.36739 3.5 9.5V10.5H2V6C2 5.72438 2.26188 5.5 2.58313 5.5H13.4169C13.7381 5.5 14 5.72438 14 6V10.5ZM12.5 7.25C12.5 7.39834 12.456 7.54334 12.3736 7.66668C12.2912 7.79001 12.1741 7.88614 12.037 7.94291C11.9 7.99968 11.7492 8.01453 11.6037 7.98559C11.4582 7.95665 11.3246 7.88522 11.2197 7.78033C11.1148 7.67544 11.0434 7.5418 11.0144 7.39632C10.9855 7.25083 11.0003 7.10003 11.0571 6.96299C11.1139 6.82594 11.21 6.70881 11.3333 6.6264C11.4567 6.54399 11.6017 6.5 11.75 6.5C11.9489 6.5 12.1397 6.57902 12.2803 6.71967C12.421 6.86032 12.5 7.05109 12.5 7.25Z" />
    </symbol>
    <symbol id="mono-icon-copylink" viewBox="0 0 16 16">
       <path d="M10.3537 5.64624C10.4002 5.69268 10.4371 5.74782 10.4622 5.80852C10.4874 5.86922 10.5003 5.93429 10.5003 5.99999C10.5003 6.0657 10.4874 6.13076 10.4622 6.19146C10.4371 6.25216 10.4002 6.30731 10.3537 6.35374L6.35368 10.3537C6.30723 10.4002 6.25208 10.437 6.19138 10.4622C6.13069 10.4873 6.06563 10.5003 5.99993 10.5003C5.93424 10.5003 5.86918 10.4873 5.80849 10.4622C5.74779 10.437 5.69264 10.4002 5.64618 10.3537C5.59973 10.3073 5.56288 10.2521 5.53774 10.1914C5.5126 10.1307 5.49966 10.0657 5.49966 9.99999C5.49966 9.9343 5.5126 9.86924 5.53774 9.80855C5.56288 9.74785 5.59973 9.6927 5.64618 9.64624L9.64618 5.64624C9.69262 5.59975 9.74776 5.56288 9.80846 5.53771C9.86916 5.51255 9.93423 5.4996 9.99993 5.4996C10.0656 5.4996 10.1307 5.51255 10.1914 5.53771C10.2521 5.56288 10.3072 5.59975 10.3537 5.64624ZM13.4749 2.52499C13.1499 2.19995 12.7641 1.94211 12.3394 1.7662C11.9147 1.59028 11.4596 1.49974 10.9999 1.49974C10.5403 1.49974 10.0851 1.59028 9.66046 1.7662C9.2358 1.94211 8.84994 2.19995 8.52493 2.52499L6.64618 4.40312C6.55236 4.49694 6.49966 4.62419 6.49966 4.75687C6.49966 4.88955 6.55236 5.0168 6.64618 5.11062C6.74 5.20444 6.86725 5.25715 6.99993 5.25715C7.13262 5.25715 7.25986 5.20444 7.35368 5.11062L9.23243 3.23562C9.70299 2.7754 10.336 2.51932 10.9942 2.52294C11.6524 2.52657 12.2826 2.78961 12.7481 3.25498C13.2135 3.72035 13.4767 4.35051 13.4804 5.00869C13.4842 5.66688 13.2282 6.29998 12.7681 6.77062L10.8887 8.64937C10.7949 8.74311 10.7421 8.87027 10.7421 9.0029C10.742 9.13552 10.7946 9.26274 10.8884 9.35656C10.9821 9.45038 11.1093 9.50312 11.2419 9.50318C11.3745 9.50323 11.5017 9.45061 11.5956 9.35687L13.4749 7.47499C13.8 7.14998 14.0578 6.76413 14.2337 6.33947C14.4096 5.91481 14.5002 5.45965 14.5002 4.99999C14.5002 4.54034 14.4096 4.08518 14.2337 3.66052C14.0578 3.23586 13.8 2.85 13.4749 2.52499ZM8.64618 10.8887L6.76743 12.7675C6.53623 13.0039 6.26043 13.1921 5.95601 13.3211C5.65158 13.4502 5.32457 13.5176 4.99392 13.5194C4.66326 13.5212 4.33553 13.4575 4.0297 13.3317C3.72387 13.206 3.44602 13.0209 3.21223 12.7871C2.97844 12.5532 2.79335 12.2754 2.6677 11.9695C2.54204 11.6636 2.47831 11.3359 2.48019 11.0053C2.48207 10.6746 2.54952 10.3476 2.67865 10.0432C2.80777 9.73879 2.996 9.46303 3.23243 9.23187L5.11056 7.35374C5.20438 7.25992 5.25709 7.13268 5.25709 6.99999C5.25709 6.86731 5.20438 6.74006 5.11056 6.64624C5.01674 6.55242 4.88949 6.49971 4.75681 6.49971C4.62413 6.49971 4.49688 6.55242 4.40306 6.64624L2.52493 8.52499C1.86852 9.1814 1.49976 10.0717 1.49976 11C1.49976 11.9283 1.86852 12.8186 2.52493 13.475C3.18135 14.1314 4.07163 14.5002 4.99993 14.5002C5.92824 14.5002 6.81852 14.1314 7.47493 13.475L9.35368 11.5956C9.44742 11.5018 9.50005 11.3746 9.49999 11.242C9.49993 11.1093 9.44719 10.9822 9.35337 10.8884C9.25955 10.7947 9.13234 10.7421 8.99971 10.7421C8.86709 10.7422 8.73992 10.7949 8.64618 10.8887Z" />
    </symbol>
    <symbol id="mono-icon-download" viewBox="0 0 32 32" fill="none">
        <rect x="0.75" y="0.75" width="30.5" height="30.5" rx="15.25" stroke-width="1.5"/>
        <path d="M11.1463 15.3538C11.0524 15.2599 10.9997 15.1327 10.9997 15C10.9997 14.8673 11.0524 14.7401 11.1463 14.6462C11.2401 14.5524 11.3673 14.4997 11.5 14.4997C11.6327 14.4997 11.7599 14.5524 11.8537 14.6462L15.5 18.2931V10C15.5 9.86739 15.5527 9.74021 15.6464 9.64645C15.7402 9.55268 15.8674 9.5 16 9.5C16.1326 9.5 16.2598 9.55268 16.3536 9.64645C16.4473 9.74021 16.5 9.86739 16.5 10V18.2931L20.1462 14.6462C20.1927 14.5998 20.2479 14.5629 20.3086 14.5378C20.3692 14.5127 20.4343 14.4997 20.5 14.4997C20.5657 14.4997 20.6308 14.5127 20.6914 14.5378C20.7521 14.5629 20.8073 14.5998 20.8538 14.6462C20.9002 14.6927 20.9371 14.7479 20.9622 14.8086C20.9873 14.8692 21.0003 14.9343 21.0003 15C21.0003 15.0657 20.9873 15.1308 20.9622 15.1914C20.9371 15.2521 20.9002 15.3073 20.8538 15.3538L16.3538 19.8538C16.3073 19.9002 16.2522 19.9371 16.1915 19.9623C16.1308 19.9874 16.0657 20.0004 16 20.0004C15.9343 20.0004 15.8692 19.9874 15.8085 19.9623C15.7478 19.9371 15.6927 19.9002 15.6462 19.8538L11.1463 15.3538ZM21.5 21H10.5C10.3674 21 10.2402 21.0527 10.1464 21.1464C10.0527 21.2402 10 21.3674 10 21.5C10 21.6326 10.0527 21.7598 10.1464 21.8536C10.2402 21.9473 10.3674 22 10.5 22H21.5C21.6326 22 21.7598 21.9473 21.8536 21.8536C21.9473 21.7598 22 21.6326 22 21.5C22 21.3674 21.9473 21.2402 21.8536 21.1464C21.7598 21.0527 21.6326 21 21.5 21Z" />
    </symbol>
    <symbol id="mono-icon-linkedin" viewBox="0 0 16 16" xmlns="http://www.w3.org/2000/svg">
        <path fill-rule="evenodd" clip-rule="evenodd" d="M5.14286 13V6.57139H3V13H5.14286ZM4.05327 5.14286C4.36804 5.14286 4.62833 5.03995 4.83414 4.83414C5.03995 4.62833 5.14286 4.38015 5.14286 4.08959C5.14286 3.77482 5.04601 3.51453 4.8523 3.30872C4.65859 3.1029 4.40436 3 4.08959 3C3.77482 3 3.51453 3.1029 3.30872 3.30872C3.1029 3.51453 3 3.77482 3 4.08959C3 4.38015 3.09685 4.62833 3.29056 4.83414C3.48426 5.03995 3.7385 5.14286 4.05327 5.14286ZM13 13V9.32649C13 8.42036 12.7768 7.73466 12.3304 7.26935C11.884 6.80404 11.3036 6.57139 10.5893 6.57139C9.82401 6.57139 9.18626 6.91424 8.67605 7.59996V6.71833H6.57146V13H8.67605V9.4367C8.67605 9.1918 8.70156 9.02037 8.75258 8.92241C8.95666 8.43261 9.3138 8.18772 9.82401 8.18772C10.5383 8.18772 10.8954 8.64077 10.8954 9.5469V13H13Z" />
    </symbol>
    <symbol id="download" xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24">
        <g fill="none" fill-rule="evenodd">
            <g>
                <g>
                    <g>
                        <path d="M0 0H24V24H0z"
                            transform="translate(-802.000000, -1914.000000) translate(0.000000, 1756.000000) translate(802.000000, 158.000000)" />
                        <path fill="currentColor" fill-rule="nonzero"
                            d="M12 2C6.49 2 2 6.49 2 12s4.49 10 10 10 10-4.49 10-10S17.51 2 12 2zm-1 8V6h2v4h3l-4 4-4-4h3zm6 7H7v-2h10v2z"
                            transform="translate(-802.000000, -1914.000000) translate(0.000000, 1756.000000) translate(802.000000, 158.000000)" />
                    </g>
                </g>
            </g>
        </g>
    </symbol>
    <symbol id="mono-icon-pinterest" viewBox="0 0 10 10">
       <path d="M7.91041 1.02475C7.22206 0.363947 6.26946 0 5.22811 0C3.6374 0 2.65904 0.652053 2.11841 1.19903C1.45212 1.87311 1.07007 2.76817 1.07007 3.65474C1.07007 4.76789 1.53568 5.62227 2.31539 5.94012C2.36773 5.96157 2.42041 5.97237 2.47205 5.97237C2.63654 5.97237 2.76687 5.86473 2.81203 5.69209C2.83836 5.59305 2.89933 5.34869 2.92586 5.24262C2.98261 5.03314 2.93676 4.93238 2.81297 4.7865C2.58746 4.51967 2.48244 4.20414 2.48244 3.79349C2.48244 2.57374 3.39068 1.27741 5.07403 1.27741C6.4097 1.27741 7.23939 2.03655 7.23939 3.25855C7.23939 4.02968 7.07329 4.74383 6.77159 5.26951C6.56194 5.63479 6.19329 6.0702 5.62735 6.0702C5.38262 6.0702 5.16278 5.96967 5.02407 5.7944C4.89303 5.62871 4.84983 5.41469 4.90254 5.19162C4.96208 4.93959 5.04327 4.6767 5.12184 4.42256C5.26514 3.95837 5.40061 3.51996 5.40061 3.17017C5.40061 2.57188 5.0328 2.16987 4.48543 2.16987C3.78981 2.16987 3.24482 2.8764 3.24482 3.77835C3.24482 4.2207 3.36238 4.55156 3.4156 4.67859C3.32797 5.04988 2.80715 7.25731 2.70836 7.67357C2.65123 7.91655 2.30712 9.83578 2.87668 9.98881C3.5166 10.1607 4.08861 8.29156 4.14684 8.08034C4.19403 7.90857 4.35912 7.25901 4.4603 6.85973C4.76922 7.15729 5.26663 7.35847 5.75061 7.35847C6.66302 7.35847 7.48357 6.94788 8.06113 6.20243C8.62127 5.47938 8.92977 4.4716 8.92977 3.36488C8.92973 2.49968 8.55816 1.64671 7.91041 1.02475Z" />
    </symbol>
    <symbol id="icon-fullscreen" xmlns="http://www.w3.org/2000/svg" fill="white" viewBox="0 0 1024 1024">
        <path
            d="M290 236.4l43.9-43.9a8.01 8.01 0 0 0-4.7-13.6L169 160c-5.1-.6-9.5 3.7-8.9 8.9L179 329.1c.8 6.6 8.9 9.4 13.6 4.7l43.7-43.7L370 423.7c3.1 3.1 8.2 3.1 11.3 0l42.4-42.3c3.1-3.1 3.1-8.2 0-11.3L290 236.4zm352.7 187.3c3.1 3.1 8.2 3.1 11.3 0l133.7-133.6 43.7 43.7a8.01 8.01 0 0 0 13.6-4.7L863.9 169c.6-5.1-3.7-9.5-8.9-8.9L694.8 179c-6.6.8-9.4 8.9-4.7 13.6l43.9 43.9L600.3 370a8.03 8.03 0 0 0 0 11.3l42.4 42.4zM845 694.9c-.8-6.6-8.9-9.4-13.6-4.7l-43.7 43.7L654 600.3a8.03 8.03 0 0 0-11.3 0l-42.4 42.3a8.03 8.03 0 0 0 0 11.3L734 787.6l-43.9 43.9a8.01 8.01 0 0 0 4.7 13.6L855 864c5.1.6 9.5-3.7 8.9-8.9L845 694.9zm-463.7-94.6a8.03 8.03 0 0 0-11.3 0L236.3 733.9l-43.7-43.7a8.01 8.01 0 0 0-13.6 4.7L160.1 855c-.6 5.1 3.7 9.5 8.9 8.9L329.2 845c6.6-.8 9.4-8.9 4.7-13.6L290 787.6 423.7 654c3.1-3.1 3.1-8.2 0-11.3l-42.4-42.4z" />
    </symbol>
    <symbol id="mono-icon-tumblr" viewBox="0 0 512 512">
        <g>
            <path d="M321.2,396.3c-11.8,0-22.4-2.8-31.5-8.3c-6.9-4.1-11.5-9.6-14-16.4c-2.6-6.9-3.6-22.3-3.6-46.4V224h96v-64h-96V48h-61.9
                c-2.7,21.5-7.5,44.7-14.5,58.6c-7,13.9-14,25.8-25.6,35.7c-11.6,9.9-25.6,17.9-41.9,23.3V224h48v140.4c0,19,2,33.5,5.9,43.5
                c4,10,11.1,19.5,21.4,28.4c10.3,8.9,22.8,15.7,37.3,20.5c14.6,4.8,31.4,7.2,50.4,7.2c16.7,0,30.3-1.7,44.7-5.1
                c14.4-3.4,30.5-9.3,48.2-17.6v-65.6C363.2,389.4,342.3,396.3,321.2,396.3z"></path>
        </g>
    </symbol>
    <symbol id="mono-icon-twitter" viewBox="0 0 16 16">
        <path d="M8.65379 7.23432L12.1904 3H11.3523L8.2815 6.6766L5.82885 3H3L6.70889 8.55967L3 13H3.83811L7.08097 9.11739L9.67115 13H12.5L8.65379 7.23432ZM7.50589 8.60865L7.1301 8.05503L4.14009 3.64984H5.42737L7.84034 7.20497L8.21613 7.75859L11.3527 12.3797H10.0654L7.50589 8.60865Z" />
    </symbol>
    <symbol id="mono-icon-youtube" viewBox="0 0 512 512">
        <g>
            <path fill-rule="evenodd" d="M508.6,148.8c0-45-33.1-81.2-74-81.2C379.2,65,322.7,64,265,64c-3,0-6,0-9,0s-6,0-9,0c-57.6,0-114.2,1-169.6,3.6
                c-40.8,0-73.9,36.4-73.9,81.4C1,184.6-0.1,220.2,0,255.8C-0.1,291.4,1,327,3.4,362.7c0,45,33.1,81.5,73.9,81.5
                c58.2,2.7,117.9,3.9,178.6,3.8c60.8,0.2,120.3-1,178.6-3.8c40.9,0,74-36.5,74-81.5c2.4-35.7,3.5-71.3,3.4-107
                C512.1,220.1,511,184.5,508.6,148.8z M207,353.9V157.4l145,98.2L207,353.9z"></path>
        </g>
    </symbol>
    <symbol id="mono-icon-tiktok" viewBox="0 0 512 512">
        <path
            d="M412.19,118.66a109.27,109.27,0,0,1-9.45-5.5,132.87,132.87,0,0,1-24.27-20.62c-18.1-20.71-24.86-41.72-27.35-56.43h.1C349.14,23.9,350,16,350.13,16H267.69V334.78c0,4.28,0,8.51-.18,12.69,0,.52-.05,1-.08,1.56,0,.23,0,.47-.05.71,0,.06,0,.12,0,.18a70,70,0,0,1-35.22,55.56,68.8,68.8,0,0,1-34.11,9c-38.41,0-69.54-31.32-69.54-70s31.13-70,69.54-70a68.9,68.9,0,0,1,21.41,3.39l.1-83.94a153.14,153.14,0,0,0-118,34.52,161.79,161.79,0,0,0-35.3,43.53c-3.48,6-16.61,30.11-18.2,69.24-1,22.21,5.67,45.22,8.85,54.73v.2c2,5.6,9.75,24.71,22.38,40.82A167.53,167.53,0,0,0,115,470.66v-.2l.2.2C155.11,497.78,199.36,496,199.36,496c7.66-.31,33.32,0,62.46-13.81,32.32-15.31,50.72-38.12,50.72-38.12a158.46,158.46,0,0,0,27.64-45.93c7.46-19.61,9.95-43.13,9.95-52.53V176.49c1,.6,14.32,9.41,14.32,9.41s19.19,12.3,49.13,20.31c21.48,5.7,50.42,6.9,50.42,6.9V131.27C453.86,132.37,433.27,129.17,412.19,118.66Z">
        </path>
    </symbol>
    <symbol id="icon-magnify" viewBox="0 0 30 30" xmlns="http://www.w3.org/2000/svg">
        <path
            d="M21.876 18.281l-.314.548L30 27.343 27.343 30l-8.437-8.516-.546.392c-2.083 1.3-4.245 1.951-6.486 1.951-3.28 0-6.08-1.171-8.398-3.515C1.16 17.968 0 15.156 0 11.874c0-3.28 1.159-6.08 3.476-8.398C5.794 1.16 8.595 0 11.876 0c3.282 0 6.079 1.159 8.398 3.476 2.318 2.318 3.477 5.119 3.477 8.4a11.786 11.786 0 0 1-1.875 6.405zm-3.36-13.046c-1.823-1.824-4.037-2.736-6.642-2.736-2.604 0-4.818.912-6.639 2.736-1.824 1.822-2.736 4.035-2.736 6.64 0 2.606.912 4.818 2.736 6.64 1.822 1.823 4.035 2.734 6.64 2.734 2.606 0 4.818-.91 6.64-2.733 1.876-1.875 2.813-4.088 2.813-6.642 0-2.55-.937-4.764-2.812-6.639z"
            fill-rule="evenodd" />
    </symbol>
    <symbol id="icon-chevron-right" viewBox="0 0 24 24">
        <path fill="currentColor"
            d="M9.62,5.29a.91.91,0,0,0-1.34,0A1,1,0,0,0,8.2,6.61l.08.1,5,5.29-5,5.29a1,1,0,0,0-.08,1.32l.08.1a.91.91,0,0,0,1.25.08l.09-.08L16,12Z" />
    </symbol>
    <symbol id="icon-chevron-down" viewBox="0 0 24 24">
        <path fill="currentColor" d="M5.29,9.62a.91.91,0,0,1,0-1.34A1,1,0,0,1,6.61,8.2l.1.08,5.29,5,5.29-5a1,1,0,0,1,1.32-.08l.1.08a.91.91,0,0,1,.08,1.25l-.08.09L12,16Z"/>
    </symbol>
    <symbol id="icon-chevron-left" viewBox="0 0 24 24">
        <path fill="currentColor"
            d="M14.38,5.29a.91.91,0,0,1,1.34,0,1,1,0,0,1,.08,1.32l-.08.1-5,5.29,5,5.29a1,1,0,0,1,.08,1.32l-.08.1a.91.91,0,0,1-1.25.08l-.09-.08L8,12Z" />
    </symbol>
    <symbol id="burger-menu" viewBox="0 0 14 10">
        <g>
            <path fill-rule="evenodd" d="M0 5.5v-1h14v1H0zM0 1V0h14v1H0zm0 9V9h14v1H0z"></path>
        </g>
    </symbol>
    <symbol id="close-x" viewBox="0 0 14 14" xmlns="http://www.w3.org/2000/svg">
        <g>
            <path fill-rule="nonzero"
                d="M6.336 7L0 .664.664 0 7 6.336 13.336 0 14 .664 7.664 7 14 13.336l-.664.664L7 7.664.664 14 0 13.336 6.336 7z">
            </path>
        </g>
    </symbol>
    <symbol id="share-more-arrow" viewBox="0 0 512 512" style="enable-background:new 0 0 512 512;">
        <g>
            <g>
                <path
                    d="M512,241.7L273.643,3.343v156.152c-71.41,3.744-138.015,33.337-188.958,84.28C30.075,298.384,0,370.991,0,448.222v60.436
                    l29.069-52.985c45.354-82.671,132.173-134.027,226.573-134.027c5.986,0,12.004,0.212,18.001,0.632v157.779L512,241.7z
                    M255.642,290.666c-84.543,0-163.661,36.792-217.939,98.885c26.634-114.177,129.256-199.483,251.429-199.483h15.489V78.131
                    l163.568,163.568L304.621,405.267V294.531l-13.585-1.683C279.347,291.401,267.439,290.666,255.642,290.666z">
                </path>
            </g>
        </g>
    </symbol>
    <symbol id="chevron" viewBox="0 0 100 100">
        <g>
            <path
                d="M22.4566257,37.2056786 L-21.4456527,71.9511488 C-22.9248661,72.9681457 -24.9073712,72.5311671 -25.8758148,70.9765924 L-26.9788683,69.2027424 C-27.9450684,67.6481676 -27.5292733,65.5646602 -26.0500598,64.5484493 L20.154796,28.2208967 C21.5532435,27.2597011 23.3600078,27.2597011 24.759951,28.2208967 L71.0500598,64.4659264 C72.5292733,65.4829232 72.9450684,67.5672166 71.9788683,69.1217913 L70.8750669,70.8956413 C69.9073712,72.4502161 67.9241183,72.8848368 66.4449048,71.8694118 L22.4566257,37.2056786 Z"
                id="Transparent-Chevron"
                transform="translate(22.500000, 50.000000) rotate(90.000000) translate(-22.500000, -50.000000) "></path>
        </g>
    </symbol>
    <symbol id="chevron-down" viewBox="0 0 10 6" xmlns="http://www.w3.org/2000/svg">
        <path
            d="M5.108 4.088L.965.158a.587.587 0 0 0-.8 0 .518.518 0 0 0 0 .758L5.13 5.625 9.845.905a.517.517 0 0 0-.021-.758.588.588 0 0 0-.8.02l-3.916 3.92z"
            fill-rule="evenodd" />
    </symbol>
    <symbol id="chevron-up" viewBox="0 0 284.929 284.929" xmlns="http://www.w3.org/2000/svg">
        <path
            d="M282.082 195.285L149.028 62.24c-1.901-1.903-4.088-2.856-6.562-2.856s-4.665.953-6.567 2.856L2.856 195.285C.95 197.191 0 199.378 0 201.853c0 2.474.953 4.664 2.856 6.566l14.272 14.271c1.903 1.903 4.093 2.854 6.567 2.854s4.664-.951 6.567-2.854l112.204-112.202 112.208 112.209c1.902 1.903 4.093 2.848 6.563 2.848 2.478 0 4.668-.951 6.57-2.848l14.274-14.277c1.902-1.902 2.847-4.093 2.847-6.566.001-2.476-.944-4.666-2.846-6.569z" />
    </symbol>
    <symbol id="icon-activity" viewBox="0 0 20 20">
        <g fill="currentColor" fill-rule="evenodd">
            <path d="M4 4h16v2H4zM0 4h2v2H0zM4 9h14v2H4zM0 9h2v2H0zM4 14h10v2H4zM0 14h2v2H0z"/>
        </g>
    </symbol>
    <symbol id="icon-arrow-down" viewBox="0 0 10 6" xmlns="http://www.w3.org/2000/svg">
        <path
            d="M5.108 4.088L.965.158a.587.587 0 0 0-.8 0 .518.518 0 0 0 0 .758L5.13 5.625 9.845.905a.517.517 0 0 0-.021-.758.588.588 0 0 0-.8.02l-3.916 3.92z"
            fill="inherit" fill-rule="evenodd" />
    </symbol>
    <symbol id="icon-arrow-right" viewBox="0 0 15 11">
        <path
            d="m9.91.876.088.067 4.5 4 .014.013.044.045-.058-.058a.757.757 0 0 1 .192.266c.039.09.06.19.06.295l-.006.095a.748.748 0 0 1-.169.386l-.019.022a.755.755 0 0 1-.044.045l-.014.012-4.5 4a.75.75 0 0 1-1.074-1.04l.078-.08 3.023-2.69H1A.75.75 0 0 1 .898 4.76L1 4.754h11.026l-3.024-2.69a.75.75 0 0 1-.13-.97l.067-.088a.75.75 0 0 1 .971-.13z"
            fill-rule="nonzero" />
    </symbol>
    <symbol id="icon-star" viewBox="0 0 24 24">
        <g fill="none" fill-rule="evenodd">
            <path d="M0 0L24 0 24 24 0 24z"/>
            <path d="M0 0L24 0 24 24 0 24z"/>
            <path fill="currentColor" d="M12 18.324L19.416 22.8 17.448 14.364 24 8.688 15.372 7.956 12 0 8.628 7.956 0 8.688 6.552 14.364 4.584 22.8z"/>
        </g>
    </symbol>
    <symbol id="icon-wand" viewBox="0 0 24 24">
        <g fill="none" fill-rule="evenodd">
            <path d="M0.003 0L24.003 0 24.003 24 0.003 24z"/>
            <path fill="currentColor" d="M24 0l-2.857 1.6L18.286 0l1.6 2.857-1.6 2.857 2.857-1.6L24 5.714l-1.6-2.857L24 0zm-8.719 6.045c-.446-.446-1.166-.446-1.611 0L.334 19.381c-.445.445-.445 1.165 0 1.61l2.674 2.675c.446.445 1.166.445 1.611 0l13.325-13.324c.445-.446.445-1.166 0-1.612L15.28 6.045zm-1.177 6.274l-2.423-2.423 2.789-2.788 2.422 2.422-2.788 2.789z"/>
        </g>
    </symbol>
    <symbol id="icon-note" viewBox="0 0 24 24">
        <g fill="none" fill-rule="evenodd">
            <path fill="currentColor" d="M24.333 3H5.653C4.187 3 3 4.2 3 5.667l.013 18.666C3.013 25.8 4.2 27 5.667 27H19l8-8V5.667C27 4.2 25.8 3 24.333 3zm-16 6.667h13.334v2.666H8.333V9.667zm6.667 8H8.333V15H15v2.667zM17.667 25v-7.333H25L17.667 25z" />
        </g>
    </symbol>
    <symbol id="icon-warning" viewBox="0 0 24 24">
        <g fill="none" fill-rule="evenodd">
            <path d="M0 0L24 0 24 24 0 24z"/>
            <path fill="currentColor" d="M0 22.727h24L12 2 0 22.727zm13.09-3.272h-2.18v-2.182h2.18v2.182zm0-4.364h-2.18v-4.364h2.18v4.364z"/>
        </g>
    </symbol>
    <symbol id="play-arrow" viewBox="0 0 30 30">
        <g fill-rule="evenodd">
            <path d="M9 9l12 6-12 6z"></path>
        </g>
    </symbol>
    <symbol id="play-icon" viewBox="0 0 50 50" xmlns="http://www.w3.org/2000/svg">
        <g stroke="none" stroke-width="1" fill="none" fill-rule="nonzero">
            <circle fill="currentColor" cx="25" cy="25" r="24" />
            <polygon fill="#FFFFFF" points="18 36.25 18 13.75 33 25" />
        </g>
    </symbol>
    <symbol id="player-play" viewBox="0 0 40 40">
        <path fill="currentColor"
            d="M17.6 27.8l9.34-7c.54-.4.54-1.2 0-1.6l-9.34-7c-.66-.5-1.6-.02-1.6.8v14c0 .82.94 1.3 1.6.8zM20 0C8.96 0 0 8.96 0 20s8.96 20 20 20 20-8.96 20-20S31.04 0 20 0zm0 38c-9.922 0-18-8.078-18-18S10.078 2 20 2s18 8.078 18 18-8.078 18-18 18z" />
    </symbol>
    <symbol id="player-pause" viewBox="0 0 40 40">
        <path fill="currentColor"
            d="M20 0C8.96 0 0 8.96 0 20s8.96 20 20 20 20-8.96 20-20S31.04 0 20 0zm0 38c-9.922 0-18-8.078-18-18S10.078 2 20 2s18 8.078 18 18-8.078 18-18 18zm-4-26c.552 0 1 .448 1 1v14c0 .552-.448 1-1 1s-1-.448-1-1V13c0-.552.448-1 1-1zm8 0c.552 0 1 .448 1 1v14c0 .552-.448 1-1 1s-1-.448-1-1V13c0-.552.448-1 1-1z" />
    </symbol>
    <symbol id="grid" viewBox="0 0 32 32">
        <g>
            <path
                d="M6.4,5.7 C6.4,6.166669 6.166669,6.4 5.7,6.4 L0.7,6.4 C0.233331,6.4 0,6.166669 0,5.7 L0,0.7 C0,0.233331 0.233331,0 0.7,0 L5.7,0 C6.166669,0 6.4,0.233331 6.4,0.7 L6.4,5.7 Z M19.2,5.7 C19.2,6.166669 18.966669,6.4 18.5,6.4 L13.5,6.4 C13.033331,6.4 12.8,6.166669 12.8,5.7 L12.8,0.7 C12.8,0.233331 13.033331,0 13.5,0 L18.5,0 C18.966669,0 19.2,0.233331 19.2,0.7 L19.2,5.7 Z M32,5.7 C32,6.166669 31.766669,6.4 31.3,6.4 L26.3,6.4 C25.833331,6.4 25.6,6.166669 25.6,5.7 L25.6,0.7 C25.6,0.233331 25.833331,0 26.3,0 L31.3,0 C31.766669,0 32,0.233331 32,0.7 L32,5.7 Z M6.4,18.5 C6.4,18.966669 6.166669,19.2 5.7,19.2 L0.7,19.2 C0.233331,19.2 0,18.966669 0,18.5 L0,13.5 C0,13.033331 0.233331,12.8 0.7,12.8 L5.7,12.8 C6.166669,12.8 6.4,13.033331 6.4,13.5 L6.4,18.5 Z M19.2,18.5 C19.2,18.966669 18.966669,19.2 18.5,19.2 L13.5,19.2 C13.033331,19.2 12.8,18.966669 12.8,18.5 L12.8,13.5 C12.8,13.033331 13.033331,12.8 13.5,12.8 L18.5,12.8 C18.966669,12.8 19.2,13.033331 19.2,13.5 L19.2,18.5 Z M32,18.5 C32,18.966669 31.766669,19.2 31.3,19.2 L26.3,19.2 C25.833331,19.2 25.6,18.966669 25.6,18.5 L25.6,13.5 C25.6,13.033331 25.833331,12.8 26.3,12.8 L31.3,12.8 C31.766669,12.8 32,13.033331 32,13.5 L32,18.5 Z M6.4,31.3 C6.4,31.766669 6.166669,32 5.7,32 L0.7,32 C0.233331,32 0,31.766669 0,31.3 L0,26.3 C0,25.833331 0.233331,25.6 0.7,25.6 L5.7,25.6 C6.166669,25.6 6.4,25.833331 6.4,26.3 L6.4,31.3 Z M19.2,31.3 C19.2,31.766669 18.966669,32 18.5,32 L13.5,32 C13.033331,32 12.8,31.766669 12.8,31.3 L12.8,26.3 C12.8,25.833331 13.033331,25.6 13.5,25.6 L18.5,25.6 C18.966669,25.6 19.2,25.833331 19.2,26.3 L19.2,31.3 Z M32,31.3 C32,31.766669 31.766669,32 31.3,32 L26.3,32 C25.833331,32 25.6,31.766669 25.6,31.3 L25.6,26.3 C25.6,25.833331 25.833331,25.6 26.3,25.6 L31.3,25.6 C31.766669,25.6 32,25.833331 32,26.3 L32,31.3 Z"
                id=""></path>
        </g>
    </symbol>
    <symbol id="filter" viewBox="0 0 16 12">
        <path d="M0 2V0h16v2H0zm2.4 5V5h11.2v2H2.4zm2.4 5v-2h6.4v2H4.8z"></path>
    </symbol>
    <symbol id="icon-filter" viewBox="0 0 512 512">
        <path fill="currentColor"
            d="M487.976 0H24.028C2.71 0-8.047 25.866 7.058 40.971L192 225.941V432c0 7.831 3.821 15.17 10.237 19.662l80 55.98C298.02 518.69 320 507.493 320 487.98V225.941l184.947-184.97C520.021 25.896 509.338 0 487.976 0z">
        </path>
    </symbol>
    <symbol id="icon-radio-on" viewBox="0 0 24 24">
        <path fill="currentColor" fill-rule="nonzero"
            d="M12 7c-2.76 0-5 2.24-5 5s2.24 5 5 5 5-2.24 5-5-2.24-5-5-5zm0-5C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.42 0-8-3.58-8-8s3.58-8 8-8 8 3.58 8 8-3.58 8-8 8z" />
    </symbol>
    <symbol id="icon-radio-off" viewBox="0 0 24 24">
        <path fill="currentColor" fill-rule="nonzero"
            d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.42 0-8-3.58-8-8s3.58-8 8-8 8 3.58 8 8-3.58 8-8 8z" />
    </symbol>
    <symbol id="icon-pause" viewBox="0 0 13 16">
        <rect width="4.636" height="16" rx="2.318" />
        <rect width="4.636" height="16" x="7.727" rx="2.318" />
    </symbol>
    <symbol id="icon-plus" viewBox="0 0 14 14" height="14px" width="14px">
        <path
            d="M13, 6H8V1A1, 1, 0, 0, 0, 6, 1V6H1A1, 1, 0, 0, 0, 1, 8H6v5a1, 1, 0, 0, 0, 2, 0V8h5a1, 1, 0, 0, 0, 0-2Z" />
    </symbol>
    <symbol id="icon-minus" viewBox="0 0 14 14" height="14px" width="14px">
        <path d="M13, 8H1A1, 1, 0, 0, 1, 1, 6H13a1, 1, 0, 0, 1, 0, 2Z" />
    </symbol>
    <symbol id="amazon-alexa" fill="none" viewBox="0 0 14 14">
        <path clip-rule="evenodd"
            d="m52.4998 105c-28.9946 0-52.4998-23.5055-52.4998-52.5003 0-26.6214 19.8151-48.61142 45.5003-52.03433v10.57883c0 2.9832-1.8814 5.6636-4.7091 6.6127-14.8197 4.9787-25.4216 19.1433-25.0311 35.7287.4754 20.1911 16.923 36.0663 37.1187 35.8628 20.122-.2035 36.3714-16.5785 36.3714-36.7487 0-.4597-.0113-.9172-.0283-1.3721-.004-.102-.0072-.2048-.0113-.307-.0194-.4228-.0452-.8446-.0784-1.2639-.0097-.1335-.0234-.2666-.0355-.3998-.0259-.2928-.0558-.5837-.0889-.8739-.0372-.3297-.08-.6576-.1261-.9838-.0202-.1492-.0404-.2988-.063-.4467-4.4995-29.6389-43.1025-46.296896-43.3144-46.388077 2.2893-.304462 4.6239-.464423 6.9955-.464423 28.9951 0 52.5002 23.5048 52.5002 52.4997 0 28.9948-23.5051 52.5003-52.5002 52.5003z"
            fill="#5fcaf4" fill-rule="evenodd" transform="matrix(.133333 0 0 -.133333 0 14)" />
    </symbol>
    <symbol id="apple" viewBox="0 0 511.86 511.86">
        <rect fill="#822cbe" width="511.86" height="511.86" rx="113.87" />
        <path fill="#ffffff"
            d="M240.44,448.26c-15.27-5.46-18.54-12.88-24.81-56.38-7.28-50.55-8.87-81.84-4.65-91.75,5.59-13.14,20.78-20.6,42-20.68,21.07-.09,36.39,7.44,42,20.68,4.24,9.89,2.65,41.2-4.64,91.75-4.95,35.32-7.67,44.25-14.5,50.25-9.38,8.31-22.69,10.61-35.32,6.14Zm-65.22-51.87c-52.73-25.94-86.51-69.82-98.79-128.2-3.07-15.07-3.59-51-.69-64.84,7.68-37.11,22.36-66.13,46.75-91.79,35.15-37.06,80.37-56.65,130.7-56.65,49.82,0,94.86,19.23,129.16,55.18,26.1,27.13,40.77,55.84,48.28,93.67,2.56,12.59,2.56,46.92.17,61.08a181.4,181.4,0,0,1-69.1,113c-13,9.79-44.7,26.89-49.82,26.89-1.88,0-2.05-1.94-1.19-9.81,1.53-12.63,3.07-15.25,10.23-18.26,11.44-4.77,30.89-18.63,42.83-30.61a163,163,0,0,0,42.82-75.41c4.44-17.57,3.93-56.64-1-74.73C390,138.36,343.1,93.66,285.61,81.72c-16.73-3.42-47.1-3.42-64,0-58.18,11.94-106.29,58.86-121,117.89-3.92,16-3.92,55.11,0,71.15,9.73,39.07,35,74.9,68.08,96.23a147.45,147.45,0,0,0,17.58,10.07c7.16,3.07,8.7,5.63,10.06,18.25.85,7.68.68,9.9-1.19,9.9-1.2,0-9.9-3.75-19.11-8.19ZM175.9,327c-17.75-14.16-33.44-39.28-39.93-63.91-3.92-14.88-3.92-43.17.17-58,10.75-40.06,40.27-71.12,81.22-85.71,14-4.94,45-6,62.27-2.25C339,130.33,381.15,189.79,373,248.77c-3.24,23.77-11.43,43.29-25.93,61.42-7.17,9.16-24.57,24.54-27.64,24.54-.51,0-1-5.8-1-12.87V309l8.88-10.58c33.44-40.06,31.05-96-5.46-132.74-14.16-14.29-30.54-22.69-51.7-26.56-13.65-2.53-16.55-2.53-30.88-.17-21.76,3.55-38.61,12-53.58,26.78C148.94,202,146.55,258.29,180,298.38L188.8,309v13c0,7.17-.57,13-1.27,13s-5.63-3.41-10.92-7.68Zm59.2-69.66c-15.18-7.07-23.37-20.39-23.54-37.76,0-15.61,8.7-29.23,23.71-37.2,9.56-5,26.45-5,36,0a46.34,46.34,0,0,1,22.18,26.85c9.9,33.65-25.76,63.13-58,48.07Z"
            transform="translate(-0.14 -0.14)" />
        <circle fill="#ffffff" cx="255.74" cy="221.24" r="42.55" />
        <path fill="#ffffff"
            d="M260,280.42a83.61,83.61,0,0,1,14.25,2.9,51.55,51.55,0,0,1,14.26,7.13c3.76,2.73,6.49,5.56,8.19,9s2.56,7.54,3.07,14.25c.34,6.72.34,16-1.19,33.44s-4.61,42.79-7,59.08-4.09,23.55-6.31,28.84a25.82,25.82,0,0,1-18.94,16.55,41,41,0,0,1-9.89.85,42.41,42.41,0,0,1-9.9-.85c-3.92-.86-9-2.39-12.8-5.46-3.92-3.07-6.48-7.51-8.53-13.31s-3.58-12.8-5.63-26.79-4.78-34.8-6.48-50.67-2.39-26.79-2.53-34.13.17-11,1-14.5a28.93,28.93,0,0,1,4.09-9.38,31.14,31.14,0,0,1,6.83-7,27.87,27.87,0,0,1,8-4.3A60.8,60.8,0,0,1,241.35,283c4.43-.85,9.55-1.7,12.18-2.05a13.34,13.34,0,0,1,5.56,0Z"
            transform="translate(-0.14 -0.14)" />
    </symbol>
    <symbol id="google" fill="none" viewBox="0 0 14 14">
        <path d="m0 0v2.12148.84795 2.12148h1.75v-2.12148-.84795-2.12148z" fill="#fab908"
            transform="translate(6.125 4.45453)" />
        <path
            d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
            fill="#0066d9" transform="translate(0 5.64764)" />
        <path
            d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
            fill="#0066d9" transform="translate(0 6.60236)" />
        <path d="m1.75 0h-1.75v.954546h1.75z" fill="#0066d9" transform="translate(0 6.52264)" />
        <path
            d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
            fill="#4285f4" transform="translate(12.25 6.60236)" />
        <path
            d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
            fill="#4285f4" transform="translate(12.25 5.64764)" />
        <path d="m1.75 0h-1.75v.954546h1.75z" fill="#4285f4" transform="matrix(-1 0 0 -1 14 7.47736)" />
        <path
            d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
            fill="#ea4335" transform="translate(3.02274 8.51141)" />
        <path
            d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
            fill="#ea4335" transform="translate(3.02274 9.46594)" />
        <path d="m1.75 0h-1.75v.954546h1.75z" fill="#ea4335" transform="translate(3.02274 9.38641)" />
        <path
            d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
            fill="#ea4335" transform="translate(3.02274 2.78406)" />
        <path
            d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
            fill="#ea4335" transform="translate(3.02274 5.88641)" />
        <path d="m1.75 0h-1.75v3.12216h1.75z" fill="#ea4335" transform="translate(3.02274 3.65906)" />
        <path
            d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
            fill="#34a853" transform="translate(9.22726 3.73859)" />
        <path
            d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
            fill="#34a853" transform="translate(9.22726 2.78406)" />
        <path d="m1.75 0h-1.75v.954546h1.75z" fill="#34a853" transform="matrix(-1 0 0 -1 10.9773 4.61359)" />
        <g fill="#fab908">
            <path
                d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
                transform="translate(6.125 .954529)" />
            <path
                d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
                transform="translate(6.125)" />
            <path d="m1.75 0h-1.75v.954546h1.75z" transform="matrix(-1 0 0 -1 7.875 1.82953)" />
            <path
                d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
                transform="translate(6.125 12.25)" />
            <path
                d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
                transform="translate(6.125 11.2955)" />
            <path d="m1.75 0h-1.75v.954546h1.75z" transform="matrix(-1 0 0 -1 7.875 13.125)" />
        </g>
        <path
            d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
            fill="#34a853" transform="translate(9.22726 9.46594)" />
        <path
            d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
            fill="#34a853" transform="translate(9.22726 6.36359)" />
        <path d="m1.75 0h-1.75v3.10227h1.75z" fill="#34a853" transform="matrix(-1 0 0 -1 10.9773 10.3409)" />
        <path
            d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
            fill="#fab908" transform="translate(6.125 3.57953)" />
        <path
            d="m.875 1.75c.48325 0 .875-.39175.875-.875 0-.483249-.39175-.875-.875-.875-.483249 0-.875.391751-.875.875 0 .48325.391751.875.875.875z"
            fill="#fab908" transform="translate(6.125 8.67047)" />
    </symbol>
    <symbol id="npr-one" viewBox="0 0 15 16">
        <g clip-rule="evenodd" fill-rule="evenodd">
            <path
                d="m-.00000001 3.99903 3.11681001 1.9192c.6747-1.24356 1.93544-2.08032 3.37935-2.08032v-3.83791c-2.77571 0-5.1993 1.60843-6.49616001 3.99903z"
                fill="#d61900" transform="translate(1.00378)" />
            <path
                d="m3.78823 5.28599c-.12325-.40495-.18984-.83705-.18984-1.28579 0-.75804.19011-1.4688.52217-2.081-1.53085-.942623-2.25153-1.386398-3.11681-1.91919993-.638301 1.17671993-1.00375 2.54287993-1.00375 4.00019993 0 1.45723.365449 2.82349 1.00375 4.0002l1.97257-1.21466z"
                fill="#f30" transform="translate(0 4.00128)" />
            <path
                d="m-.00000001 1.21467c1.29686001 2.3906 3.72045001 3.99903 6.49616001 3.99903v-3.83801c-1.15017 0-2.18402-.530854-2.89814-1.37539816h-1.62563l.00018-.00029136z"
                fill="#83aeed" transform="translate(1.00378 10.7867)" />
            <path
                d="m6.49625 1.9192-3.1168-1.91919949c-.67471 1.24355949-1.93535 2.08022949-3.37944981 2.08022949v3.838c2.77589981 0 5.19938981-1.60843 6.49624981-3.99903z"
                fill="#3266cc" transform="translate(7.50012 10.0768)" />
            <path
                d="m.522174 4.0002c0 .75815-.190114 1.46881-.52217447 2.08101l3.11681047 1.91919c.63839-1.17671 1.00375-2.54297 1.00375-4.0002 0-1.45732-.36536-2.82348-1.00375-4.00019993-.86528.53280193-1.58596.97657693-3.11681047 1.91919993.33206047.6122.52217447 1.32296.52217447 2.081z"
                fill="#3a3a3a" transform="translate(10.8795 4.00128)" />
            <path
                d="m.00000019 3.83791c1.44409981 0 2.70473981.83676 3.37944981 2.08032l3.1168-1.9192c-1.29686-2.3906-3.72044-3.99903-6.49624981-3.99903z"
                fill="#191919" transform="translate(7.50012)" />
        </g>
    </symbol>
    <symbol id="overcast" viewBox="0 0 365 365" fill="none">
        <g xmlns="http://www.w3.org/2000/svg" id="surface1">
            <path style=" stroke:none;fill-rule:nonzero;fill:rgb(96.099854%,49.398804%,12.5%);fill-opacity:1;"
                d="M 90.179688 274.820313 C 66.550781 251.195313 51.9375 218.554688 51.9375 182.5 C 51.9375 146.445313 66.550781 113.804688 90.179688 90.179688 L 101.789063 101.789063 C 81.136719 122.445313 68.359375 150.980469 68.359375 182.5 C 68.359375 214.019531 81.136719 242.554688 101.789063 263.210938 Z M 125.890625 239.109375 C 111.402344 224.621094 102.441406 204.609375 102.441406 182.5 C 102.441406 160.390625 111.402344 140.378906 125.890625 125.890625 L 137.503906 137.503906 C 125.988281 149.019531 118.863281 164.925781 118.863281 182.5 C 118.863281 200.074219 125.988281 215.980469 137.503906 227.496094 Z M 227.496094 227.496094 C 239.011719 215.980469 246.136719 200.074219 246.136719 182.5 C 246.136719 164.925781 239.011719 149.019531 227.496094 137.503906 L 239.109375 125.890625 C 253.597656 140.378906 262.558594 160.390625 262.558594 182.5 C 262.558594 204.609375 253.597656 224.621094 239.109375 239.109375 Z M 274.820313 274.820313 L 263.210938 263.210938 C 283.863281 242.554688 296.640625 214.019531 296.640625 182.5 C 296.640625 150.980469 283.863281 122.445313 263.210938 101.789063 L 274.820313 90.179688 C 298.449219 113.804688 313.0625 146.445313 313.0625 182.5 C 313.0625 218.554688 298.449219 251.195313 274.820313 274.820313 Z M 182.5 16.640625 C 90.898438 16.640625 16.640625 90.898438 16.640625 182.5 C 16.640625 255.765625 64.148438 317.933594 130.039063 339.886719 L 172.632813 212.101563 C 160.238281 207.972656 151.296875 196.28125 151.296875 182.5 C 151.296875 165.265625 165.265625 151.296875 182.5 151.296875 C 199.734375 151.296875 213.703125 165.265625 213.703125 182.5 C 213.703125 196.28125 204.761719 207.972656 192.367188 212.101563 L 234.960938 339.886719 C 300.851563 317.933594 348.359375 255.765625 348.359375 182.5 C 348.359375 90.898438 274.101563 16.640625 182.5 16.640625 Z M 202.902344 347.109375 C 195.519531 341.375 188.371094 335.058594 181.539063 328.164063 C 174.933594 334.996094 168.046875 341.269531 160.945313 346.96875 C 168 347.882813 175.195313 348.359375 182.5 348.359375 C 189.40625 348.359375 196.214844 347.933594 202.902344 347.109375 Z M 191.792969 316.824219 C 200.890625 327.066406 210.65625 336.113281 220.847656 343.898438 C 221.527344 343.734375 222.203125 343.570313 222.878906 343.402344 L 205.261719 299.355469 C 200.972656 305.472656 196.472656 311.300781 191.792969 316.824219 Z M 182.257813 305.34375 C 187.945313 298.007813 193.300781 290.164063 198.257813 281.84375 L 182.5 242.453125 L 166.550781 282.324219 C 171.425781 290.464844 176.679688 298.148438 182.257813 305.34375 Z M 143.78125 343.804688 C 153.617188 336.28125 163.054688 327.59375 171.875 317.78125 C 167.367188 312.621094 163.03125 307.179688 158.894531 301.46875 L 142.121094 343.402344 C 142.671875 343.539063 143.226563 343.671875 143.78125 343.804688 Z M 182.5 364.796875 C 81.820313 364.796875 0.207031 283.179688 0.207031 182.5 C 0.207031 81.820313 81.820313 0.203125 182.5 0.203125 C 283.179688 0.203125 364.796875 81.820313 364.796875 182.5 C 364.796875 283.179688 283.179688 364.796875 182.5 364.796875 " />
            <path style=" stroke:none;fill-rule:nonzero;fill:rgb(100%,100%,100%);fill-opacity:1;"
                d="M 90.179688 274.820313 L 90.324219 274.675781 C 66.734375 251.085938 52.140625 218.496094 52.140625 182.5 C 52.140625 146.503906 66.730469 113.914063 90.324219 90.324219 L 90.179688 90.179688 L 90.03125 90.324219 L 101.644531 101.9375 L 101.789063 101.789063 L 101.644531 101.644531 C 80.953125 122.339844 68.15625 150.925781 68.15625 182.5 C 68.15625 214.074219 80.953125 242.660156 101.644531 263.355469 L 101.789063 263.210938 L 101.644531 263.0625 L 90.03125 274.675781 L 90.179688 274.820313 L 90.324219 274.675781 L 90.179688 274.820313 L 90.324219 274.96875 L 102.082031 263.210938 L 101.9375 263.0625 C 81.316406 242.445313 68.566406 213.964844 68.566406 182.5 C 68.566406 151.035156 81.316406 122.554688 101.9375 101.9375 L 102.082031 101.789063 L 90.179688 89.886719 L 90.03125 90.03125 C 66.367188 113.695313 51.730469 146.390625 51.730469 182.5 C 51.730469 218.609375 66.367188 251.304688 90.03125 274.96875 L 90.179688 275.113281 L 90.324219 274.96875 Z M 125.890625 239.109375 L 126.035156 238.964844 C 111.582031 224.515625 102.644531 204.550781 102.644531 182.5 C 102.644531 160.449219 111.582031 140.484375 126.035156 126.035156 L 125.890625 125.890625 L 125.742188 126.035156 L 137.355469 137.648438 L 137.503906 137.503906 L 137.355469 137.355469 C 125.804688 148.910156 118.660156 164.871094 118.660156 182.5 C 118.660156 200.128906 125.804688 216.089844 137.355469 227.644531 L 137.503906 227.496094 L 137.355469 227.351563 L 125.742188 238.964844 L 125.890625 239.109375 L 126.035156 238.964844 L 125.890625 239.109375 L 126.035156 239.257813 L 137.792969 227.496094 L 137.648438 227.351563 C 126.167969 215.871094 119.070313 200.015625 119.070313 182.5 C 119.070313 164.984375 126.167969 149.128906 137.648438 137.648438 L 137.792969 137.503906 L 125.890625 125.597656 L 125.742188 125.742188 C 111.21875 140.269531 102.234375 160.335938 102.234375 182.5 C 102.234375 204.664063 111.21875 224.730469 125.742188 239.257813 L 125.890625 239.402344 L 126.035156 239.257813 Z M 227.496094 227.496094 L 227.644531 227.644531 C 239.195313 216.089844 246.339844 200.128906 246.339844 182.5 C 246.339844 164.871094 239.195313 148.910156 227.644531 137.355469 L 227.496094 137.503906 L 227.644531 137.648438 L 239.257813 126.035156 L 239.109375 125.890625 L 238.964844 126.035156 C 253.417969 140.484375 262.355469 160.449219 262.355469 182.5 C 262.355469 204.550781 253.417969 224.515625 238.964844 238.964844 L 239.109375 239.109375 L 239.257813 238.964844 L 227.644531 227.351563 L 227.496094 227.496094 L 227.644531 227.644531 L 227.496094 227.496094 L 227.351563 227.644531 L 239.109375 239.402344 L 239.257813 239.257813 C 253.78125 224.730469 262.765625 204.664063 262.765625 182.5 C 262.765625 160.335938 253.78125 140.269531 239.257813 125.742188 L 239.109375 125.597656 L 227.207031 137.503906 L 227.351563 137.648438 C 238.832031 149.128906 245.929688 164.984375 245.929688 182.5 C 245.929688 200.015625 238.832031 215.871094 227.351563 227.351563 L 227.207031 227.496094 L 227.351563 227.644531 Z M 274.820313 274.820313 L 274.96875 274.675781 L 263.355469 263.0625 L 263.210938 263.210938 L 263.355469 263.355469 C 284.046875 242.660156 296.84375 214.074219 296.84375 182.5 C 296.84375 150.925781 284.046875 122.339844 263.355469 101.644531 L 263.210938 101.789063 L 263.355469 101.9375 L 274.96875 90.324219 L 274.820313 90.179688 L 274.675781 90.324219 C 298.265625 113.914063 312.855469 146.503906 312.855469 182.5 C 312.855469 218.496094 298.265625 251.085938 274.675781 274.675781 L 274.820313 274.820313 L 274.96875 274.675781 L 274.820313 274.820313 L 274.96875 274.96875 C 298.632813 251.304688 313.269531 218.609375 313.269531 182.5 C 313.269531 146.390625 298.632813 113.695313 274.96875 90.03125 L 274.820313 89.886719 L 262.917969 101.789063 L 263.0625 101.9375 C 283.683594 122.554688 296.433594 151.035156 296.433594 182.5 C 296.433594 213.964844 283.683594 242.445313 263.0625 263.0625 L 262.917969 263.210938 L 274.820313 275.113281 L 274.96875 274.96875 Z M 182.5 16.640625 L 182.5 16.433594 C 90.785156 16.433594 16.433594 90.785156 16.433594 182.5 C 16.433594 255.859375 64.003906 318.097656 129.972656 340.082031 L 130.167969 340.144531 L 172.894531 211.972656 L 172.699219 211.90625 C 160.382813 207.804688 151.503906 196.191406 151.503906 182.5 C 151.503906 173.941406 154.972656 166.191406 160.582031 160.582031 C 166.191406 154.972656 173.9375 151.503906 182.5 151.503906 C 191.058594 151.503906 198.808594 154.972656 204.417969 160.582031 C 210.027344 166.191406 213.496094 173.9375 213.496094 182.5 C 213.496094 196.191406 204.617188 207.804688 192.300781 211.90625 L 192.105469 211.972656 L 234.832031 340.144531 L 235.027344 340.082031 C 301 318.097656 348.566406 255.859375 348.566406 182.5 C 348.566406 90.785156 274.214844 16.433594 182.5 16.433594 L 182.5 16.84375 C 228.246094 16.84375 269.65625 35.386719 299.636719 65.363281 C 329.613281 95.34375 348.15625 136.753906 348.15625 182.5 C 348.15625 255.675781 300.703125 317.765625 234.898438 339.691406 L 234.960938 339.886719 L 235.15625 339.820313 L 192.5625 212.035156 L 192.367188 212.101563 L 192.433594 212.296875 C 204.910156 208.140625 213.90625 196.375 213.910156 182.5 C 213.90625 165.152344 199.847656 151.09375 182.5 151.089844 C 165.152344 151.09375 151.09375 165.152344 151.089844 182.5 C 151.09375 196.375 160.089844 208.140625 172.566406 212.296875 L 172.632813 212.101563 L 172.4375 212.035156 L 129.84375 339.820313 L 130.039063 339.886719 L 130.101563 339.691406 C 64.296875 317.765625 16.84375 255.675781 16.84375 182.5 C 16.84375 136.753906 35.386719 95.34375 65.363281 65.363281 C 95.34375 35.386719 136.753906 16.84375 182.5 16.84375 Z M 202.902344 347.109375 L 203.027344 346.949219 C 195.652344 341.21875 188.511719 334.90625 181.683594 328.019531 L 181.535156 327.867188 L 181.390625 328.019531 C 174.792969 334.847656 167.910156 341.113281 160.816406 346.808594 L 160.441406 347.109375 L 160.917969 347.171875 C 167.984375 348.089844 175.1875 348.566406 182.5 348.566406 C 189.414063 348.566406 196.230469 348.136719 202.925781 347.316406 L 203.417969 347.253906 L 203.027344 346.949219 L 202.902344 347.109375 L 202.875 346.90625 C 196.199219 347.726563 189.398438 348.15625 182.5 348.15625 C 175.203125 348.15625 168.019531 347.679688 160.972656 346.765625 L 160.945313 346.96875 L 161.074219 347.128906 C 168.179688 341.421875 175.078125 335.144531 181.6875 328.304688 L 181.539063 328.164063 L 181.394531 328.308594 C 188.230469 335.210938 195.386719 341.53125 202.773438 347.273438 L 202.902344 347.109375 L 202.875 346.90625 Z M 191.792969 316.824219 L 191.636719 316.964844 C 200.742188 327.210938 210.519531 336.269531 220.722656 344.058594 L 220.800781 344.117188 L 220.894531 344.097656 C 221.574219 343.9375 222.253906 343.769531 222.929688 343.601563 L 223.15625 343.542969 L 205.3125 298.929688 L 205.09375 299.238281 C 200.808594 305.347656 196.3125 311.171875 191.636719 316.695313 L 191.519531 316.832031 L 191.636719 316.964844 L 191.792969 316.824219 L 191.949219 316.960938 C 196.632813 311.429688 201.136719 305.59375 205.429688 299.472656 L 205.261719 299.355469 L 205.070313 299.433594 L 222.6875 343.476563 L 222.878906 343.402344 L 222.828125 343.203125 C 222.152344 343.371094 221.476563 343.535156 220.800781 343.695313 L 220.847656 343.898438 L 220.972656 343.734375 C 210.789063 335.957031 201.035156 326.917969 191.945313 316.691406 L 191.792969 316.824219 L 191.949219 316.960938 Z M 182.257813 305.34375 L 182.421875 305.46875 C 188.113281 298.128906 193.472656 290.273438 198.433594 281.945313 L 198.484375 281.859375 L 182.5 241.898438 L 166.320313 282.34375 L 166.375 282.429688 C 171.253906 290.578125 176.511719 298.269531 182.097656 305.46875 L 182.257813 305.679688 L 182.421875 305.46875 L 182.257813 305.34375 L 182.421875 305.21875 C 176.847656 298.03125 171.597656 290.351563 166.726563 282.21875 L 166.550781 282.324219 L 166.742188 282.402344 L 182.5 243.003906 L 198.066406 281.917969 L 198.257813 281.84375 L 198.078125 281.738281 C 193.128906 290.050781 187.777344 297.890625 182.097656 305.21875 L 182.257813 305.34375 L 182.421875 305.21875 Z M 143.78125 343.804688 L 143.90625 343.96875 C 153.75 336.4375 163.199219 327.738281 172.027344 317.917969 L 172.152344 317.785156 L 172.03125 317.648438 C 167.527344 312.492188 163.195313 307.054688 159.058594 301.351563 L 158.839844 301.046875 L 141.84375 343.542969 L 142.070313 343.601563 C 142.625 343.738281 143.179688 343.871094 143.734375 344.007813 L 143.828125 344.027344 L 143.90625 343.96875 L 143.78125 343.804688 L 143.828125 343.605469 C 143.273438 343.472656 142.722656 343.339844 142.171875 343.203125 L 142.121094 343.402344 L 142.3125 343.476563 L 159.085938 301.546875 L 158.894531 301.46875 L 158.726563 301.589844 C 162.871094 307.304688 167.207031 312.753906 171.722656 317.917969 L 171.875 317.78125 L 171.722656 317.644531 C 162.910156 327.445313 153.480469 336.128906 143.65625 343.644531 L 143.78125 343.804688 L 143.828125 343.605469 Z M 182.5 364.796875 L 182.5 364.589844 C 132.21875 364.589844 86.695313 344.210938 53.742188 311.257813 C 20.792969 278.304688 0.410156 232.78125 0.410156 182.5 C 0.410156 132.21875 20.792969 86.695313 53.742188 53.742188 C 86.695313 20.789063 132.21875 0.410156 182.5 0.410156 C 232.78125 0.410156 278.304688 20.789063 311.257813 53.742188 C 344.210938 86.695313 364.589844 132.21875 364.589844 182.5 C 364.589844 232.78125 344.210938 278.304688 311.257813 311.257813 C 278.304688 344.210938 232.78125 364.589844 182.5 364.589844 L 182.5 365 C 283.292969 365 365 283.292969 365 182.5 C 365 81.707031 283.292969 0 182.5 0 C 81.707031 0 0 81.707031 0 182.5 C 0 283.292969 81.707031 365 182.5 365 L 182.5 364.796875 " />
        </g>
    </symbol>
    <symbol id="pandora" viewBox="0 0 180 200">
        <g id="bg">
            <rect fill="#FFFFFF" width="180" height="200" />
        </g>
        <g id="icons">
            <g>
                <path fill="#019FEE" d="M160.7,74.2c-0.9-8.8-3.4-17.1-8.8-24.4c-4.1-5.6-9.4-9.8-15.6-13c-6-3-12.3-5-19-5.9l0,0
                    c-3.9-0.6-7.8-0.9-11.8-0.9H43.8c-0.4,0-0.7,0.3-0.7,0.7l0,0c0,46.1,0,92.2,0,138.3v0.1c0,0.4,0.3,0.7,0.7,0.7l0,0
                    c12.3,0,24.7,0,37,0c3.3,0,6-2.7,6.1-5.9c0-0.3,0-0.6,0-0.7c0-8.6,0-17.1,0-25.5v-0.3c0-0.4,0.3-0.7,0.7-0.7c0,0,0,0,0.1,0
                    c3.1,0,6.4,0,9.6,0c2.4,0,4.9,0,7.3-0.3c7.8-0.6,15.7-2,23.1-5c2.3-0.9,4.6-2,6.9-3.1c9-4.9,15.8-11.7,20.6-20.8
                    c2.3-4.6,3.9-9.4,4.9-14.6c0.6-2.7,0.9-5.4,1-8.3c0-0.1,0-0.1,0-0.3s0-0.1,0-0.3v-7c0,0,0,0,0-0.1C160.9,76,160.8,75.1,160.7,74.2
                    z" />
            </g>
        </g>
    </symbol>
    <symbol id="pocket-casts" viewBox="0 0 39 36" style="enable-background:new 0 0 39 36;">
        <g>
            <path fill="#F44336" d="M18,36c9.9,0,18-8,18-18S28,0,18,0S0,8,0,18S8,36,18,36L18,36L18,36z" />
            <path fill="#FFFFFF" d="M17.8,27.1c-4.8-0.2-8.7-4.1-8.7-9c0-5,4.1-9,9-9s8.9,3.9,9,8.7c0,0.2,0.1,0.3,0.3,0.3H30
                c0.2,0,0.3-0.1,0.3-0.3C30.1,11.2,24.7,5.9,18,5.9c-6.8,0-12.3,5.5-12.3,12.3c0,6.7,5.3,12.1,11.9,12.3c0.2,0,0.3-0.1,0.3-0.3v-2.6
                C18.1,27.2,17.9,27.1,17.8,27.1L17.8,27.1L17.8,27.1z M18.1,11c-3.9,0-7.1,3.2-7.1,7.1c0,3.8,3,6.9,6.8,7.1c0.2,0,0.3-0.1,0.3-0.3
                v-2.1c0-0.2-0.1-0.3-0.3-0.3c-2.3-0.2-4.1-2.1-4.1-4.4c0-2.4,2-4.4,4.4-4.4c2.3,0,4.2,1.8,4.4,4.1c0,0.2,0.2,0.3,0.3,0.3h2.1
                c0.2,0,0.3-0.2,0.3-0.3C25,14,21.9,11,18.1,11L18.1,11L18.1,11z" />
        </g>
    </symbol>
    <symbol id="rss" viewBox="0 0 12 12">
        <path
            d="m1.59148 8.7795c-.878186.0032-1.58780186.71645-1.58566708 1.5938.00213478.8773.71521308 1.5871 1.59340708 1.5861.87819-.0011 1.58954-.7126 1.58955-1.59-.0032-.879-.71739-1.58991-1.59729-1.5899zm-1.59147997-4.7118v2.32108c1.48808997.00154 2.91461997.59358 3.96575997 1.64589 1.05115 1.05231 1.64082 2.47873 1.63927 3.96533h2.32333c.00464-2.10318-.82881-4.12172-2.31634-5.60999-1.48753-1.48826-3.5068-2.32386-5.61201997-2.32231zm0-4.06189726v2.32108726c5.33125997.00952 9.65431997 4.31803 9.67666997 9.64411h2.32333c-.0096-6.61422-5.37938-11.97100707-11.99999997-11.9710001z"
            fill="#257BBC" />
    </symbol>
    <symbol id="spotify" viewBox="0 0 170.1 170.1" style="enable-background:new 0 0 170.1 170.1;" xml:space="preserve">
        <g>
            <g>
                <g>
                    <path fill="#1ED760" d="M85,1.3C38.8,1.3,1.3,38.8,1.3,85c0,46.3,37.5,83.7,83.7,83.7c46.3,0,83.7-37.5,83.7-83.7
                        C168.8,38.8,131.3,1.3,85,1.3z M123.4,122.1c-1.5,2.5-4.7,3.2-7.2,1.7c-19.7-12-44.4-14.7-73.6-8.1c-2.8,0.6-5.6-1.1-6.2-3.9
                        c-0.6-2.8,1.1-5.6,3.9-6.2c31.9-7.3,59.3-4.2,81.3,9.3C124.2,116.4,124.9,119.6,123.4,122.1z M133.7,99.3c-1.9,3.1-5.9,4-9,2.2
                        c-22.5-13.8-56.8-17.8-83.4-9.8c-3.5,1-7.1-0.9-8.1-4.3c-1-3.5,0.9-7.1,4.4-8.1c30.4-9.2,68.2-4.8,94.1,11.1
                        C134.6,92.2,135.6,96.2,133.7,99.3z M134.6,75.5c-27-16-71.5-17.5-97.3-9.7c-4.1,1.3-8.5-1.1-9.8-5.2c-1.3-4.1,1.1-8.5,5.2-9.8
                        c29.6-9,78.8-7.2,109.8,11.2c3.7,2.2,4.9,7,2.7,10.7C143.1,76.5,138.3,77.7,134.6,75.5z" />
                </g>
            </g>
        </g>
    </symbol>
    <symbol id="stitcher" viewBox="0 0 122.88 51.61" style="enable-background:new 0 0 122.88 51.61">
        <g>
            <polygon fill="#3590C5" points="0,10.14 21.5,10.14 21.5,49.15 0,49.15 0,10.14" />
            <polygon fill="#C53827" points="101.38,7.99 122.88,7.99 122.88,43.93 101.38,43.93 101.38,7.99" />
            <polygon fill="#EC8B24" points="76.19,0 97.69,0 97.69,46.7 76.19,46.7 76.19,0" />
            <polygon fill="#FBC618" points="51,6.76 72.5,6.76 72.5,51.61 51,51.61 51,6.76" />
            <polygon fill="#612268" points="25.5,3.07 47,3.07 47,46.39 25.5,46.39 25.5,3.07" />
        </g>
    </symbol>
    <symbol id="tuneIn" viewBox="56 56 200 88" fill="none">
        <g id="Logos">
            <g id="Logo__x2013__Horizontal_1A_12_">
                <g id="Logo_2_">
                    <path fill="#1C203C" d="M95,96.8v4c0,0.4-0.4,0.8-0.8,0.8h-5c-0.2,0-0.4,0.2-0.4,0.4v21.2c0,0.4-0.4,0.8-0.8,0.8h-4
				c-0.4,0-0.8-0.4-0.8-0.8V102c0-0.2-0.2-0.4-0.4-0.4h-5c-0.4,0-0.8-0.4-0.8-0.8v-4c0-0.4,0.4-0.8,0.8-0.8h16.4
				C94.6,96,95,96.4,95,96.8z M117,96h-4c-0.4,0-0.8,0.4-0.8,0.8v18.8c0,1.8-1.4,3.2-3.9,3.2c-2.4,0-3.8-1.4-3.8-3.2V96.8
				c0-0.4-0.4-0.8-0.8-0.8h-4c-0.4,0-0.8,0.4-0.8,0.8v18.8c0,4.8,4,8.8,9.4,8.8c5.5,0,9.5-4,9.5-8.8V96.8
				C117.8,96.4,117.4,96,117,96z M139.6,96h-4c-0.4,0-0.8,0.4-0.8,0.8v15c0,0.2-0.3,0.3-0.4,0.1l-5.5-15.2c-0.1-0.4-0.4-0.7-1-0.7
				h-4.8c-0.4,0-0.8,0.4-0.8,0.8v26.4c0,0.4,0.4,0.8,0.8,0.8h4c0.4,0,0.8-0.4,0.8-0.8v-13.8c0-0.2,0.3-0.3,0.4-0.1l5.4,14
				c0.1,0.3,0.4,0.7,1.1,0.7h4.7c0.4,0,0.8-0.4,0.8-0.8V96.8C140.4,96.4,140,96,139.6,96z M160.3,118.4h-9.5c-0.2,0-0.4-0.2-0.4-0.4
				v-4.8c0-0.2,0.2-0.4,0.4-0.4h9c0.4,0,0.8-0.4,0.8-0.8v-4c0-0.4-0.4-0.8-0.8-0.8h-9c-0.2,0-0.4-0.2-0.4-0.4V102
				c0-0.2,0.2-0.4,0.4-0.4h9.3c0.4,0,0.8-0.4,0.8-0.8v-4c0-0.4-0.4-0.8-0.8-0.8h-14.5c-0.4,0-0.8,0.4-0.8,0.8v26.4
				c0,0.4,0.4,0.8,0.8,0.8h14.7c0.4,0,0.8-0.4,0.8-0.8v-4C161.1,118.8,160.7,118.4,160.3,118.4z M256,59v62c0,1.7-1.3,3-3,3h-69v17
				c0,1.7-1.3,3-3,3H59c-1.7,0-3-1.3-3-3V79c0-1.7,1.3-3,3-3h119V59c0-1.7,1.3-3,3-3h72C254.7,56,256,57.3,256,59z M178,82H62.5
				c-0.3,0-0.5,0.2-0.5,0.5v55c0,0.3,0.2,0.5,0.5,0.5h115c0.3,0,0.5-0.2,0.5-0.5V82z M213.8,99.4c0-0.4-0.4-0.8-0.8-0.8h-3.4
				c-0.2,0-0.4-0.2-0.4-0.4V81.8c0-0.2,0.2-0.4,0.4-0.4h3c0.4,0,0.8-0.4,0.8-0.8v-3.8c0-0.4-0.4-0.8-0.8-0.8h-12.4
				c-0.4,0-0.8,0.4-0.8,0.8v3.8c0,0.4,0.4,0.8,0.8,0.8h3c0.2,0,0.4,0.2,0.4,0.4v16.4c0,0.2-0.2,0.4-0.4,0.4h-3.4
				c-0.4,0-0.8,0.4-0.8,0.8v3.8c0,0.4,0.4,0.8,0.8,0.8H213c0.4,0,0.8-0.4,0.8-0.8V99.4z M236.2,76.8c0-0.4-0.4-0.8-0.8-0.8h-4
				c-0.4,0-0.8,0.4-0.8,0.8v15c0,0.2-0.3,0.3-0.4,0.1l-5.5-15.2c-0.1-0.4-0.4-0.7-1-0.7H219c-0.4,0-0.8,0.4-0.8,0.8v26.4
				c0,0.4,0.4,0.8,0.8,0.8h4c0.4,0,0.8-0.4,0.8-0.8V89.4c0-0.2,0.3-0.3,0.4-0.1l5.4,14c0.1,0.3,0.4,0.7,1.1,0.7h4.7
				c0.4,0,0.8-0.4,0.8-0.8V76.8z" />
                </g>
            </g>
        </g>
    </symbol>
    <symbol id="icon-launch" viewBox="0 0 24 24">
        <path d="M0 0h24v24H0z" fill="none"/>
        <path d="M19 19H5V5h7V3H5c-1.11 0-2 .9-2 2v14c0 1.1.89 2 2 2h14c1.1 0 2-.9 2-2v-7h-2v7zM14 3v2h3.59l-9.83 9.83 1.41 1.41L19 6.41V10h2V3h-7z"/>
    </symbol>
    <symbol id="globe" viewBox="0 0 16 16" >
        <path d="M8 1.25C6.66498 1.25 5.35994 1.64588 4.2499 2.38758C3.13987 3.12928 2.27471 4.18349 1.76382 5.41689C1.25292 6.65029 1.11925 8.00749 1.3797 9.31686C1.64015 10.6262 2.28303 11.829 3.22703 12.773C4.17104 13.717 5.37377 14.3598 6.68314 14.6203C7.99252 14.8808 9.34971 14.7471 10.5831 14.2362C11.8165 13.7253 12.8707 12.8601 13.6124 11.7501C14.3541 10.6401 14.75 9.33502 14.75 8C14.748 6.2104 14.0362 4.49466 12.7708 3.22922C11.5053 1.96378 9.78961 1.25199 8 1.25ZM6.69188 10.75H9.30813C9.02459 11.6137 8.5808 12.4163 8 13.1156C7.4192 12.4163 6.97541 11.6137 6.69188 10.75ZM6.33813 9.25C6.22063 8.42081 6.22063 7.57919 6.33813 6.75H9.66188C9.77938 7.57919 9.77938 8.42081 9.66188 9.25H6.33813ZM2.75 8C2.74998 7.57873 2.80098 7.15901 2.90188 6.75H4.82625C4.72458 7.58023 4.72458 8.41977 4.82625 9.25H2.90188C2.80098 8.84099 2.74998 8.42127 2.75 8ZM9.30813 5.25H6.69188C6.97541 4.38627 7.4192 3.58372 8 2.88438C8.5808 3.58372 9.02459 4.38627 9.30813 5.25ZM11.1738 6.75H13.0981C13.3006 7.57103 13.3006 8.42897 13.0981 9.25H11.1738C11.2754 8.41977 11.2754 7.58023 11.1738 6.75ZM12.47 5.25H10.875C10.6716 4.51628 10.3788 3.81036 10.0031 3.14812C11.0254 3.5729 11.8883 4.30815 12.47 5.25ZM6 3.14812C5.62323 3.81021 5.32936 4.51614 5.125 5.25H3.53C4.1125 4.30765 4.97659 3.57234 6 3.14812ZM3.53 10.75H5.125C5.32936 11.4839 5.62323 12.1898 6 12.8519C4.97659 12.4277 4.1125 11.6923 3.53 10.75ZM10.0031 12.8519C10.3788 12.1896 10.6716 11.4837 10.875 10.75H12.47C11.8883 11.6918 11.0254 12.4271 10.0031 12.8519Z"/>
    </symbol>
    <svg id="phone" viewBox="0 0 16 16" xmlns="http://www.w3.org/2000/svg">
        <path  d="M14 9.67473L11.0569 8.35535L11.0456 8.35035C10.8543 8.26788 10.6454 8.23467 10.4379 8.25378C10.2305 8.27289 10.0312 8.3437 9.85813 8.45973C9.83388 8.47596 9.81051 8.49349 9.78813 8.51223L8.39375 9.69973C7.58125 9.2591 6.74188 8.4266 6.30063 7.6241L7.49188 6.20785C7.51103 6.18499 7.52877 6.16099 7.545 6.13598C7.65799 5.96357 7.72659 5.7659 7.74469 5.56057C7.76279 5.35524 7.72984 5.14861 7.64875 4.9591C7.64683 4.95547 7.64516 4.95171 7.64375 4.94785L6.325 1.99973C6.21676 1.75318 6.03201 1.54803 5.7981 1.41464C5.5642 1.28126 5.29357 1.22672 5.02625 1.2591C4.11899 1.37828 3.28612 1.82365 2.68322 2.51201C2.08031 3.20037 1.74859 4.08466 1.75 4.99973C1.75 10.1004 5.89938 14.2497 11 14.2497C11.9151 14.2511 12.7994 13.9194 13.4877 13.3165C14.1761 12.7136 14.6214 11.8807 14.7406 10.9735C14.773 10.7062 14.7185 10.4355 14.5851 10.2016C14.4517 9.96772 14.2466 9.78297 14 9.67473ZM11 12.7497C8.94534 12.7472 6.97554 11.9299 5.52267 10.4771C4.0698 9.02419 3.25249 7.05439 3.25 4.99973C3.24857 4.48191 3.42437 3.97919 3.74818 3.57511C4.07199 3.17103 4.52432 2.88991 5.03 2.77848L6.20625 5.40348L5.00875 6.82973C4.9894 6.85279 4.97145 6.877 4.955 6.90223C4.83697 7.08257 4.76758 7.29037 4.75356 7.50545C4.73954 7.72053 4.78138 7.93559 4.875 8.12973C5.46375 9.33473 6.67688 10.5397 7.89438 11.1297C8.08982 11.2224 8.30595 11.2627 8.52165 11.2469C8.73736 11.231 8.94525 11.1594 9.125 11.0391C9.14917 11.0228 9.17234 11.0051 9.19438 10.986L10.5963 9.7941L13.2213 10.9697C13.1098 11.4754 12.8287 11.9277 12.4246 12.2516C12.0205 12.5754 11.5178 12.7512 11 12.7497Z" />
    </svg>
    <svg id="email-company" viewBox="0 0 16 16" xmlns="http://www.w3.org/2000/svg">
        <path  d="M14 2.75H2C1.80109 2.75 1.61032 2.82902 1.46967 2.96967C1.32902 3.11032 1.25 3.30109 1.25 3.5V12C1.25 12.3315 1.3817 12.6495 1.61612 12.8839C1.85054 13.1183 2.16848 13.25 2.5 13.25H13.5C13.8315 13.25 14.1495 13.1183 14.3839 12.8839C14.6183 12.6495 14.75 12.3315 14.75 12V3.5C14.75 3.30109 14.671 3.11032 14.5303 2.96967C14.3897 2.82902 14.1989 2.75 14 2.75ZM12.0719 4.25L8 7.9825L3.92812 4.25H12.0719ZM2.75 11.75V5.205L7.49312 9.55313C7.63146 9.67997 7.81232 9.75033 8 9.75033C8.18768 9.75033 8.36854 9.67997 8.50688 9.55313L13.25 5.205V11.75H2.75Z" />
    </svg>
</svg>



<bsp-header class="Page-header">
    <div class="Page-header-hamburger-menu">
        <div class="Page-header-hamburger-menu-wrapper">
            <div class="Page-header-hamburger-menu-content">
                
                    <nav class="Navigation" data-nav-align="center">
    
        <ul class="Navigation-items">
            
                <li class="Navigation-items-item"><div class="NavigationItem  has-menu">
    <div class="NavigationItem-text">
        
            <a  href="https://www.biospace.com/news">News</a>
        
        
            <div class="NavigationItem-more">
                <button aria-label="More"><svg class="chevron"><use xlink:href="#chevron-down"></use></svg></button>
            </div>
        
    </div>

    
        <ul class="NavigationItem-items">
            
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/drug-development"><span class="NavigationLink-text">Drug Development</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/fda"><span class="NavigationLink-text">FDA</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/drug-delivery"><span class="NavigationLink-text">Manufacturing</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/deals"><span class="NavigationLink-text">Deals</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/business"><span class="NavigationLink-text">Business</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/job-trends"><span class="NavigationLink-text">Job Trends</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/cell-and-gene-therapy"><span class="NavigationLink-text">Cell and Gene Therapy</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/cancer"><span class="NavigationLink-text">Cancer</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/opinion-column"><span class="NavigationLink-text">Opinions</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/search-press-releases"><span class="NavigationLink-text">Press Releases</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/latest-news-press-releases"><span class="NavigationLink-text">All News &amp; Releases</span></a>
</li>
                
            
        </ul>
    
</div>
</li>
            
                <li class="Navigation-items-item"><div class="NavigationItem ">
    <div class="NavigationItem-text">
        
            <a  href="https://www.biospace.com/podcasts">Podcasts</a>
        
        
    </div>

    
</div>
</li>
            
                <li class="Navigation-items-item"><div class="NavigationItem ">
    <div class="NavigationItem-text">
        
            <a  href="https://www.biospace.com/events">Events</a>
        
        
    </div>

    
</div>
</li>
            
                <li class="Navigation-items-item"><div class="NavigationItem ">
    <div class="NavigationItem-text">
        
            <a  href="https://jobs.biospace.com/searchjobs/">Jobs</a>
        
        
    </div>

    
</div>
</li>
            
                <li class="Navigation-items-item"><div class="NavigationItem ">
    <div class="NavigationItem-text">
        
            <a  href="https://www.biospace.com/companies">Companies</a>
        
        
    </div>

    
</div>
</li>
            
                <li class="Navigation-items-item"><div class="NavigationItem ">
    <div class="NavigationItem-text">
        
            <a  href="https://www.biospace.com/hotbeds">Hotbeds</a>
        
        
    </div>

    
</div>
</li>
            
                <li class="Navigation-items-item"><div class="NavigationItem  has-menu">
    <div class="NavigationItem-text">
        
            <span>More</span>
        
        
            <div class="NavigationItem-more">
                <button aria-label="More"><svg class="chevron"><use xlink:href="#chevron-down"></use></svg></button>
            </div>
        
    </div>

    
        <ul class="NavigationItem-items">
            
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/reports"><span class="NavigationLink-text">Reports</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/career-advice"><span class="NavigationLink-text">Career Advice</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/nextgen"><span class="NavigationLink-text">NextGen: Top Startups to Watch</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/biospace-40-under-40"><span class="NavigationLink-text">40 Under 40</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/best-places-to-work"><span class="NavigationLink-text">Best Places to Work</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/employer-resources"><span class="NavigationLink-text">Employer Resources</span></a>
</li>
                
            
        </ul>
    
</div>
</li>
            
                <li class="Navigation-items-item"><div class="NavigationItem  has-menu">
    <div class="NavigationItem-text">
        
            <span>Advertise</span>
        
        
            <div class="NavigationItem-more">
                <button aria-label="More"><svg class="chevron"><use xlink:href="#chevron-down"></use></svg></button>
            </div>
        
    </div>

    
        <ul class="NavigationItem-items">
            
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://employer.biospace.com/pricing/"><span class="NavigationLink-text">Post Jobs</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/talent-solutions"><span class="NavigationLink-text">Talent Solutions</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/advertise"><span class="NavigationLink-text">Advertise</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/press-release-solutions"><span class="NavigationLink-text">Submit a Press Release</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://events.biospace.com/"><span class="NavigationLink-text">Submit an Event</span></a>
</li>
                
            
        </ul>
    
</div>
</li>
            
        </ul>
    

    <div class="Page-header-leaderboard-ad">
        
            <div id="googleAd8cef668d-4469-48dd-a6da-b50c84368632" data-module class="GoogleDfpAd" data-slot-name="21692246607/BioSpace_RunOfSite" data-slot-sizes="[[728, 90]]" data-slot-adSizeMap="[[[1365, 1], [728, 90]]]" data-targeting-data="{&quot;id&quot;:&quot;00000199-7a85-d809-a1fd-7aa7ca300001&quot;,&quot;type&quot;:&quot;press-release&quot;,&quot;tags&quot;:[&quot;Multiple sclerosis&quot;,&quot;Northern California&quot;,&quot;Data&quot;,&quot;Phase II&quot;,&quot;Events&quot;],&quot;category&quot;:&quot;Press Releases&quot;,&quot;companies&quot;:[&quot;Genentech, Inc.&quot;]}">
    <span class="GoogleDfpAd-placeholder"></span>
</div>

        
    </div>
</nav>

                
                
                <div class="ButtonNavigation">
                    
                        
                            <a href="https://www.biospace.com/subscribe-to-newsletters" class="Button" data-theme="secondary">SUBSCRIBE</a>
                        
                    
                </div>
            </div>
        </div>
    </div>

    <div class="Page-header-bar">
        <button class="Page-header-menu-trigger" aria-expanded="false"><svg class="burger-menu"><use xlink:href="#burger-menu"></use></svg><svg class="close-x"><use xlink:href="#close-x"></use></svg><span class="label">Menu</span></button>

        
            
                <div class="Page-header-bar-logo"><a aria-label="home page" href="/"  >
    
        <picture>
            
            
                
                    

                
            

            
            
                
    
        <source type="image/webp"  width="250" height="67" srcset="https://static.biospace.com/dims4/default/9075aee/2147483647/strip/true/crop/496x132+0+0/resize/250x67!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fe4%2Fed%2F07b192644c508cbc301bc9ae721c%2Flogo.png 1x,https://static.biospace.com/dims4/default/b360a3f/2147483647/strip/true/crop/496x132+0+0/resize/500x134!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fe4%2Fed%2F07b192644c508cbc301bc9ae721c%2Flogo.png 2x"/>

    

    
        <source width="250" height="67" srcset="https://static.biospace.com/dims4/default/193f35f/2147483647/strip/true/crop/496x132+0+0/resize/250x67!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fe4%2Fed%2F07b192644c508cbc301bc9ae721c%2Flogo.png 1x,https://static.biospace.com/dims4/default/d12264c/2147483647/strip/true/crop/496x132+0+0/resize/500x134!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fe4%2Fed%2F07b192644c508cbc301bc9ae721c%2Flogo.png 2x"/>

    


            
            
    <img class="Image" alt="BioSpace logo" srcset="https://static.biospace.com/dims4/default/193f35f/2147483647/strip/true/crop/496x132+0+0/resize/250x67!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fe4%2Fed%2F07b192644c508cbc301bc9ae721c%2Flogo.png 1x,https://static.biospace.com/dims4/default/d12264c/2147483647/strip/true/crop/496x132+0+0/resize/500x134!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fe4%2Fed%2F07b192644c508cbc301bc9ae721c%2Flogo.png 2x" width="250" height="67" src="https://static.biospace.com/dims4/default/193f35f/2147483647/strip/true/crop/496x132+0+0/resize/250x67!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fe4%2Fed%2F07b192644c508cbc301bc9ae721c%2Flogo.png"
    >


        </picture>
    
    </a>
</div>
            
        

        <div class="Page-header-button-navigation">
            
                
                    <a href="https://www.biospace.com/subscribe-to-newsletters" class="Button" data-theme="secondary">SUBSCRIBE</a>
                
            
        </div>

        <div class="Page-header-end">
            
            
                <bsp-search-overlay class="SearchOverlay">
    
    
    <button class="SearchOverlay-search-button">
        <svg class="icon-magnify">
            <use xlink:href="#icon-magnify"></use>
        </svg>
        <span class="sr-only">
            Show Search
        </span>
        <svg class="close-x">
            <use xlink:href="#close-x"></use>
        </svg>
    </button>
</bsp-search-overlay>

            
        </div>
    </div>

    <div class="Page-header-navigation">
        
            <nav class="Navigation" data-nav-align="center">
    
        <ul class="Navigation-items">
            
                <li class="Navigation-items-item"><div class="NavigationItem  has-menu">
    <div class="NavigationItem-text">
        
            <a  href="https://www.biospace.com/news">News</a>
        
        
            <div class="NavigationItem-more">
                <button aria-label="More"><svg class="chevron"><use xlink:href="#chevron-down"></use></svg></button>
            </div>
        
    </div>

    
        <ul class="NavigationItem-items">
            
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/drug-development"><span class="NavigationLink-text">Drug Development</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/fda"><span class="NavigationLink-text">FDA</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/drug-delivery"><span class="NavigationLink-text">Manufacturing</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/deals"><span class="NavigationLink-text">Deals</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/business"><span class="NavigationLink-text">Business</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/job-trends"><span class="NavigationLink-text">Job Trends</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/cell-and-gene-therapy"><span class="NavigationLink-text">Cell and Gene Therapy</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/cancer"><span class="NavigationLink-text">Cancer</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/opinion-column"><span class="NavigationLink-text">Opinions</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/search-press-releases"><span class="NavigationLink-text">Press Releases</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/latest-news-press-releases"><span class="NavigationLink-text">All News &amp; Releases</span></a>
</li>
                
            
        </ul>
    
</div>
</li>
            
                <li class="Navigation-items-item"><div class="NavigationItem ">
    <div class="NavigationItem-text">
        
            <a  href="https://www.biospace.com/podcasts">Podcasts</a>
        
        
    </div>

    
</div>
</li>
            
                <li class="Navigation-items-item"><div class="NavigationItem ">
    <div class="NavigationItem-text">
        
            <a  href="https://www.biospace.com/events">Events</a>
        
        
    </div>

    
</div>
</li>
            
                <li class="Navigation-items-item"><div class="NavigationItem ">
    <div class="NavigationItem-text">
        
            <a  href="https://jobs.biospace.com/searchjobs/">Jobs</a>
        
        
    </div>

    
</div>
</li>
            
                <li class="Navigation-items-item"><div class="NavigationItem ">
    <div class="NavigationItem-text">
        
            <a  href="https://www.biospace.com/companies">Companies</a>
        
        
    </div>

    
</div>
</li>
            
                <li class="Navigation-items-item"><div class="NavigationItem ">
    <div class="NavigationItem-text">
        
            <a  href="https://www.biospace.com/hotbeds">Hotbeds</a>
        
        
    </div>

    
</div>
</li>
            
                <li class="Navigation-items-item"><div class="NavigationItem  has-menu">
    <div class="NavigationItem-text">
        
            <span>More</span>
        
        
            <div class="NavigationItem-more">
                <button aria-label="More"><svg class="chevron"><use xlink:href="#chevron-down"></use></svg></button>
            </div>
        
    </div>

    
        <ul class="NavigationItem-items">
            
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/reports"><span class="NavigationLink-text">Reports</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/career-advice"><span class="NavigationLink-text">Career Advice</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/nextgen"><span class="NavigationLink-text">NextGen: Top Startups to Watch</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/biospace-40-under-40"><span class="NavigationLink-text">40 Under 40</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/best-places-to-work"><span class="NavigationLink-text">Best Places to Work</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/employer-resources"><span class="NavigationLink-text">Employer Resources</span></a>
</li>
                
            
        </ul>
    
</div>
</li>
            
                <li class="Navigation-items-item"><div class="NavigationItem  has-menu">
    <div class="NavigationItem-text">
        
            <span>Advertise</span>
        
        
            <div class="NavigationItem-more">
                <button aria-label="More"><svg class="chevron"><use xlink:href="#chevron-down"></use></svg></button>
            </div>
        
    </div>

    
        <ul class="NavigationItem-items">
            
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://employer.biospace.com/pricing/"><span class="NavigationLink-text">Post Jobs</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/talent-solutions"><span class="NavigationLink-text">Talent Solutions</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/advertise"><span class="NavigationLink-text">Advertise</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/press-release-solutions"><span class="NavigationLink-text">Submit a Press Release</span></a>
</li>
                
                    <li class="NavigationItem-items-item"><a class="NavigationLink" href="https://events.biospace.com/"><span class="NavigationLink-text">Submit an Event</span></a>
</li>
                
            
        </ul>
    
</div>
</li>
            
        </ul>
    

    <div class="Page-header-leaderboard-ad">
        
            <div id="googleAd8cef668d-4469-48dd-a6da-b50c84368632" data-module class="GoogleDfpAd" data-slot-name="21692246607/BioSpace_RunOfSite" data-slot-sizes="[[728, 90]]" data-slot-adSizeMap="[[[1365, 1], [728, 90]]]" data-targeting-data="{&quot;id&quot;:&quot;00000199-7a85-d809-a1fd-7aa7ca300001&quot;,&quot;type&quot;:&quot;press-release&quot;,&quot;tags&quot;:[&quot;Multiple sclerosis&quot;,&quot;Northern California&quot;,&quot;Data&quot;,&quot;Phase II&quot;,&quot;Events&quot;],&quot;category&quot;:&quot;Press Releases&quot;,&quot;companies&quot;:[&quot;Genentech, Inc.&quot;]}">
    <span class="GoogleDfpAd-placeholder"></span>
</div>

        
    </div>
</nav>

        
    </div>

    <div class="SearchOverlay-search-overlay">
        <form class="SearchOverlay-search-form" action="https://www.biospace.com/search#nt=navsearch" novalidate="" autocomplete="off">
            <label class="SearchOverlay-search-label">
                <input placeholder="Keyword Search..." type="text" class="SearchOverlay-search-input" name="q" required="true">
                <span class="sr-only">
                    Search Query
                </span>
                <button type="submit" class="SearchOverlay-search-submit">
                    <svg>
                        <use xlink:href="#icon-magnify"></use>
                    </svg>
                    <span class="sr-only">Submit Search</span>
                </button>
            </label>
        </form>
    </div>

    
</bsp-header>

    


        
    <div class="Page-above" data-modulewell><div id="googleAdc930e077-7674-4f48-89ce-a7fb1bd53892" data-module class="GoogleDfpAd" data-slot-name="21692246607/BioSpace_RunOfSite" data-slot-sizes="[[300, 50]]" data-slot-adSizeMap="[[[1, 1365], [300, 50]], [[1, 320], [300, 50]]]" data-targeting-data="{&quot;id&quot;:&quot;00000199-7a85-d809-a1fd-7aa7ca300001&quot;,&quot;type&quot;:&quot;press-release&quot;,&quot;tags&quot;:[&quot;Multiple sclerosis&quot;,&quot;Northern California&quot;,&quot;Data&quot;,&quot;Phase II&quot;,&quot;Events&quot;],&quot;category&quot;:&quot;Press Releases&quot;,&quot;companies&quot;:[&quot;Genentech, Inc.&quot;]}" data-leaderboard-ad>
    <span class="GoogleDfpAd-placeholder"></span>
</div>
</div>


        


        <div class="Page-content">
            
            <div class="Page-twoColumn">
                <main class="Page-main" data-module data-padding="none">
                    
                        <div class="ArticlePage-lede">
                            <div class="ArticlePage-lede-content">
                                
    <div class="Page-breadcrumbs"><a class="Link" href="https://www.biospace.com/press-releases">Press Releases</a>
</div>



                                
    <h1 class="Page-headline">Genentech Presents New Data for Ocrevus and Fenebrutinib Across Broad Patient Populations at ECTRIMS 2025</h1>



                                <div class="ArticlePage-actions-wrapper">
                                    <div class="Page-byline"><div class="Page-datePublished">September 24, 2025&nbsp;<span class="divider">|</span>&nbsp;</div><div class="Page-readTime">18 min read</div></div>


                                    


                                    
    <div class="Page-actions">
        <div class="ActionBar">
    <ul class="ActionBar-items">
        
            <li class="ActionBar-items-item"><a class="ActionLink" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.biospace.com%2Fpress-releases%2Fgenentech-presents-new-data-for-ocrevus-and-fenebrutinib-across-broad-patient-populations-at-ectrims-2025&text=Genentech%20Presents%20New%20Data%20for%20Ocrevus%20and%20Fenebrutinib%20Across%20Broad%20Patient%20Populations%20at%20ECTRIMS%202025"
    target="_blank" data-social-service="twitter">
    <svg><use xlink:href="#mono-icon-twitter" /></svg><span>Twitter</span>
</a>
</li>
        
            <li class="ActionBar-items-item"><a class="ActionLink" href="https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fwww.biospace.com%2Fpress-releases%2Fgenentech-presents-new-data-for-ocrevus-and-fenebrutinib-across-broad-patient-populations-at-ectrims-2025&mini=true&title=Genentech%20Presents%20New%20Data%20for%20Ocrevus%20and%20Fenebrutinib%20Across%20Broad%20Patient%20Populations%20at%20ECTRIMS%202025&source=BioSpace"
    target="_blank" data-social-service="linkedin">
    <svg><use xlink:href="#mono-icon-linkedin"></use></svg><span>LinkedIn</span>
</a>
</li>
        
            <li class="ActionBar-items-item"> <a class="ActionLink" href="https://www.facebook.com/dialog/share?app_id=2120989681618413&display=popup&href=https%3A%2F%2Fwww.biospace.com%2Fpress-releases%2Fgenentech-presents-new-data-for-ocrevus-and-fenebrutinib-across-broad-patient-populations-at-ectrims-2025"
    target="_blank" data-social-service="facebook">
    <svg><use xlink:href="#mono-icon-facebook"></use></svg><span>Facebook</span>
</a>
</li>
        
            <li class="ActionBar-items-item"><a class="ActionLink" href="mailto:?subject=Check%20out%20this%20article%20on%20BioSpace&body=Genentech%20Presents%20New%20Data%20for%20Ocrevus%20and%20Fenebrutinib%20Across%20Broad%20Patient%20Populations%20at%20ECTRIMS%202025%0A%0Ahttps%3A%2F%2Fwww.biospace.com%2Fpress-releases%2Fgenentech-presents-new-data-for-ocrevus-and-fenebrutinib-across-broad-patient-populations-at-ectrims-2025"
    data-social-service="mailto">
    <svg>
        <use xlink:href="#mono-icon-mailto"></use>
    </svg>
    <span>
        Email
    </span>
</a>
</li>
        
            <li class="ActionBar-items-item"><a class="ActionLink" href="javascript:window.print()" data-social-service="print">
    <svg>
        <use xlink:href="#mono-icon-print"></use>
    </svg>
    <span>
        Print
    </span>
</a>
</li>
        
    </ul>
</div>


        
            
        
    </div>


                                </div>
                            </div>
                        </div>
                        
                            
                                
                                    

                                
                            
                        
                    

                    <div class="Page-articleBody">

                            


                            

                                

                            
                                <div class="RichTextArticleBody RichTextBody">
                                    <p class="bwalignc">
- <i>Ocrevus subcutaneous maintains consistent benefit-risk profile after two years -</i></p><p class="bwalignc">
- <i>New late-breaking data confirms Ocrevus significantly reduces disability progression in adults with advanced PPMS -</i></p><p class="bwalignc">
- <i>One-year data reinforce that majority of infants potentially exposed to Ocrevus during pregnancy or breastfeeding exhibit antibody responses -</i></p><p class="bwalignc">
- <i>Fenebrutinib two-year Phase II data demonstrate near-complete suppression of disease activity at 96 weeks -</i></p>
    <div id="googleAdc43b0dde-2b04-4cab-adf2-8929307214fc" data-module class="GoogleDfpAd" data-slot-name="21692246607/Biospace_PressReleases" data-slot-sizes="[[728, 90], [300, 50]]" data-slot-adSizeMap="[[[320, 1], [300, 50]], [[992, 1], [728, 90]]]" data-targeting-data="{&quot;id&quot;:&quot;00000199-7a85-d809-a1fd-7aa7ca300001&quot;,&quot;type&quot;:&quot;press-release&quot;,&quot;tags&quot;:[&quot;Multiple sclerosis&quot;,&quot;Northern California&quot;,&quot;Data&quot;,&quot;Phase II&quot;,&quot;Events&quot;],&quot;category&quot;:&quot;Press Releases&quot;,&quot;companies&quot;:[&quot;Genentech, Inc.&quot;]}">
    <span class="GoogleDfpAd-placeholder"></span>
</div>

<p>SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), presents new data for Ocrevus<sup>®</sup> (ocrelizumab) and the investigational Bruton’s tyrosine kinase (BTK) inhibitor fenebrutinib at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Barcelona, Spain (September 24-26).</p><br><span class="LinkEnhancement"><a class="Link" href="https://mms.businesswire.com/media/20250923346934/en/1138268/5/GENE_LOCKUP_Primary_FullColor_RGB_square.jpg" target="_blank" rel="noopener"><img src="https://mms.businesswire.com/media/20250923346934/en/1138268/22/GENE_LOCKUP_Primary_FullColor_RGB_square.jpg"></a></span><br><span class="LinkEnhancement"><a class="Link" href="https://mms.businesswire.com/media/20250923346934/en/1138268/5/GENE_LOCKUP_Primary_FullColor_RGB_square.jpg" target="_blank" rel="noopener"><img src="https://mms.businesswire.com/media/20250923346934/en/1138268/21/GENE_LOCKUP_Primary_FullColor_RGB_square.jpg"></a></span><p>
New data show that treatment with Ocrevus provides significant benefit in preventing disability progression across diverse groups of people with multiple sclerosis (MS), including children with relapsing-remitting multiple sclerosis (RRMS), women with MS who are pregnant or breastfeeding, and adults with advanced primary progressive multiple sclerosis (PPMS). From Genentech’s MS pipeline, Phase II data for fenebrutinib showing near-complete suppression of disease activity at 96 weeks will be presented ahead of upcoming pivotal study readouts.</p><p>
"We have made significant scientific progress in the treatment of MS and improving outcomes for people living with it, including key life moments such as planning for a family,” said Levi Garraway, M.D., Ph.D., Genentech’s chief medical officer and head of Global Product Development. “With over a decade of efficacy and safety evidence, Ocrevus has transformed the course of MS for people with RMS and PPMS, and the new data further reinforce its role in preventing disability progression. We are also encouraged by the potential of fenebrutinib in redefining future treatment.”</p><p>
“ECTRIMS 2025 marks over a decade of scientific advancement since the first Phase III pivotal data from Ocrevus. The deepened understanding of B cells has led to breakthrough therapies that have revolutionized MS management by focusing on slowing disease progression,” said Professor Stephen L. Hauser, Director of the UCSF Weill Institute for Neurosciences. “While significant progress has been made, continued innovation focused on preventing both relapses and progression is essential to empowering people with MS to live life to the fullest. This year’s breadth of data demonstrates our collective commitment towards achieving these goals.”</p><p>
<b>Two-year Ocrevus subcutaneous Phase III data</b></p>
    <div id="googleAd0ccee4c3-2e1f-4cec-a125-ef68e1001c58" data-module class="GoogleDfpAd" data-slot-name="21692246607/Biospace_PressReleases" data-slot-sizes="[[728, 90], [300, 50]]" data-slot-adSizeMap="[[[320, 1], [300, 50]], [[992, 1], [728, 90]]]" data-targeting-data="{&quot;id&quot;:&quot;00000199-7a85-d809-a1fd-7aa7ca300001&quot;,&quot;type&quot;:&quot;press-release&quot;,&quot;tags&quot;:[&quot;Multiple sclerosis&quot;,&quot;Northern California&quot;,&quot;Data&quot;,&quot;Phase II&quot;,&quot;Events&quot;],&quot;category&quot;:&quot;Press Releases&quot;,&quot;companies&quot;:[&quot;Genentech, Inc.&quot;]}">
    <span class="GoogleDfpAd-placeholder"></span>
</div>

<p>
Final data from the Phase III OCARINA II study show that Ocrevus subcutaneous (SC) injection maintains a consistent benefit-risk profile for up to two years, similar to the well-established Ocrevus intravenous infusion (IV), with continued near-complete suppression of relapses, brain lesion activity and disability progression.</p><p>
<b>Phase IIIb Ocrevus results in broad PPMS population</b></p><p>
The ORATORIO-HAND expanded on the PPMS population studied in the registrational ORATORIO study by including older patients (age up to 65) and patients with advanced disability (Expanded Disability Status Scale [EDSS] score up to 8.0), for whom maintaining upper limb function is even more important for preserving quality of life and independence.</p><p>
Ocrevus shows 30% reduction in the risk of time to onset of 12-week composite confirmed disability progression (cCDP) in adults with advanced PPMS compared to placebo after a median 2.75 years of treatment (p=0.0007) in new late-breaking data from the Phase IIIb ORATORIO-HAND study. An even greater reduction of 55% in the risk of time to onset of 12-week cCDP was observed in patients with MRI lesion activity at baseline (p&lt;0.0001).</p><p>
In a large PPMS population that included patients with more advanced disease, Ocrevus was superior to placebo in delaying overall disability progression (EDSS) and worsening of upper limb function (9-hole peg test).</p>
    <div id="googleAdbb63d5b0-922a-43b1-98d9-dd48ff62caec" data-module class="GoogleDfpAd" data-slot-name="21692246607/Biospace_PressReleases" data-slot-sizes="[[728, 90], [300, 50]]" data-slot-adSizeMap="[[[320, 1], [300, 50]], [[992, 1], [728, 90]]]" data-targeting-data="{&quot;id&quot;:&quot;00000199-7a85-d809-a1fd-7aa7ca300001&quot;,&quot;type&quot;:&quot;press-release&quot;,&quot;tags&quot;:[&quot;Multiple sclerosis&quot;,&quot;Northern California&quot;,&quot;Data&quot;,&quot;Phase II&quot;,&quot;Events&quot;],&quot;category&quot;:&quot;Press Releases&quot;,&quot;companies&quot;:[&quot;Genentech, Inc.&quot;]}">
    <span class="GoogleDfpAd-placeholder"></span>
</div>

<p>
The safety profile of Ocrevus was consistent with previous studies, and no new safety signals were reported. Ocrevus is the first and only approved treatment for PPMS, and these data demonstrate that the benefit extends to patients with more advanced disease.</p><p>
<b>Infant outcomes in pregnant and breastfeeding women treated with Ocrevus</b></p><p>
An analysis of more than 5,000 pregnancies from the ocrelizumab pregnancy registry, the largest dataset of pregnancy outcomes for an anti-CD20 therapy in MS, will reinforce previous data that showed in-utero exposure to Ocrevus does not increase the risk of adverse pregnancy or infant outcomes.</p><p>
The majority of infants with potential Ocrevus exposure during pregnancy or breastfeeding exhibited meaningful antibody responses to childhood vaccines in one-year data from the Phase IV MINORE and SOPRANINO studies. Protective antibody responses to eight common vaccines given in the first year of life were observed in 86-100% of infants with potential exposure to Ocrevus during their mother’s pregnancy in MINORE and in 78-100% of infants with potential exposure to Ocrevus during breastfeeding in SOPRANINO. This means these children can recognize and fight the disease if encountered later, preventing severe illness and long-term harm.</p><p>
Infant B-cell levels also remained within normal range after 13 months in 95% (n=20/21) of infants in MINORE and 100% (n=11/11) of infants in SOPRANINO. Further data on the growth and development of infants with potential Ocrevus exposure during the first year of life will also be presented.</p>
    <div id="googleAd96f26175-ddb1-4317-8ec0-c206ae66916a" data-module class="GoogleDfpAd" data-slot-name="21692246607/Biospace_PressReleases" data-slot-sizes="[[728, 90], [300, 50]]" data-slot-adSizeMap="[[[320, 1], [300, 50]], [[992, 1], [728, 90]]]" data-targeting-data="{&quot;id&quot;:&quot;00000199-7a85-d809-a1fd-7aa7ca300001&quot;,&quot;type&quot;:&quot;press-release&quot;,&quot;tags&quot;:[&quot;Multiple sclerosis&quot;,&quot;Northern California&quot;,&quot;Data&quot;,&quot;Phase II&quot;,&quot;Events&quot;],&quot;category&quot;:&quot;Press Releases&quot;,&quot;companies&quot;:[&quot;Genentech, Inc.&quot;]}">
    <span class="GoogleDfpAd-placeholder"></span>
</div>

<p>
<b>Ocrevus in pediatric RRMS</b></p><p>
Late-breaking data from the Phase III OPERETTA 2 study investigating efficacy and safety of Ocrevus in children 10–17 years of age with RRMS will be presented on September 26 at 10:30 CEST. The OPERETTA 2 presentation will be the first time that data from the primary analysis of a pediatric-onset MS trial comparing a high-efficacy DMT (ocrelizumab) versus a globally approved treatment (fingolimod) will be shown. Also, long-term, 96-week results from the Phase II OPERETTA 1 pediatric study will be an oral presentation on September 25 at 15:15 CEST.</p><p>
<b>Fenebrutinib two-year Phase II FENopta OLE results</b></p><p>
Two-year data from the Phase II FENopta open-label extension (OLE) study will be presented, showing that patients with relapsing multiple sclerosis (RMS) treated with fenebrutinib maintained near-complete suppression of disease activity at 96 weeks. Patients enrolled in the OLE had a low annualized relapse rate (ARR) of 0.06, and during this time, there was no disability progression, as measured by the EDSS. At two years, MRI scans detected zero new T1 gadolinium-enhancing (T1-Gd+) lesions, which are markers of active inflammation.</p><p>
Neurofilament light chain, a marker of nerve cell damage, was decreased to healthy donor range in the first year and maintained in the second year of fenebrutinb treatment. Three Phase III clinical trials for fenebrutinib are ongoing, including the FENhance I and II studies in RMS and the FENtrepid study in PPMS. Initial data from the FENtrepid study are expected at the end of this year.</p><p>
In total, Genentech and Roche will present 25 abstracts, including six oral and four late-breaking presentations at ECTRIMS 2025. Follow Genentech on X via @Genentech and keep up to date with ECTRIMS 2025 news and updates by using the hashtag #ECTRIMS2025.</p><p>
<b>About Ocrevus<sup>®</sup> (ocrelizumab)</b></p><p>
Ocrevus is a humanized monoclonal antibody designed to target CD20-positive B cells, a specific type of immune cell thought to be a key contributor to myelin (nerve cell insulation and support) and axonal (nerve cell) damage. Ocrevus IV and Ocrevus subcutaneous (SC; marketed as Ocrevus Zunovo<sup>®</sup> [ocrelizumab hyaluronidase-ocsq] in the U.S.) are the only therapies approved for both RMS (including relapsing-remitting multiple sclerosis [RRMS] and active, secondary progressive multiple sclerosis [SPMS], as well as clinically isolated syndrome [CIS] in the U.S.) and primary progressive multiple sclerosis (PPMS). Both Ocrevus IV and SC are administered every six months. The initial IV dose is given as two 300 mg infusions two weeks apart with subsequent doses given as single 600 mg infusions. Ocrevus SC is given as a single 920 mg subcutaneous injection every six months.</p><p>
<b>About fenebrutinib</b></p><p>
Fenebrutinib is an investigational oral, central nervous system (CNS)-penetrant, reversible and non-covalent Bruton’s tyrosine kinase (BTK) inhibitor with an optimized pharmacokinetics (PK) profile. Fenebrutinib has been shown to be 130 times more selective for BTK vs. other kinases. Fenebrutinib is an inhibitor of both B-cell and microglia activation. This dual inhibition may be able to reduce both multiple sclerosis disease activity and disability progression, thereby potentially addressing the key unmet medical need of disability progression in people living with multiple sclerosis and providing comprehensive MS care. The fenebrutinib Phase III program includes two identical trials in relapsing multiple sclerosis (RMS) (FENhance 1 &amp; 2) with active comparator teriflunomide and the only trial in primary progressive multiple sclerosis (PPMS) (FENtrepid) in which a BTK inhibitor is being evaluated against Ocrevus.</p><p>
<b>About multiple sclerosis</b></p><p>
Multiple sclerosis (MS) is a chronic disease that affects more than 2.9 million people worldwide. MS occurs when the immune system abnormally attacks the insulation and support around nerve cells (myelin sheath) in the central nervous system (brain, spinal cord and optic nerves), causing inflammation and consequent damage. This damage can cause a wide range of symptoms, including weakness, fatigue and difficulty seeing, and may eventually lead to disability. Most people with MS experience their first symptom between 20 and 40 years of age, making the disease the leading cause of acquired non-traumatic disability in younger adults.</p><p>
People with all forms of MS experience disease progression – permanent loss of nerve cells in the central nervous system – from the beginning of their disease even if their symptoms aren’t apparent or don’t appear to be getting worse. Delays in diagnosis and treatment can negatively impact people with MS, in terms of their physical and mental health, and contribute to the negative financial impact on the individual and society. An important goal of treating MS is to slow, stop and ideally prevent progression as early as possible.</p><p>
Relapsing-remitting MS (RRMS) is the most common form of the disease and is characterized by episodes of new or worsening signs or symptoms (relapses) followed by periods of recovery. Approximately 85% of people with MS are initially diagnosed with RRMS. The majority of people who are diagnosed with RRMS will eventually transition to secondary progressive MS (SPMS), in which they experience steadily worsening disability over time. Relapsing forms of MS (RMS) include people with RRMS and people with SPMS who continue to experience relapses. Primary progressive MS (PPMS) is a debilitating form of the disease marked by steadily worsening symptoms but typically without distinct relapses or periods of remission. Approximately 15% of people with MS are diagnosed with the primary progressive form of the disease. Until the FDA approval of Ocrevus intravenous (IV) infusion, there had been no FDA-approved treatments for PPMS and Ocrevus IV and Ocrevus Zunovo are the only approved treatments for PPMS.</p><p>
<b>About Genentech in neuroscience</b></p><p>
Neuroscience is a major focus of research and development at Genentech and Roche. Our goal is to pursue groundbreaking science to develop new treatments that help improve the lives of people with chronic and potentially devastating diseases.</p><p>
Genentech and Roche are investigating more than a dozen medicines for neurological disorders, including multiple sclerosis, stroke, Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, Duchenne muscular dystrophy and autism spectrum disorder. Together with our partners, we are committed to pushing the boundaries of scientific understanding to solve some of the most difficult challenges in neuroscience today.</p><p>
<b>About Genentech Access Solutions</b></p><p>
Access Solutions is part of Genentech’s commitment to helping people access the Genentech medicines they are prescribed, regardless of their ability to pay. The team of in-house specialists at Access Solutions is dedicated to helping people navigate the access and reimbursement process and to providing assistance to eligible patients in the United States who are uninsured or cannot afford the out-of-pocket costs for their medicine. To date, the team has helped more than 2 million patients access the medicines they need. Please contact Access Solutions (866) 4ACCESS/(866) 422-2377 or visit <span class="LinkEnhancement"><a class="Link" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.genentech-access.com&amp;esheet=54327136&amp;newsitemid=20250923346934&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.Genentech-Access.com&amp;index=1&amp;md5=613c7656570a19b0f072986c750f70c5" target="_blank" rel="noopener">http://www.Genentech-Access.com</a></span> for more information.</p><p>
<b>About Genentech</b></p><p>
Founded nearly 50 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit <span class="LinkEnhancement"><a class="Link" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.gene.com&amp;esheet=54327136&amp;newsitemid=20250923346934&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.gene.com&amp;index=2&amp;md5=1165ad0db114613f20b97ab5818bac0d" target="_blank" rel="noopener">http://www.gene.com</a></span>.</p><p>
<b>Indications and Important Safety Information</b></p><p>
<b>What are Ocrevus and Ocrevus Zunovo?</b></p><p>
Ocrevus and Ocrevus Zunovo are prescription medicines used to treat:</p><ul class="bwlistdisc">
<li>
Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults</li>
<li>
Primary progressive MS, in adults.</li>
</ul><p>
It is not known if Ocrevus and Ocrevus Zunovo are safe and effective in children.</p><p>
Who should not receive Ocrevus and Ocrevus Zunovo?</p><p>
Do not receive Ocrevus or Ocrevus Zunovo if you:</p><ul class="bwlistdisc">
<li>
have an active hepatitis B virus (HBV) infection.</li>
<li>
have had a life-threatening administration reaction to ocrelizumab.</li>
<li>
have had a life-threatening allergic reaction to ocrelizumab, hyaluronidase, or any of the ingredients of Ocrevus Zunovo. Tell your healthcare provider if you have had an allergic reaction to Ocrevus or Ocrevus Zunovo or any of their ingredients in the past.</li>
</ul><p>
What is the most important information I should know about Ocrevus and Ocrevus Zunovo?</p><p>
Ocrevus and Ocrevus Zunovo can cause serious side effects, including:</p><ul class="bwlistdisc">
<li>
Infusion reactions (Ocrevus): Infusion reactions are a common side effect of Ocrevus, which can be serious and may require you to be hospitalized. You will be monitored during your infusion and for at least 1 hour after each infusion of Ocrevus for signs and symptoms of an infusion reaction.</li>
<li>
Injection reactions (Ocrevus Zunovo): Injection reactions are a common side effect of Ocrevus Zunovo, which can be serious and may require you to be hospitalized. You will be monitored for signs and symptoms of an injection reaction when you receive Ocrevus Zunovo. This will happen during all injections for at least 1 hour after your first injection, and for at least 15 minutes after all injections following the first injection.</li>
</ul><p>
Tell your healthcare provider or nurse if you get any of these symptoms:</p><ul class="bwlistdisc">
<li>
itchy skin</li>
<li>
rash</li>
<li>
hives</li>
<li>
tiredness</li>
<li>
coughing or wheezing</li>
<li>
trouble breathing</li>
<li>
throat irritation or pain</li>
<li>
feeling faint</li>
<li>
fever</li>
<li>
redness on your face (flushing)</li>
<li>
nausea</li>
<li>
headache</li>
<li>
swelling of the throat</li>
<li>
dizziness</li>
<li>
shortness of breath</li>
<li>
fatigue</li>
<li>
fast heartbeat</li>
</ul><p>
Additionally, for Ocrevus Zunovo:</p><ul class="bwlistdisc">
<li>
injection site pain</li>
<li>
swelling</li>
<li>
redness</li>
</ul><p>
These infusion and injection reactions can happen during or up to 24 hours after administration. It is important that you call your healthcare provider right away if you get any of the signs or symptoms listed above after each infusion or injection.</p><ul class="bwlistdisc">
<li>
Infection:
<ul class="bwlistcircle">
<li>
Infections are a common side effect. Ocrevus and Ocrevus Zunovo increase your risk of getting upper respiratory tract infections, lower respiratory tract infections, skin infections, and herpes infections. Serious infections can happen with Ocrevus and Ocrevus Zunovo, which can be life-threatening or cause death. Tell your healthcare provider if you have an infection or have any of the following signs of infection including fever, chills, or a cough that does not go away, or painful urination. Signs of herpes infection include: cold sores, shingles, genital sores, skin rash, pain, and itching. Signs of more serious herpes infection include: changes in vision, eye redness or eye pain, severe or persistent headache, stiff neck, and confusion. Signs of infection can happen during treatment or after you have received your last dose of Ocrevus or Ocrevus Zunovo. Tell your healthcare provider right away if you have an infection. Your healthcare provider should delay your treatment with Ocrevus or Ocrevus Zunovo until your infection is gone.</li>
<li>
Hepatitis B virus (HBV) reactivation: Before starting treatment with ocrelizumab, your healthcare provider will do blood tests to check for hepatitis B viral infection. If you have ever had hepatitis B virus infection, the hepatitis B virus may become active again during or after treatment with Ocrevus or Ocrevus Zunovo. Hepatitis B virus becoming active again (called reactivation) may cause serious liver problems including liver failure or death. Your healthcare provider will monitor you if you are at risk for hepatitis B virus reactivation during treatment and after you stop receiving Ocrevus or Ocrevus Zunovo.</li>
<li>
Weakened immune system: Ocrevus or Ocrevus Zunovo taken before or after other medicines that weaken the immune system could increase your risk of getting infections.</li>
</ul></li>
</ul><ul class="bwlistdisc">
<li>
Progressive Multifocal Leukoencephalopathy (PML): PML is a rare brain infection that usually leads to death or severe disability and has been reported with ocrelizumab. Symptoms of PML get worse over days to weeks. It is important that you call your healthcare provider right away if you have any new or worsening neurologic signs or symptoms that have lasted several days, including problems with:
<ul class="bwlistcircle">
<li>
thinking</li>
<li>
eyesight</li>
<li>
strength</li>
<li>
balance</li>
<li>
weakness on 1 side of your body</li>
<li>
using your arms or legs</li>
</ul></li>
</ul><ul class="bwlistdisc">
<li>
Decreased immunoglobulins: Ocrevus and Ocrevus Zunovo may cause a decrease in some types of antibodies. Your healthcare provider will do blood tests to check your blood immunoglobulin levels.</li>
</ul><p>
Before receiving Ocrevus or Ocrevus Zunovo, tell your healthcare provider about all of your medical conditions, including if you:</p><ul class="bwlistdisc">
<li>
have or think you have an infection. See “What is the most important information I should know about Ocrevus and Ocrevus Zunovo?”</li>
<li>
have ever taken, take, or plan to take medicines that affect your immune system, or other treatments for MS. These medicines could increase your risk of getting an infection.</li>
<li>
have ever had hepatitis B or are a carrier of the hepatitis B virus.</li>
<li>
have a history of inflammatory bowel disease or colitis.</li>
<li>
have a history of liver problems.</li>
<li>
have had a recent vaccination or are scheduled to receive any vaccinations.
<ul class="bwlistcircle">
<li>
You should receive any required ‘live’ or ‘live-attenuated’ vaccines at least 4 weeks before you start treatment with Ocrevus or Ocrevus Zunovo. You should not receive ‘live’ or ‘live-attenuated’ vaccines while you are being treated with Ocrevus or Ocrevus Zunovo and until your healthcare provider tells you that your immune system is no longer weakened.</li>
<li>
When possible, you should receive any ‘non-live’ vaccines at least 2 weeks before you start treatment with Ocrevus or Ocrevus Zunovo. If you would like to receive any non-live (inactivated) vaccines, including the seasonal flu vaccine, while you are being treated with Ocrevus or Ocrevus Zunovo, talk to your healthcare provider.</li>
<li>
If you have a baby and you received Ocrevus or Ocrevus Zunovo during your pregnancy, it is important to tell your baby’s healthcare provider about receiving Ocrevus or Ocrevus Zunovo so they can decide when your baby should be vaccinated.</li>
</ul></li>
<li>
are pregnant, think that you might be pregnant, or plan to become pregnant. It is not known if Ocrevus and Ocrevus Zunovo will harm your unborn baby. You should use birth control (contraception) during treatment with Ocrevus and Ocrevus Zunovo and for 6 months after your last dose of Ocrevus or Ocrevus Zunovo. Talk with your healthcare provider about what birth control method is right for you during this time. Tell your healthcare provider if you become pregnant while receiving Ocrevus or Ocrevus Zunovo.</li>
<li>
are breastfeeding or plan to breastfeed. It is not known if Ocrevus and Ocrevus Zunovo pass into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take Ocrevus or Ocrevus Zunovo.</li>
</ul><p>
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.</p><p>
What are the possible side effects of Ocrevus and Ocrevus Zunovo?</p><p>
Ocrevus and Ocrevus Zunovo may cause serious side effects, including:</p><ul class="bwlistdisc">
<li>
Risk of cancers (malignancies) including breast cancer: Follow your healthcare provider’s instructions about standard screening guidelines for breast cancer.</li>
<li>
Inflammation of the colon, or colitis: Tell your healthcare provider if you have any symptoms of colitis, such as:
<ul class="bwlistcircle">
<li>
Diarrhea (loose stools) or more frequent bowel movements than usual</li>
<li>
Stools that are black, tarry, sticky or have blood or mucus</li>
<li>
Severe stomach-area (abdomen) pain or tenderness</li>
</ul></li>
<li>
Liver damage. Ocrevus and Ocrevus Zunovo may cause liver damage. Your healthcare provider will do blood tests to check your liver before you start Ocrevus or Ocrevus Zunovo and while you take Ocrevus or Ocrevus Zunovo if needed. Tell your healthcare provider right away if you have any symptoms of liver damage, such as:
<ul class="bwlistcircle">
<li>
yellowing of the skin and eyes (jaundice)</li>
<li>
nausea</li>
<li>
vomiting</li>
<li>
unusual darkening of the urine</li>
<li>
feeling tired or weak</li>
</ul></li>
</ul><p>
The most common side effects of Ocrevus Zunovo include:</p><ul class="bwlistdisc">
<li>
Injection reactions</li>
<li>
Respiratory tract infections</li>
<li>
Skin infections</li>
</ul><p>
These are not all the possible side effects of Ocrevus and Ocrevus Zunovo.</p><p>
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Genentech at (888) 835-2555.</p><p>
For more information, go to <span class="LinkEnhancement"><a class="Link" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ocrevus.com%2F&amp;esheet=54327136&amp;newsitemid=20250923346934&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.Ocrevus.com&amp;index=3&amp;md5=c27b5857af21be139e08303062a03f9d" target="_blank" rel="noopener">https://www.Ocrevus.com</a></span> or call 1-844-627-3887.</p><p>
For additional safety information, please see the full <span class="LinkEnhancement"><a class="Link" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gene.com%2Fdownload%2Fpdf%2Focrevus_prescribing.pdf&amp;esheet=54327136&amp;newsitemid=20250923346934&amp;lan=en-US&amp;anchor=Prescribing+Information&amp;index=4&amp;md5=9a54d6c3803fe53ceb27c24a5e0b21a6" target="_blank" rel="noopener">Prescribing Information</a></span> and <span class="LinkEnhancement"><a class="Link" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gene.com%2Fdownload%2Fpdf%2Focrevus_medguide.pdf&amp;esheet=54327136&amp;newsitemid=20250923346934&amp;lan=en-US&amp;anchor=Medication+Guide+for+Ocrevus&amp;index=5&amp;md5=184e9345340b4864de9f7b6e6c853cb9" target="_blank" rel="noopener">Medication Guide for Ocrevus</a></span>.</p><p>
For additional safety information, please see the full <span class="LinkEnhancement"><a class="Link" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gene.com%2Fdownload%2Fpdf%2Focrevus_zunovo_prescribing.pdf&amp;esheet=54327136&amp;newsitemid=20250923346934&amp;lan=en-US&amp;anchor=Prescribing+Information&amp;index=6&amp;md5=4290bf96b16a47d0171b929a5372c728" target="_blank" rel="noopener">Prescribing Information</a></span> and <span class="LinkEnhancement"><a class="Link" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gene.com%2Fdownload%2Fpdf%2Focrevus_zunovo_medguide.pdf&amp;esheet=54327136&amp;newsitemid=20250923346934&amp;lan=en-US&amp;anchor=Medication+Guide+for+Ocrevus+Zunovo&amp;index=7&amp;md5=25fa449b28bf5c7fad7a786131882dc7" target="_blank" rel="noopener">Medication Guide for Ocrevus Zunovo</a></span>.</p><br> <b>Contacts</b> <br><p>
<b>For Questions:
<br>Media Contact:</b><br>Michelle McCourt
<br>(650) 467-6800</p><p>
<b>Advocacy Contact:</b><br>Lily Rose Atherton
<br>(202) 713-0083</p><p>
<b>Investor Contacts:</b><br>Loren Kalm
<br>(650) 225-3217</p><p>
Bruno Eschli
<br>+4161 68-75284</p>
                                </div>
                            

                            
                    </div>

                    
    <div class="Page-articleBelow">
        
            <div class="Page-actions-bottom">
                
    <div class="Page-actions">
        <div class="ActionBar">
    <ul class="ActionBar-items">
        
            <li class="ActionBar-items-item"><a class="ActionLink" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.biospace.com%2Fpress-releases%2Fgenentech-presents-new-data-for-ocrevus-and-fenebrutinib-across-broad-patient-populations-at-ectrims-2025&text=Genentech%20Presents%20New%20Data%20for%20Ocrevus%20and%20Fenebrutinib%20Across%20Broad%20Patient%20Populations%20at%20ECTRIMS%202025"
    target="_blank" data-social-service="twitter">
    <svg><use xlink:href="#mono-icon-twitter" /></svg><span>Twitter</span>
</a>
</li>
        
            <li class="ActionBar-items-item"><a class="ActionLink" href="https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fwww.biospace.com%2Fpress-releases%2Fgenentech-presents-new-data-for-ocrevus-and-fenebrutinib-across-broad-patient-populations-at-ectrims-2025&mini=true&title=Genentech%20Presents%20New%20Data%20for%20Ocrevus%20and%20Fenebrutinib%20Across%20Broad%20Patient%20Populations%20at%20ECTRIMS%202025&source=BioSpace"
    target="_blank" data-social-service="linkedin">
    <svg><use xlink:href="#mono-icon-linkedin"></use></svg><span>LinkedIn</span>
</a>
</li>
        
            <li class="ActionBar-items-item"> <a class="ActionLink" href="https://www.facebook.com/dialog/share?app_id=2120989681618413&display=popup&href=https%3A%2F%2Fwww.biospace.com%2Fpress-releases%2Fgenentech-presents-new-data-for-ocrevus-and-fenebrutinib-across-broad-patient-populations-at-ectrims-2025"
    target="_blank" data-social-service="facebook">
    <svg><use xlink:href="#mono-icon-facebook"></use></svg><span>Facebook</span>
</a>
</li>
        
            <li class="ActionBar-items-item"><a class="ActionLink" href="mailto:?subject=Check%20out%20this%20article%20on%20BioSpace&body=Genentech%20Presents%20New%20Data%20for%20Ocrevus%20and%20Fenebrutinib%20Across%20Broad%20Patient%20Populations%20at%20ECTRIMS%202025%0A%0Ahttps%3A%2F%2Fwww.biospace.com%2Fpress-releases%2Fgenentech-presents-new-data-for-ocrevus-and-fenebrutinib-across-broad-patient-populations-at-ectrims-2025"
    data-social-service="mailto">
    <svg>
        <use xlink:href="#mono-icon-mailto"></use>
    </svg>
    <span>
        Email
    </span>
</a>
</li>
        
            <li class="ActionBar-items-item"><a class="ActionLink" href="javascript:window.print()" data-social-service="print">
    <svg>
        <use xlink:href="#mono-icon-print"></use>
    </svg>
    <span>
        Print
    </span>
</a>
</li>
        
    </ul>
</div>


        
            
        
    </div>


            </div>
        

        
    <div class="Page-tags">
        
            <a class="Button" data-size="small" data-style="pill" data-theme="secondary" href="https://www.biospace.com/multiple-sclerosis" >Multiple sclerosis</a>
        
            <a class="Button" data-size="small" data-style="pill" data-theme="secondary" href="https://www.biospace.com/northern-california" >Northern California</a>
        
            <a class="Button" data-size="small" data-style="pill" data-theme="secondary" href="https://www.biospace.com/data" >Data</a>
        
            <a class="Button" data-size="small" data-style="pill" data-theme="secondary" href="https://www.biospace.com/phase-ii-clinical-trials" >Phase II</a>
        
            <a class="Button" data-size="small" data-style="pill" data-theme="secondary" href="https://www.biospace.com/event" >Events</a>
        
    </div>



    <div class="Page-tags Page-companies">
        
            <a class="Button" data-size="small" data-style="pill" data-theme="secondary" href="https://www.biospace.com/employer/248101/genentech-inc" >Genentech, Inc.</a>
        
    </div>



        


        
    


    </div>

                </main>

                
                    <aside class="Page-aside">
                        
                            
                                <div id="googleAd795c6468-5349-44eb-8c47-2945756d40a6" data-module class="GoogleDfpAd" data-slot-name="21692246607/biospace_article" data-slot-sizes="[[300, 600]]" data-slot-adSizeMap="[[[320, 1], [300, 600]]]" data-targeting-data="{&quot;id&quot;:&quot;00000199-7a85-d809-a1fd-7aa7ca300001&quot;,&quot;type&quot;:&quot;press-release&quot;,&quot;tags&quot;:[&quot;Multiple sclerosis&quot;,&quot;Northern California&quot;,&quot;Data&quot;,&quot;Phase II&quot;,&quot;Events&quot;],&quot;category&quot;:&quot;Press Releases&quot;,&quot;companies&quot;:[&quot;Genentech, Inc.&quot;]}">
    <span class="GoogleDfpAd-placeholder"></span>
</div>

                            
                        
                            
                                
<div class="PageListRightRailB" data-module  data-show-loadmore="true" data-module-title-size="3">
    

    
    <a class="AnchorLink" href="#latest" id="latest" name="latest"></a>




    <div class="ModuleHeader">
        
        
            <div class="ModuleHeader-title">LATEST</div>
        
        
        
    </div>



    
        <ul class="PageList-items" data-with-borders>
            
            <li class="PageList-items-item">
                
                    
                        <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right">
    
        
    <div class="PagePromo-media"><a class="Link" aria-label="Acadia Scraps Prader-Willi Drug After Late-Stage Failure" href="https://www.biospace.com/drug-development/acadia-scraps-prader-willi-drug-after-late-stage-failure" ><picture>
    
    
        
            

        
    

    
    
        
    
        <source type="image/webp"  width="100" height="100" srcset="https://static.biospace.com/dims4/default/588634a/2147483647/strip/true/crop/2576x2576+644+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F11%2F85%2Fce1f07fb4d93bb868d288ea04166%2Fistock-1452404759.jpg 1x,https://static.biospace.com/dims4/default/1c3a774/2147483647/strip/true/crop/2576x2576+644+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F11%2F85%2Fce1f07fb4d93bb868d288ea04166%2Fistock-1452404759.jpg 2x"/>

    

    
        <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/f6fabd5/2147483647/strip/true/crop/2576x2576+644+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F11%2F85%2Fce1f07fb4d93bb868d288ea04166%2Fistock-1452404759.jpg 1x,https://static.biospace.com/dims4/default/5e49bc9/2147483647/strip/true/crop/2576x2576+644+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F11%2F85%2Fce1f07fb4d93bb868d288ea04166%2Fistock-1452404759.jpg 2x"/>

    


    
    
    <img class="Image" alt="Accumulated problems, contradictions. Dead end, we need to go back. You cannot continue further. Complete impossibility to continue. Rejection of an idea. Hard sanctions. Fatal error." srcset="https://static.biospace.com/dims4/default/f6fabd5/2147483647/strip/true/crop/2576x2576+644+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F11%2F85%2Fce1f07fb4d93bb868d288ea04166%2Fistock-1452404759.jpg 1x,https://static.biospace.com/dims4/default/5e49bc9/2147483647/strip/true/crop/2576x2576+644+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F11%2F85%2Fce1f07fb4d93bb868d288ea04166%2Fistock-1452404759.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/f6fabd5/2147483647/strip/true/crop/2576x2576+644+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F11%2F85%2Fce1f07fb4d93bb868d288ea04166%2Fistock-1452404759.jpg" loading="lazy"
    >


</picture>

</a></div>


    

    <div class="PagePromo-content">
        
    
        <div class="PagePromo-category">
            <a class="Link" href="https://www.biospace.com/rare-diseases">Rare diseases</a>
        </div>
    



        
    <div class="PagePromo-title">
        <a class="Link" href="https://www.biospace.com/drug-development/acadia-scraps-prader-willi-drug-after-late-stage-failure">Acadia Scraps Prader-Willi Drug After Late-Stage Failure</a>
    </div>



        


        
    
        <div class="PagePromo-byline"><div class="PagePromo-date">September 24, 2025</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-readTime">1 min read</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/dan-samorodnitsky">Dan Samorodnitsky</a></div></div>
    



        

    </div>
</div>
                    
                
            </li>
            
            <li class="PageList-items-item">
                
                    
                        <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right">
    
        
    <div class="PagePromo-media"><a class="Link" aria-label="Sanofi Fattens Venture Unit With $625M Infusion for Rare Disease, Neuro Innovation" href="https://www.biospace.com/business/sanofi-fattens-venture-unit-with-625m-infusion-for-rare-disease-neuro-innovation" ><picture>
    
    
        
            

        
    

    
    
        
    
        <source type="image/webp"  width="100" height="100" srcset="https://static.biospace.com/dims4/default/248597f/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F38F5384C-FB5D-40FD-9F84-5481198818D3.jpg 1x,https://static.biospace.com/dims4/default/88dbc16/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F38F5384C-FB5D-40FD-9F84-5481198818D3.jpg 2x"/>

    

    
        <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/eed2688/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F38F5384C-FB5D-40FD-9F84-5481198818D3.jpg 1x,https://static.biospace.com/dims4/default/453abee/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F38F5384C-FB5D-40FD-9F84-5481198818D3.jpg 2x"/>

    


    
    
    <img class="Image" alt="Pictured: Blue and white Sanofi sign on building/R" srcset="https://static.biospace.com/dims4/default/eed2688/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F38F5384C-FB5D-40FD-9F84-5481198818D3.jpg 1x,https://static.biospace.com/dims4/default/453abee/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F38F5384C-FB5D-40FD-9F84-5481198818D3.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/eed2688/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F38F5384C-FB5D-40FD-9F84-5481198818D3.jpg" loading="lazy"
    >


</picture>

</a></div>


    

    <div class="PagePromo-content">
        
    
        <div class="PagePromo-category">
            <a class="Link" href="https://www.biospace.com/venture-capital">Venture capital</a>
        </div>
    



        
    <div class="PagePromo-title">
        <a class="Link" href="https://www.biospace.com/business/sanofi-fattens-venture-unit-with-625m-infusion-for-rare-disease-neuro-innovation">Sanofi Fattens Venture Unit With $625M Infusion for Rare Disease, Neuro Innovation</a>
    </div>



        


        
    
        <div class="PagePromo-byline"><div class="PagePromo-date">September 24, 2025</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-readTime">2 min read</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/tristan-manalac">Tristan Manalac</a></div></div>
    



        

    </div>
</div>
                    
                
            </li>
            
            <li class="PageList-items-item">
                
                    
                        <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right">
    
        
    <div class="PagePromo-media"><a class="Link" aria-label="UniQure ‘Exceeds Expectations’ in Much-Anticipated 3-Year Huntington’s Readout" href="https://www.biospace.com/drug-development/uniqure-exceeds-expectations-in-much-anticipated-3-year-huntingtons-readout" ><picture>
    
    
        
            

        
    

    
    
        
    
        <source type="image/webp"  width="100" height="100" srcset="https://static.biospace.com/dims4/default/7603c48/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F0E5A5BBC-DD9C-4A23-B9C8-1C8865DF596F.jpg 1x,https://static.biospace.com/dims4/default/65cf209/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F0E5A5BBC-DD9C-4A23-B9C8-1C8865DF596F.jpg 2x"/>

    

    
        <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/a9fe43f/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F0E5A5BBC-DD9C-4A23-B9C8-1C8865DF596F.jpg 1x,https://static.biospace.com/dims4/default/e63bb2f/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F0E5A5BBC-DD9C-4A23-B9C8-1C8865DF596F.jpg 2x"/>

    


    
    
    <img class="Image" alt="Pictured: uniQure headquarters in Amsterdam" srcset="https://static.biospace.com/dims4/default/a9fe43f/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F0E5A5BBC-DD9C-4A23-B9C8-1C8865DF596F.jpg 1x,https://static.biospace.com/dims4/default/e63bb2f/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F0E5A5BBC-DD9C-4A23-B9C8-1C8865DF596F.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/a9fe43f/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F0E5A5BBC-DD9C-4A23-B9C8-1C8865DF596F.jpg" loading="lazy"
    >


</picture>

</a></div>


    

    <div class="PagePromo-content">
        
    
        <div class="PagePromo-category">
            <a class="Link" href="https://www.biospace.com/huntingtons-disease">Huntington’s disease</a>
        </div>
    



        
    <div class="PagePromo-title">
        <a class="Link" href="https://www.biospace.com/drug-development/uniqure-exceeds-expectations-in-much-anticipated-3-year-huntingtons-readout">UniQure ‘Exceeds Expectations’ in Much-Anticipated 3-Year Huntington’s Readout</a>
    </div>



        


        
    
        <div class="PagePromo-byline"><div class="PagePromo-date">September 24, 2025</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-readTime">2 min read</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/heather-mckenzie">Heather McKenzie</a></div></div>
    



        

    </div>
</div>
                    
                
            </li>
            
            <li class="PageList-items-item">
                
                    
                        <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right">
    
        
    <div class="PagePromo-media"><a class="Link" aria-label="FDA Hits J&amp;J With Warning Letter Over ‘Significant Violations’ at Korean Production Plant" href="https://www.biospace.com/business/fda-hits-j-j-with-warning-letter-over-significant-violations-at-korean-production-plant" ><picture>
    
    
        
            

        
    

    
    
        
    
        <source type="image/webp"  width="100" height="100" srcset="https://static.biospace.com/dims4/default/e09ccfc/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F700C5EF6-F62F-4F4B-9F66-39D9C2BBC281.jpg 1x,https://static.biospace.com/dims4/default/12a83d0/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F700C5EF6-F62F-4F4B-9F66-39D9C2BBC281.jpg 2x"/>

    

    
        <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/f1ac7c5/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F700C5EF6-F62F-4F4B-9F66-39D9C2BBC281.jpg 1x,https://static.biospace.com/dims4/default/a1e62b3/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F700C5EF6-F62F-4F4B-9F66-39D9C2BBC281.jpg 2x"/>

    


    
    
    <img class="Image" alt="Pictured: Johnson &amp; Johnson Sign/iStock, JHVEPhoto" srcset="https://static.biospace.com/dims4/default/f1ac7c5/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F700C5EF6-F62F-4F4B-9F66-39D9C2BBC281.jpg 1x,https://static.biospace.com/dims4/default/a1e62b3/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F700C5EF6-F62F-4F4B-9F66-39D9C2BBC281.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/f1ac7c5/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F700C5EF6-F62F-4F4B-9F66-39D9C2BBC281.jpg" loading="lazy"
    >


</picture>

</a></div>


    

    <div class="PagePromo-content">
        
    
        <div class="PagePromo-category">
            <a class="Link" href="https://www.biospace.com/manufacturing">Manufacturing</a>
        </div>
    



        
    <div class="PagePromo-title">
        <a class="Link" href="https://www.biospace.com/business/fda-hits-j-j-with-warning-letter-over-significant-violations-at-korean-production-plant">FDA Hits J&amp;J With Warning Letter Over ‘Significant Violations’ at Korean Production Plant</a>
    </div>



        


        
    
        <div class="PagePromo-byline"><div class="PagePromo-date">September 24, 2025</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-readTime">2 min read</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/tristan-manalac">Tristan Manalac</a></div></div>
    



        

    </div>
</div>
                    
                
            </li>
            
            <li class="PageList-items-item">
                
                    
                        <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right">
    
        
    <div class="PagePromo-media"><a class="Link" aria-label="Lilly Unveils Second Facility in Manufacturing Push, Naming Texas as Site of New $6.5B Plant" href="https://www.biospace.com/business/lilly-unveils-second-facility-in-manufacturing-push-naming-texas-as-site-of-new-6-5b-plant" ><picture>
    
    
        
            

        
    

    
    
        
    
        <source type="image/webp"  width="100" height="100" srcset="https://static.biospace.com/dims4/default/78b9f69/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F7412A77B-7BA4-4C73-B35E-BE592118378E.jpg 1x,https://static.biospace.com/dims4/default/7941fab/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F7412A77B-7BA4-4C73-B35E-BE592118378E.jpg 2x"/>

    

    
        <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/724c74d/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F7412A77B-7BA4-4C73-B35E-BE592118378E.jpg 1x,https://static.biospace.com/dims4/default/9587c0b/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F7412A77B-7BA4-4C73-B35E-BE592118378E.jpg 2x"/>

    


    
    
    <img class="Image" alt="Pictured: Eli Lilly&#x27;s headquarters in Indianapolis" srcset="https://static.biospace.com/dims4/default/724c74d/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F7412A77B-7BA4-4C73-B35E-BE592118378E.jpg 1x,https://static.biospace.com/dims4/default/9587c0b/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F7412A77B-7BA4-4C73-B35E-BE592118378E.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/724c74d/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F7412A77B-7BA4-4C73-B35E-BE592118378E.jpg" loading="lazy"
    >


</picture>

</a></div>


    

    <div class="PagePromo-content">
        
    
        <div class="PagePromo-category">
            <a class="Link" href="https://www.biospace.com/manufacturing">Manufacturing</a>
        </div>
    



        
    <div class="PagePromo-title">
        <a class="Link" href="https://www.biospace.com/business/lilly-unveils-second-facility-in-manufacturing-push-naming-texas-as-site-of-new-6-5b-plant">Lilly Unveils Second Facility in Manufacturing Push, Naming Texas as Site of New $6.5B Plant</a>
    </div>



        


        
    
        <div class="PagePromo-byline"><div class="PagePromo-date">September 24, 2025</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-readTime">2 min read</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/tristan-manalac">Tristan Manalac</a></div></div>
    



        

    </div>
</div>
                    
                
            </li>
            
        </ul>
    
    

</div>

                            
                        
                            
                                <div id="googleAdd70a12ff-001e-462c-86d5-ea95491ebbbd" data-module class="GoogleDfpAd" data-slot-name="21692246607/biospace_article" data-slot-sizes="[[300, 250]]" data-slot-adSizeMap="[[[320, 1], [300, 250]]]" data-targeting-data="{&quot;id&quot;:&quot;00000199-7a85-d809-a1fd-7aa7ca300001&quot;,&quot;type&quot;:&quot;press-release&quot;,&quot;tags&quot;:[&quot;Multiple sclerosis&quot;,&quot;Northern California&quot;,&quot;Data&quot;,&quot;Phase II&quot;,&quot;Events&quot;],&quot;category&quot;:&quot;Press Releases&quot;,&quot;companies&quot;:[&quot;Genentech, Inc.&quot;]}">
    <span class="GoogleDfpAd-placeholder"></span>
</div>

                            
                        
                            
                                
<div class="PageListRightRailB" data-module  data-show-loadmore="true" data-module-title-size="3">
    

    
    <a class="AnchorLink" href="#article-right-rail-featured" id="article-right-rail-featured" name="article-right-rail-featured"></a>




    <div class="ModuleHeader">
        
        
            <div class="ModuleHeader-title">FEATURED STORIES</div>
        
        
        
    </div>



    
        <ul class="PageList-items" data-with-borders>
            
            <li class="PageList-items-item">
                
                    
                        <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right">
    
        
    <div class="PagePromo-media"><a class="Link" aria-label="As Kennedy Takes Aim at Childhood Vaccines, a History of Merck’s ProQuad" href="https://www.biospace.com/policy/as-kennedy-takes-aim-at-childhood-vaccines-a-history-of-mercks-proquad" ><picture>
    
    
        
            

        
    

    
    
        
    
        <source type="image/webp"  width="100" height="100" srcset="https://static.biospace.com/dims4/default/b7f57d1/2147483647/strip/true/crop/1482x1482+271+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F2c%2F27%2F9d78f91d4afbbe023cf8289c265e%2Fistock-2047522092.jpg 1x,https://static.biospace.com/dims4/default/9b702d5/2147483647/strip/true/crop/1482x1482+271+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F2c%2F27%2F9d78f91d4afbbe023cf8289c265e%2Fistock-2047522092.jpg 2x"/>

    

    
        <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/5f5242b/2147483647/strip/true/crop/1482x1482+271+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F2c%2F27%2F9d78f91d4afbbe023cf8289c265e%2Fistock-2047522092.jpg 1x,https://static.biospace.com/dims4/default/705b1bd/2147483647/strip/true/crop/1482x1482+271+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F2c%2F27%2F9d78f91d4afbbe023cf8289c265e%2Fistock-2047522092.jpg 2x"/>

    


    
    
    <img class="Image" alt="Immunization of kids abstract concept vector illustration. Family doctor vaccinates a child in walk-in clinic, preventive care for kids, medicine sector, make an injection abstract metaphor." srcset="https://static.biospace.com/dims4/default/5f5242b/2147483647/strip/true/crop/1482x1482+271+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F2c%2F27%2F9d78f91d4afbbe023cf8289c265e%2Fistock-2047522092.jpg 1x,https://static.biospace.com/dims4/default/705b1bd/2147483647/strip/true/crop/1482x1482+271+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F2c%2F27%2F9d78f91d4afbbe023cf8289c265e%2Fistock-2047522092.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/5f5242b/2147483647/strip/true/crop/1482x1482+271+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F2c%2F27%2F9d78f91d4afbbe023cf8289c265e%2Fistock-2047522092.jpg" loading="lazy"
    >


</picture>

</a></div>


    

    <div class="PagePromo-content">
        
    
        <div class="PagePromo-category">
            <a class="Link" href="https://www.biospace.com/vaccines">Vaccines</a>
        </div>
    



        
    <div class="PagePromo-title">
        <a class="Link" href="https://www.biospace.com/policy/as-kennedy-takes-aim-at-childhood-vaccines-a-history-of-mercks-proquad">As Kennedy Takes Aim at Childhood Vaccines, a History of Merck’s ProQuad</a>
    </div>



        


        
    
        <div class="PagePromo-byline"><div class="PagePromo-date">September 23, 2025</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-readTime">6 min read</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/annalee-armstrong">Annalee Armstrong</a></div></div>
    



        

    </div>
</div>
                    
                
            </li>
            
            <li class="PageList-items-item">
                
                    
                        <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right">
    
        
    <div class="PagePromo-media"><a class="Link" aria-label="To Compete in Obesity, Late Entrants Invest Early in Manufacturing" href="https://www.biospace.com/business/to-compete-in-obesity-late-entrants-invest-early-in-manufacturing" ><picture>
    
    
        
            

        
    

    
    
        
    
        <source type="image/webp"  width="100" height="100" srcset="https://static.biospace.com/dims4/default/4cc5b78/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F8AD95489-7EE0-4700-840B-ED901371B2CE.jpg 1x,https://static.biospace.com/dims4/default/5416f73/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F8AD95489-7EE0-4700-840B-ED901371B2CE.jpg 2x"/>

    

    
        <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/2a3c0fc/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F8AD95489-7EE0-4700-840B-ED901371B2CE.jpg 1x,https://static.biospace.com/dims4/default/57759d7/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F8AD95489-7EE0-4700-840B-ED901371B2CE.jpg 2x"/>

    


    
    
    <img class="Image" alt="Pictured: Weight loss scale and pile of money/Tayl" srcset="https://static.biospace.com/dims4/default/2a3c0fc/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F8AD95489-7EE0-4700-840B-ED901371B2CE.jpg 1x,https://static.biospace.com/dims4/default/57759d7/2147483647/strip/true/crop/350x350+138+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F8AD95489-7EE0-4700-840B-ED901371B2CE.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/2a3c0fc/2147483647/strip/true/crop/350x350+138+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2F8AD95489-7EE0-4700-840B-ED901371B2CE.jpg" loading="lazy"
    >


</picture>

</a></div>


    

    <div class="PagePromo-content">
        
    
        <div class="PagePromo-category">
            <a class="Link" href="https://www.biospace.com/manufacturing">Manufacturing</a>
        </div>
    



        
    <div class="PagePromo-title">
        <a class="Link" href="https://www.biospace.com/business/to-compete-in-obesity-late-entrants-invest-early-in-manufacturing">To Compete in Obesity, Late Entrants Invest Early in Manufacturing</a>
    </div>



        


        
    
        <div class="PagePromo-byline"><div class="PagePromo-date">September 23, 2025</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-readTime">5 min read</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/nick-paul-taylor">Nick Paul Taylor</a></div></div>
    



        

    </div>
</div>
                    
                
            </li>
            
            <li class="PageList-items-item">
                
                    
                        <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right">
    
        
    <div class="PagePromo-media"><a class="Link" aria-label="Rare Disease Experts See Futility in FDA’s Proposed Framework" href="https://www.biospace.com/policy/rare-disease-experts-see-futility-in-fdas-proposed-framework" ><picture>
    
    
        
            

        
    

    
    
        
    
        <source type="image/webp"  width="100" height="100" srcset="https://static.biospace.com/dims4/default/0c4d023/2147483647/strip/true/crop/3000x3000+1000+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Faf%2F6d%2F5cfc82b544d4872fa8dd5b34a50b%2Fistock-1212810604.jpg 1x,https://static.biospace.com/dims4/default/c728451/2147483647/strip/true/crop/3000x3000+1000+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Faf%2F6d%2F5cfc82b544d4872fa8dd5b34a50b%2Fistock-1212810604.jpg 2x"/>

    

    
        <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/185574d/2147483647/strip/true/crop/3000x3000+1000+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Faf%2F6d%2F5cfc82b544d4872fa8dd5b34a50b%2Fistock-1212810604.jpg 1x,https://static.biospace.com/dims4/default/3bf0276/2147483647/strip/true/crop/3000x3000+1000+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Faf%2F6d%2F5cfc82b544d4872fa8dd5b34a50b%2Fistock-1212810604.jpg 2x"/>

    


    
    
    <img class="Image" alt="Black swan theory or a black swan event is a term used to describe a very rare or otherwise unexpected event that has a major effect, such as a financial crash or pandemic. The term is based on an ancient saying which presumed black swans did not exist." srcset="https://static.biospace.com/dims4/default/185574d/2147483647/strip/true/crop/3000x3000+1000+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Faf%2F6d%2F5cfc82b544d4872fa8dd5b34a50b%2Fistock-1212810604.jpg 1x,https://static.biospace.com/dims4/default/3bf0276/2147483647/strip/true/crop/3000x3000+1000+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Faf%2F6d%2F5cfc82b544d4872fa8dd5b34a50b%2Fistock-1212810604.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/185574d/2147483647/strip/true/crop/3000x3000+1000+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Faf%2F6d%2F5cfc82b544d4872fa8dd5b34a50b%2Fistock-1212810604.jpg" loading="lazy"
    >


</picture>

</a></div>


    

    <div class="PagePromo-content">
        
    
        <div class="PagePromo-category">
            <a class="Link" href="https://www.biospace.com/rare-diseases">Rare diseases</a>
        </div>
    



        
    <div class="PagePromo-title">
        <a class="Link" href="https://www.biospace.com/policy/rare-disease-experts-see-futility-in-fdas-proposed-framework">Rare Disease Experts See Futility in FDA’s Proposed Framework</a>
    </div>



        


        
    
        <div class="PagePromo-byline"><div class="PagePromo-date">September 22, 2025</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-readTime">5 min read</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/dan-samorodnitsky">Dan Samorodnitsky</a></div></div>
    



        

    </div>
</div>
                    
                
            </li>
            
            <li class="PageList-items-item">
                
                    
                        <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right">
    
        
    <div class="PagePromo-media"><a class="Link" aria-label="Psychedelics Space Enters New Era as AbbVie Dives In " href="https://www.biospace.com/drug-development/psychedelics-space-enters-new-era-as-abbvie-dives-in" ><picture>
    
    
        
            

        
    

    
    
        
    
        <source type="image/webp"  width="100" height="100" srcset="https://static.biospace.com/dims4/default/35eb4bf/2147483647/strip/true/crop/600x600+300+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fed%2F5a%2Fc1cebdf846cabe4d1afad0238c4f%2Fpsychedelics.png 1x,https://static.biospace.com/dims4/default/23b4d03/2147483647/strip/true/crop/600x600+300+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fed%2F5a%2Fc1cebdf846cabe4d1afad0238c4f%2Fpsychedelics.png 2x"/>

    

    
        <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/bb82c4f/2147483647/strip/true/crop/600x600+300+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fed%2F5a%2Fc1cebdf846cabe4d1afad0238c4f%2Fpsychedelics.png 1x,https://static.biospace.com/dims4/default/3522159/2147483647/strip/true/crop/600x600+300+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fed%2F5a%2Fc1cebdf846cabe4d1afad0238c4f%2Fpsychedelics.png 2x"/>

    


    
    
    <img class="Image" alt="An umbrella protects the human brain from negative influences. Art collage." srcset="https://static.biospace.com/dims4/default/bb82c4f/2147483647/strip/true/crop/600x600+300+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fed%2F5a%2Fc1cebdf846cabe4d1afad0238c4f%2Fpsychedelics.png 1x,https://static.biospace.com/dims4/default/3522159/2147483647/strip/true/crop/600x600+300+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fed%2F5a%2Fc1cebdf846cabe4d1afad0238c4f%2Fpsychedelics.png 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/bb82c4f/2147483647/strip/true/crop/600x600+300+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fed%2F5a%2Fc1cebdf846cabe4d1afad0238c4f%2Fpsychedelics.png" loading="lazy"
    >


</picture>

</a></div>


    

    <div class="PagePromo-content">
        
    
        <div class="PagePromo-category">
            <a class="Link" href="https://www.biospace.com/psychedelics">Psychedelics</a>
        </div>
    



        
    <div class="PagePromo-title">
        <a class="Link" href="https://www.biospace.com/drug-development/psychedelics-space-enters-new-era-as-abbvie-dives-in">Psychedelics Space Enters New Era as AbbVie Dives In </a>
    </div>



        


        
    
        <div class="PagePromo-byline"><div class="PagePromo-date">September 22, 2025</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-readTime">6 min read</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/heather-mckenzie">Heather McKenzie</a></div></div>
    



        

    </div>
</div>
                    
                
            </li>
            
            <li class="PageList-items-item">
                
                    
                        <div class="PagePromo" data-image-align-vertical="top" data-image-align-horizontal="right">
    
        
    <div class="PagePromo-media"><a class="Link" aria-label="Stealth Wins Expedited FDA Nod for First-Ever Barth Syndrome Treatment" href="https://www.biospace.com/drug-development/stealth-wins-expedited-fda-nod-for-first-ever-barth-syndrome-treatment" ><picture>
    
    
        
            

        
    

    
    
        
    
        <source type="image/webp"  width="100" height="100" srcset="https://static.biospace.com/dims4/default/bc4cd60/2147483647/strip/true/crop/512x512+86+0/resize/100x100!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F72%2Ffc%2Ff46fbe754fdf9b362c6e61de7a98%2Fcliff2.jpg 1x,https://static.biospace.com/dims4/default/1121b97/2147483647/strip/true/crop/512x512+86+0/resize/200x200!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F72%2Ffc%2Ff46fbe754fdf9b362c6e61de7a98%2Fcliff2.jpg 2x"/>

    

    
        <source width="100" height="100" srcset="https://static.biospace.com/dims4/default/0cc6178/2147483647/strip/true/crop/512x512+86+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F72%2Ffc%2Ff46fbe754fdf9b362c6e61de7a98%2Fcliff2.jpg 1x,https://static.biospace.com/dims4/default/1f6d3b5/2147483647/strip/true/crop/512x512+86+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F72%2Ffc%2Ff46fbe754fdf9b362c6e61de7a98%2Fcliff2.jpg 2x"/>

    


    
    
    <img class="Image" alt="Business vision and opportunity and determination. Businessman standing on cliff edge looking ahead. vector" srcset="https://static.biospace.com/dims4/default/0cc6178/2147483647/strip/true/crop/512x512+86+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F72%2Ffc%2Ff46fbe754fdf9b362c6e61de7a98%2Fcliff2.jpg 1x,https://static.biospace.com/dims4/default/1f6d3b5/2147483647/strip/true/crop/512x512+86+0/resize/200x200!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F72%2Ffc%2Ff46fbe754fdf9b362c6e61de7a98%2Fcliff2.jpg 2x" width="100" height="100" src="https://static.biospace.com/dims4/default/0cc6178/2147483647/strip/true/crop/512x512+86+0/resize/100x100!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F72%2Ffc%2Ff46fbe754fdf9b362c6e61de7a98%2Fcliff2.jpg" loading="lazy"
    >


</picture>

</a></div>


    

    <div class="PagePromo-content">
        
    
        <div class="PagePromo-category">
            <a class="Link" href="https://www.biospace.com/rare-diseases">Rare diseases </a>
        </div>
    



        
    <div class="PagePromo-title">
        <a class="Link" href="https://www.biospace.com/drug-development/stealth-wins-expedited-fda-nod-for-first-ever-barth-syndrome-treatment">Stealth Wins Expedited FDA Nod for First-Ever Barth Syndrome Treatment</a>
    </div>



        


        
    
        <div class="PagePromo-byline"><div class="PagePromo-date">September 21, 2025</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-readTime">7 min read</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/heather-mckenzie">Heather McKenzie</a></div></div>
    



        

    </div>
</div>
                    
                
            </li>
            
        </ul>
    
    

</div>

                            
                        
                            
                                <div class="HtmlModule">
    
    <a class="AnchorLink" href="#html-embed-module-010000" id="html-embed-module-010000" name="html-embed-module-010000"></a>


    <div style="border-width:1px; border-style:solid; border-color:#ededed; padding:0px 20px; font-family:Helvetica, Arial, Sans-Serif;">
    <p>Get daily news updates when you subscribe to GenePool!</p>
    <div style="padding:0px 20px;">
    <script charset="utf-8" type="text/javascript" src="//js.hsforms.net/forms/embed/v2.js"></script>
 <script charset="utf-8" type="text/javascript" src="//js.hsforms.net/forms/v2-legacy.js"></script> 
        <![endif]--><script charset="utf-8" type="text/javascript" src="//js.hsforms.net/forms/v2.js"></script><script> 
            hbspt.forms.create({ 
                region: "na1", 
                portalId: "4413123", 
                formId: "8bc4f5eb-90b2-4735-bb3a-cb1ac591749c",
                          onFormSubmitted: function($form, data) {
      window.dataLayer = window.dataLayer || [];
      window.dataLayer.push({
        'event': 'GTMevent',
        'event_name': 'newsletter_sign_up'
      });
    }
  });
</script>
    </div>
</div>


</div>

                            
                        
                    </aside>
                
            </div>
        </div>

        
    <div class="Page-below"  data-modulewell><div id="googleAd96fabfee-44f4-436c-8be4-3c7926c8b729" data-module class="GoogleDfpAd" data-hide-on-mobile="true" data-slot-name="21692246607/biospace_article" data-slot-sizes="[[728, 90]]" data-slot-adSizeMap="[[[992, 1], [728, 90]]]" data-targeting-data="{&quot;id&quot;:&quot;00000199-7a85-d809-a1fd-7aa7ca300001&quot;,&quot;type&quot;:&quot;press-release&quot;,&quot;tags&quot;:[&quot;Multiple sclerosis&quot;,&quot;Northern California&quot;,&quot;Data&quot;,&quot;Phase II&quot;,&quot;Events&quot;],&quot;category&quot;:&quot;Press Releases&quot;,&quot;companies&quot;:[&quot;Genentech, Inc.&quot;]}">
    <span class="GoogleDfpAd-placeholder"></span>
</div>
<div id="googleAd5b0b0dd1-ece1-41f5-834e-090c340ee640" data-module class="GoogleDfpAd" data-hide-on-desktop="true" data-slot-name="21692246607/biospace_article" data-slot-sizes="[[300, 50]]" data-slot-adSizeMap="[[[320, 1], [300, 50]]]" data-targeting-data="{&quot;id&quot;:&quot;00000199-7a85-d809-a1fd-7aa7ca300001&quot;,&quot;type&quot;:&quot;press-release&quot;,&quot;tags&quot;:[&quot;Multiple sclerosis&quot;,&quot;Northern California&quot;,&quot;Data&quot;,&quot;Phase II&quot;,&quot;Events&quot;],&quot;category&quot;:&quot;Press Releases&quot;,&quot;companies&quot;:[&quot;Genentech, Inc.&quot;]}">
    <span class="GoogleDfpAd-placeholder"></span>
</div>

<bsp-list-loadmore data-module class="PageListStandardB" data-show-loadmore="true" data-column-count="4">
    

    
    <a class="AnchorLink" href="#more-on-this-topic" id="more-on-this-topic" name="more-on-this-topic"></a>




    <div class="ModuleHeader">
        
        
            <div class="ModuleHeader-title">MORE ON THIS TOPIC</div>
        
        
        
    </div>



    
        <div class="PageList-items" data-list-loadmore-items>
            
                <div class="PageList-items-item">
                    
                        
                            
                                
                                    
                                        
                                            <div class="PagePromo" data-image-align-vertical="top" data-mobile-alt-layout="true">
    
        
    <div class="PagePromo-media" data-animate="fromBottom"><a class="Link" aria-label="FDA Action Date for Sanofi’s Oral Multiple Sclerosis Drug Bumped to December" href="https://www.biospace.com/fda/fda-action-date-for-sanofis-oral-multiple-sclerosis-drug-bumped-to-december" ><picture>
    
    
        
            

        
    

    
    
        
    
        <source type="image/webp"  width="1000" height="563" srcset="https://static.biospace.com/dims4/default/e39d458/2147483647/strip/true/crop/622x350+2+0/resize/568x320!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2FAA142EAF-8C30-456F-BBBE-413BDD20F9BF.jpg 568w,https://static.biospace.com/dims4/default/798ac8c/2147483647/strip/true/crop/622x350+2+0/resize/768x432!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2FAA142EAF-8C30-456F-BBBE-413BDD20F9BF.jpg 768w,https://static.biospace.com/dims4/default/b505080/2147483647/strip/true/crop/622x350+2+0/resize/1000x563!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2FAA142EAF-8C30-456F-BBBE-413BDD20F9BF.jpg 1000w" sizes="(max-width: 568px) 100px, 300px"/>

    

    
        <source width="1000" height="563" srcset="https://static.biospace.com/dims4/default/1e400bc/2147483647/strip/true/crop/622x350+2+0/resize/568x320!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2FAA142EAF-8C30-456F-BBBE-413BDD20F9BF.jpg 568w,https://static.biospace.com/dims4/default/2f17d6e/2147483647/strip/true/crop/622x350+2+0/resize/768x432!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2FAA142EAF-8C30-456F-BBBE-413BDD20F9BF.jpg 768w,https://static.biospace.com/dims4/default/a1944de/2147483647/strip/true/crop/622x350+2+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2FAA142EAF-8C30-456F-BBBE-413BDD20F9BF.jpg 1000w" sizes="(max-width: 568px) 100px, 300px"/>

    


    
    
    <img class="Image" alt="Pictured: Blue Sanofi sign on building in Germany at night" srcset="https://static.biospace.com/dims4/default/1e400bc/2147483647/strip/true/crop/622x350+2+0/resize/568x320!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2FAA142EAF-8C30-456F-BBBE-413BDD20F9BF.jpg 568w,https://static.biospace.com/dims4/default/2f17d6e/2147483647/strip/true/crop/622x350+2+0/resize/768x432!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2FAA142EAF-8C30-456F-BBBE-413BDD20F9BF.jpg 768w,https://static.biospace.com/dims4/default/a1944de/2147483647/strip/true/crop/622x350+2+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2FAA142EAF-8C30-456F-BBBE-413BDD20F9BF.jpg 1000w" sizes="(max-width: 568px) 100px, 300px" width="1000" height="563" src="https://static.biospace.com/dims4/default/a1944de/2147483647/strip/true/crop/622x350+2+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Flegacy%2FBioSpace-Assets%2FAA142EAF-8C30-456F-BBBE-413BDD20F9BF.jpg" loading="lazy"
    >


</picture>

</a></div>


    

    <div class="PagePromo-content" data-animate="fromBottom">
        
    
        <div class="PagePromo-category">
            <a class="Link" href="https://www.biospace.com/multiple-sclerosis">Multiple sclerosis</a>
        </div>
    



        
    <div class="PagePromo-title">
        <a class="Link" href="https://www.biospace.com/fda/fda-action-date-for-sanofis-oral-multiple-sclerosis-drug-bumped-to-december">FDA Action Date for Sanofi’s Oral Multiple Sclerosis Drug Bumped to December</a>
    </div>



        


        
    
        <div class="PagePromo-byline"><div class="PagePromo-date">September 22, 2025</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-readTime">1 min read</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/dan-samorodnitsky">Dan Samorodnitsky</a></div></div>
    



        

    </div>
</div>
                                        
                                    
                                
                            
                        
                    
                </div>
            
                <div class="PageList-items-item">
                    
                        
                            
                                
                                    
                                        
                                            <div class="PagePromo" data-image-align-vertical="top" data-mobile-alt-layout="true">
    
        
    <div class="PagePromo-media" data-animate="fromBottom"><a class="Link" aria-label="What Do AI and Hammers Have in Common?" href="https://www.biospace.com/policy/what-do-ai-and-hammers-have-in-common" ><picture>
    
    
        
            

        
    

    
    
        
    
        <source type="image/webp"  width="1000" height="563" srcset="https://static.biospace.com/dims4/default/bf7f1f0/2147483647/strip/true/crop/1000x563+0+0/resize/568x320!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fc2%2Fa3%2F564fd457451ea211cc5a9e15b6a7%2Fdenatured-20250918.png 568w,https://static.biospace.com/dims4/default/36469f0/2147483647/strip/true/crop/1000x563+0+0/resize/768x432!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fc2%2Fa3%2F564fd457451ea211cc5a9e15b6a7%2Fdenatured-20250918.png 768w,https://static.biospace.com/dims4/default/850a18c/2147483647/strip/true/crop/1000x563+0+0/resize/1000x563!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fc2%2Fa3%2F564fd457451ea211cc5a9e15b6a7%2Fdenatured-20250918.png 1000w" sizes="(max-width: 568px) 100px, 300px"/>

    

    
        <source width="1000" height="563" srcset="https://static.biospace.com/dims4/default/bb5229b/2147483647/strip/true/crop/1000x563+0+0/resize/568x320!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fc2%2Fa3%2F564fd457451ea211cc5a9e15b6a7%2Fdenatured-20250918.png 568w,https://static.biospace.com/dims4/default/beff9c0/2147483647/strip/true/crop/1000x563+0+0/resize/768x432!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fc2%2Fa3%2F564fd457451ea211cc5a9e15b6a7%2Fdenatured-20250918.png 768w,https://static.biospace.com/dims4/default/a67fdb9/2147483647/strip/true/crop/1000x563+0+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fc2%2Fa3%2F564fd457451ea211cc5a9e15b6a7%2Fdenatured-20250918.png 1000w" sizes="(max-width: 568px) 100px, 300px"/>

    


    
    
    <img class="Image" srcset="https://static.biospace.com/dims4/default/bb5229b/2147483647/strip/true/crop/1000x563+0+0/resize/568x320!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fc2%2Fa3%2F564fd457451ea211cc5a9e15b6a7%2Fdenatured-20250918.png 568w,https://static.biospace.com/dims4/default/beff9c0/2147483647/strip/true/crop/1000x563+0+0/resize/768x432!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fc2%2Fa3%2F564fd457451ea211cc5a9e15b6a7%2Fdenatured-20250918.png 768w,https://static.biospace.com/dims4/default/a67fdb9/2147483647/strip/true/crop/1000x563+0+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fc2%2Fa3%2F564fd457451ea211cc5a9e15b6a7%2Fdenatured-20250918.png 1000w" sizes="(max-width: 568px) 100px, 300px" width="1000" height="563" src="https://static.biospace.com/dims4/default/a67fdb9/2147483647/strip/true/crop/1000x563+0+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fc2%2Fa3%2F564fd457451ea211cc5a9e15b6a7%2Fdenatured-20250918.png" loading="lazy"
    >


</picture>

</a></div>


    

    <div class="PagePromo-content" data-animate="fromBottom">
        
    
        <div class="PagePromo-category">
            <a class="Link" href="https://www.biospace.com/policy">PODCAST</a>
        </div>
    



        
    <div class="PagePromo-title">
        <a class="Link" href="https://www.biospace.com/policy/what-do-ai-and-hammers-have-in-common">What Do AI and Hammers Have in Common?</a>
    </div>



        


        
    
        <div class="PagePromo-byline"><div class="PagePromo-date">September 18, 2025</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-readTime">1 min read</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/lori-ellis">Lori Ellis</a></div></div>
    



        

    </div>
</div>
                                        
                                    
                                
                            
                        
                    
                </div>
            
                <div class="PageList-items-item">
                    
                        
                            
                                
                                    
                                        
                                            <div class="PagePromo" data-image-align-vertical="top" data-mobile-alt-layout="true">
    
        
    <div class="PagePromo-media" data-animate="fromBottom"><a class="Link" aria-label="Republicans Ratchet Up Pressure as Monarez Levels Damning Allegations Against Kennedy" href="https://www.biospace.com/policy/republicans-ratchet-up-pressure-as-monarez-levels-damning-allegations-against-kennedy" ><picture>
    
    
        
            

        
    

    
    
        
    
        <source type="image/webp"  width="1000" height="563" srcset="https://static.biospace.com/dims4/default/e8a8c3f/2147483647/strip/true/crop/1337x753+0+97/resize/568x320!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F04%2Feb%2Fd97041f9401c863ca870be4b7bdf%2Fmonarez.png 568w,https://static.biospace.com/dims4/default/5eaec31/2147483647/strip/true/crop/1337x753+0+97/resize/768x432!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F04%2Feb%2Fd97041f9401c863ca870be4b7bdf%2Fmonarez.png 768w,https://static.biospace.com/dims4/default/2d8505a/2147483647/strip/true/crop/1337x753+0+97/resize/1000x563!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F04%2Feb%2Fd97041f9401c863ca870be4b7bdf%2Fmonarez.png 1000w" sizes="(max-width: 568px) 100px, 300px"/>

    

    
        <source width="1000" height="563" srcset="https://static.biospace.com/dims4/default/82db9a4/2147483647/strip/true/crop/1337x753+0+97/resize/568x320!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F04%2Feb%2Fd97041f9401c863ca870be4b7bdf%2Fmonarez.png 568w,https://static.biospace.com/dims4/default/e6502dc/2147483647/strip/true/crop/1337x753+0+97/resize/768x432!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F04%2Feb%2Fd97041f9401c863ca870be4b7bdf%2Fmonarez.png 768w,https://static.biospace.com/dims4/default/22ac7e3/2147483647/strip/true/crop/1337x753+0+97/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F04%2Feb%2Fd97041f9401c863ca870be4b7bdf%2Fmonarez.png 1000w" sizes="(max-width: 568px) 100px, 300px"/>

    


    
    
    <img class="Image" srcset="https://static.biospace.com/dims4/default/82db9a4/2147483647/strip/true/crop/1337x753+0+97/resize/568x320!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F04%2Feb%2Fd97041f9401c863ca870be4b7bdf%2Fmonarez.png 568w,https://static.biospace.com/dims4/default/e6502dc/2147483647/strip/true/crop/1337x753+0+97/resize/768x432!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F04%2Feb%2Fd97041f9401c863ca870be4b7bdf%2Fmonarez.png 768w,https://static.biospace.com/dims4/default/22ac7e3/2147483647/strip/true/crop/1337x753+0+97/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F04%2Feb%2Fd97041f9401c863ca870be4b7bdf%2Fmonarez.png 1000w" sizes="(max-width: 568px) 100px, 300px" width="1000" height="563" src="https://static.biospace.com/dims4/default/22ac7e3/2147483647/strip/true/crop/1337x753+0+97/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F04%2Feb%2Fd97041f9401c863ca870be4b7bdf%2Fmonarez.png" loading="lazy"
    >


</picture>

</a></div>


    

    <div class="PagePromo-content" data-animate="fromBottom">
        
    
        <div class="PagePromo-category">
            <a class="Link" href="https://www.biospace.com/cdc">CDC</a>
        </div>
    



        
    <div class="PagePromo-title">
        <a class="Link" href="https://www.biospace.com/policy/republicans-ratchet-up-pressure-as-monarez-levels-damning-allegations-against-kennedy">Republicans Ratchet Up Pressure as Monarez Levels Damning Allegations Against Kennedy</a>
    </div>



        


        
    
        <div class="PagePromo-byline"><div class="PagePromo-date">September 17, 2025</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-readTime">4 min read</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/heather-mckenzie">Heather McKenzie</a></div></div>
    



        

    </div>
</div>
                                        
                                    
                                
                            
                        
                    
                </div>
            
                <div class="PageList-items-item">
                    
                        
                            
                                
                                    
                                        
                                            <div class="PagePromo" data-image-align-vertical="top" data-mobile-alt-layout="true">
    
        
    <div class="PagePromo-media" data-animate="fromBottom"><a class="Link" aria-label="Webinar: Bridging Formulation &amp; Device | Integrated Supply Chain Strategies for US Pharma Manufacturing" href="https://www.biospace.com/events/webinar-bridging-formulation-device-integrated-supply-chain-strategies-for-us-pharma-manufacturing" ><picture>
    
    
        
            

        
    

    
    
        
    
        <source type="image/webp"  width="1000" height="563" srcset="https://static.biospace.com/dims4/default/f4cf7a0/2147483647/strip/true/crop/1000x563+0+0/resize/568x320!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F78%2Fc7%2F2c3b4ab642a4abfd4ae3ec559730%2Fpii-webinar-post-event-brightspot-content-image-1000-x-563.jpg 568w,https://static.biospace.com/dims4/default/be823fa/2147483647/strip/true/crop/1000x563+0+0/resize/768x432!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F78%2Fc7%2F2c3b4ab642a4abfd4ae3ec559730%2Fpii-webinar-post-event-brightspot-content-image-1000-x-563.jpg 768w,https://static.biospace.com/dims4/default/cd1e697/2147483647/strip/true/crop/1000x563+0+0/resize/1000x563!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F78%2Fc7%2F2c3b4ab642a4abfd4ae3ec559730%2Fpii-webinar-post-event-brightspot-content-image-1000-x-563.jpg 1000w" sizes="(max-width: 568px) 100px, 300px"/>

    

    
        <source width="1000" height="563" srcset="https://static.biospace.com/dims4/default/ad3b62b/2147483647/strip/true/crop/1000x563+0+0/resize/568x320!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F78%2Fc7%2F2c3b4ab642a4abfd4ae3ec559730%2Fpii-webinar-post-event-brightspot-content-image-1000-x-563.jpg 568w,https://static.biospace.com/dims4/default/db4d21f/2147483647/strip/true/crop/1000x563+0+0/resize/768x432!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F78%2Fc7%2F2c3b4ab642a4abfd4ae3ec559730%2Fpii-webinar-post-event-brightspot-content-image-1000-x-563.jpg 768w,https://static.biospace.com/dims4/default/5bcc8f6/2147483647/strip/true/crop/1000x563+0+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F78%2Fc7%2F2c3b4ab642a4abfd4ae3ec559730%2Fpii-webinar-post-event-brightspot-content-image-1000-x-563.jpg 1000w" sizes="(max-width: 568px) 100px, 300px"/>

    


    
    
    <img class="Image" srcset="https://static.biospace.com/dims4/default/ad3b62b/2147483647/strip/true/crop/1000x563+0+0/resize/568x320!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F78%2Fc7%2F2c3b4ab642a4abfd4ae3ec559730%2Fpii-webinar-post-event-brightspot-content-image-1000-x-563.jpg 568w,https://static.biospace.com/dims4/default/db4d21f/2147483647/strip/true/crop/1000x563+0+0/resize/768x432!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F78%2Fc7%2F2c3b4ab642a4abfd4ae3ec559730%2Fpii-webinar-post-event-brightspot-content-image-1000-x-563.jpg 768w,https://static.biospace.com/dims4/default/5bcc8f6/2147483647/strip/true/crop/1000x563+0+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F78%2Fc7%2F2c3b4ab642a4abfd4ae3ec559730%2Fpii-webinar-post-event-brightspot-content-image-1000-x-563.jpg 1000w" sizes="(max-width: 568px) 100px, 300px" width="1000" height="563" src="https://static.biospace.com/dims4/default/5bcc8f6/2147483647/strip/true/crop/1000x563+0+0/resize/1000x563!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F78%2Fc7%2F2c3b4ab642a4abfd4ae3ec559730%2Fpii-webinar-post-event-brightspot-content-image-1000-x-563.jpg" loading="lazy"
    >


</picture>

</a></div>


    

    <div class="PagePromo-content" data-animate="fromBottom">
        
    
        <div class="PagePromo-category">
            <a class="Link" href="https://www.biospace.com/events">IN PARTNERSHIP WITH Pii, A JABIL COMPANY</a>
        </div>
    



        
    <div class="PagePromo-title">
        <a class="Link" href="https://www.biospace.com/events/webinar-bridging-formulation-device-integrated-supply-chain-strategies-for-us-pharma-manufacturing">Webinar: Bridging Formulation &amp; Device | Integrated Supply Chain Strategies for US Pharma Manufacturing</a>
    </div>



        


        
    
        <div class="PagePromo-byline"><div class="PagePromo-date">September 17, 2025</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-readTime">1 min read</div><span class="dot">&nbsp;&#183;&nbsp;</span><div class="PagePromo-author"><a class="Link" href="https://www.biospace.com/biospace-insights">BioSpace Insights</a></div></div>
    



        

    </div>
</div>
                                        
                                    
                                
                            
                        
                    
                </div>
            
        </div>
    
    
<div class="PageList-footer">
    
</div>


</bsp-list-loadmore>
</div>


        <footer class="Page-footer">
    <div class="Page-footer-container">
        
            <div class="Page-footer-columns">
                <div class="Page-footer-column">
                    
                        
                            <div class="Page-footer-logo"><a aria-label="home page" href="/"  >
    
        <picture>
            
            
                
                    

                
            

            
            
                
    
        <source type="image/webp"  width="250" height="75" srcset="https://static.biospace.com/dims4/default/9cd548e/2147483647/strip/true/crop/1000x300+0+0/resize/250x75!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F41%2Fec%2F9e81690b459eaa7f24638948a32f%2Fbsp-logo-vector-in-white.png 1x,https://static.biospace.com/dims4/default/5dae7e5/2147483647/strip/true/crop/1000x300+0+0/resize/500x150!/format/webp/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F41%2Fec%2F9e81690b459eaa7f24638948a32f%2Fbsp-logo-vector-in-white.png 2x"/>

    

    
        <source width="250" height="75" srcset="https://static.biospace.com/dims4/default/3af6dae/2147483647/strip/true/crop/1000x300+0+0/resize/250x75!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F41%2Fec%2F9e81690b459eaa7f24638948a32f%2Fbsp-logo-vector-in-white.png 1x,https://static.biospace.com/dims4/default/776a218/2147483647/strip/true/crop/1000x300+0+0/resize/500x150!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F41%2Fec%2F9e81690b459eaa7f24638948a32f%2Fbsp-logo-vector-in-white.png 2x"/>

    


            
            
    <img class="Image" srcset="https://static.biospace.com/dims4/default/3af6dae/2147483647/strip/true/crop/1000x300+0+0/resize/250x75!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F41%2Fec%2F9e81690b459eaa7f24638948a32f%2Fbsp-logo-vector-in-white.png 1x,https://static.biospace.com/dims4/default/776a218/2147483647/strip/true/crop/1000x300+0+0/resize/500x150!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F41%2Fec%2F9e81690b459eaa7f24638948a32f%2Fbsp-logo-vector-in-white.png 2x" width="250" height="75" src="https://static.biospace.com/dims4/default/3af6dae/2147483647/strip/true/crop/1000x300+0+0/resize/250x75!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F41%2Fec%2F9e81690b459eaa7f24638948a32f%2Fbsp-logo-vector-in-white.png"
    >


        </picture>
    
    </a>
</div>
                        
                    
                    
                    
                        
                                
                                    <div class="PagePromoFooter" data-no-media>
    <div class="PagePromoFooter-content">
        
        
    <div class="PagePromo-description">
        <i>BioSpace </i>is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
    </div>



        
    </div>
</div>
                                
                            
                    
                </div>

                <div class="Page-footer-column">
                    
                        <div class="Page-footer-navigation" >
                            <nav class="FooterNavigation">
    
        <ul class="FooterNavigation-items" data-column-count="4">
            
                <li class="FooterNavigation-items-item">
                    <div class="FooterNavigationItem">
    <div class="FooterNavigationItem-text">
        
            <span>Explore</span>
        
    </div>

    
        <ul class="FooterNavigationItem-items">
            
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/news"><span class="NavigationLink-text">News</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://jobs.biospace.com/searchjobs/"><span class="NavigationLink-text">Jobs</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/subscribe-to-newsletters"><span class="NavigationLink-text">Newsletters</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/podcasts"><span class="NavigationLink-text">Podcasts</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/webinars"><span class="NavigationLink-text">Webinars</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/hotbeds"><span class="NavigationLink-text">Hotbeds</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/companies"><span class="NavigationLink-text">Companies</span></a>
</li>
                
            
        </ul>
    
</div>

                </li>
            
                <li class="FooterNavigation-items-item">
                    <div class="FooterNavigationItem">
    <div class="FooterNavigationItem-text">
        
            <span>More</span>
        
    </div>

    
        <ul class="FooterNavigationItem-items">
            
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/events"><span class="NavigationLink-text">Events</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/reports"><span class="NavigationLink-text">Reports</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/career-advice"><span class="NavigationLink-text">Career Advice</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/nextgen"><span class="NavigationLink-text">NextGen</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/best-places-to-work"><span class="NavigationLink-text">Best Places to Work</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/employer-resources"><span class="NavigationLink-text">Employer Resources</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/archive"><span class="NavigationLink-text">Archive</span></a>
</li>
                
            
        </ul>
    
</div>

                </li>
            
                <li class="FooterNavigation-items-item">
                    <div class="FooterNavigationItem">
    <div class="FooterNavigationItem-text">
        
            <span>About</span>
        
    </div>

    
        <ul class="FooterNavigationItem-items">
            
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/about-us"><span class="NavigationLink-text">About BioSpace</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/editorial"><span class="NavigationLink-text">Editorial</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/join-our-team"><span class="NavigationLink-text">Join Our Team</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/contact-us"><span class="NavigationLink-text">Support</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/terms-and-conditions"><span class="NavigationLink-text">Terms &amp; Conditions</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/privacy-policy"><span class="NavigationLink-text">Privacy Policy</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/rss-feeds"><span class="NavigationLink-text">RSS Feeds</span></a>
</li>
                
            
        </ul>
    
</div>

                </li>
            
                <li class="FooterNavigation-items-item">
                    <div class="FooterNavigationItem">
    <div class="FooterNavigationItem-text">
        
            <span>Advertise</span>
        
    </div>

    
        <ul class="FooterNavigationItem-items">
            
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://employer.biospace.com/login"><span class="NavigationLink-text">Employer Login</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://employer.biospace.com/pricing/"><span class="NavigationLink-text">Post Jobs</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/talent-solutions"><span class="NavigationLink-text">Talent Solutions</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/advertise"><span class="NavigationLink-text">Advertise</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://www.biospace.com/press-release-solutions"><span class="NavigationLink-text">Submit a Press Release</span></a>
</li>
                
                    <li class="FooterNavigationItem-items-item"><a class="NavigationLink" href="https://events.biospace.com/"><span class="NavigationLink-text">Submit an Event</span></a>
</li>
                
            
        </ul>
    
</div>

                </li>
            
        </ul>
    
</nav>

                        </div>
                    
                </div>
            </div>
            
                <div class="Page-footer-bottom">
                    
                        <div class="Page-footer-disclaimer"><p>© 1985 - 2025 BioSpace.com. All rights reserved. </p></div>
                    

                    
                        <div class="SocialBar">
    
        <ul class="SocialBar-items">
            
                <li class="SocialBar-items-item"> <a class="SocialLink" rel="noreferrer" href="https://twitter.com/biospace" target="_blank" data-social-service="twitter">
     <svg>
         <use xlink:href="#mono-icon-twitter"></use>
     </svg>
     <span class="sr-only">
         twitter
     </span>
 </a>
</li>
            
                <li class="SocialBar-items-item"> <a class="SocialLink" rel="noreferrer" href="https://www.instagram.com/biospacenews/" target="_blank" data-social-service="instagram">
     <svg>
         <use xlink:href="#mono-icon-instagram"></use>
     </svg>
     <span class="sr-only">
         instagram
     </span>
 </a>
</li>
            
                <li class="SocialBar-items-item"> <a class="SocialLink" rel="noreferrer" href="https://www.facebook.com/biospacecommunity" target="_blank" data-social-service="facebook">
     <svg>
         <use xlink:href="#mono-icon-facebook"></use>
     </svg>
     <span class="sr-only">
         facebook
     </span>
 </a>
</li>
            
                <li class="SocialBar-items-item"> <a class="SocialLink" rel="noreferrer" href="https://www.linkedin.com/company/biospaceinc" target="_blank" data-social-service="linkedin">
     <svg>
         <use xlink:href="#mono-icon-linkedin"></use>
     </svg>
     <span class="sr-only">
         linkedin
     </span>
 </a>
</li>
            
        </ul>
    
</div>

                    
                </div>
            
        
    </div>
</footer>

        
    </body>
</html>


